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Summary 
Despite continued advancements in medical care and improved survival or life expectancy, childhood 
deaths due to complex chronic conditions (CCC) or prematurity are inevitable. Deaths during the first 
year of life constitute approximately 50% of disease-related deaths, the causes of which include 
perinatal complications, prematurity, or congenital anomalies. Beyond the age of one year, the three 
most common life-limiting CCCs are neurological/neuromuscular and cardiovascular conditions 
(including genetic disorders), and malignancies. The majority of disease- and prematurity-related 
deaths occur in hospitals and for children dying at home, hospital use in their terminal stage is high. 
Symptom burden and reliance on medical technology has been reported to be considerable. 
Circumstances and characteristics of deaths, however, are known to vary by age and medical 
conditions. 
When facing the death of their child, parents experience an unimaginably painful life event 
and severe crisis that affects the whole family for life. In this highly stressful time parents are 
confronted with uncertainty and are required to make difficult decisions, e.g. withdrawal of life-
sustaining interventions. Their need for compassionate professional support is high. Paediatric 
palliative (PPC) and end-of-life (EOL) care emerged as a medical subspecialty aimed at meeting the 
specific needs of seriously ill children and their families. Meeting these needs requires a 
comprehensive and integrative approach from a compassionate and skilled multidisciplinary team. 
Parental needs have been studied in the past and an overview of themes/domains most important to 
parents can be summarised as: sincere relationships and emotional, spiritual and cultural support; 
genuine communication; alleviation of suffering; continuity, coordination and accessibility of care; 
and bereavement support. Deficiencies in meeting parental needs were identified across all themes, 
e.g. insufficient communication, lack of respect, and lack of emotional support.  
Most of the evidence related to the parental perspective of their child’s EOL care originates 
from qualitative research. To assess and explore the parental perspective effectively, an approach 
combining quantitative and qualitative information is likely to provide the most comprehensive view 
of experiences and unmet needs. A few self-administered questionnaires designed to assess the 
experiences and needs of parents of a dying child exist. None of the instruments available were 
applicable to the heterogeneous field of paediatric EOL care, including children of different age 
groups, with different underlying illnesses and in different clinical settings. 
The development of PPC in Switzerland lags behind when compared with other developed 
countries, such as the United Kingdom or the USA. Need for action has been recognised by the Federal 
Office of Public Health and the call for a thorough assessment of current practices, needs, available 
resources and existing services as requirement to formulate and plan further measures to promote 
PPC in Switzerland has been issued.  
This dissertation is embedded in the PELICAN study (Paediatric End-of-LIfe CAre Needs in 
Switzerland, 2012 – 2015). The overarching aims of the nationwide PELICAN study were to provide 
comprehensive information and to understand the current practice of EOL care (i.e. in this study, the 
last 4 weeks of life prior to death) in paediatric settings in Switzerland (hospital and community care) 
and to explore and describe parental perspectives and the perspectives of the healthcare professionals 
involved. Based on the results, recommendations for best-practice during this highly vulnerable and 
critical phase of life not only for the affected child but also for the family will be formulated. 
The dissertation is organized in 9 chapters: 
Chapter 1 introduces in the field of paediatric EOL care and reviews relevant topics. The 
epidemiology of childhood illness- and prematurity-related death is described together with 
characteristics and circumstances of death. PPC and EOL are being defined and the he provision of 
paediatric palliative and EOL care are introduced. Existing evidence about the parental perspective of 
their child’s EOL care is summarised, and a potential framework for the quantitative assessment of 
parental experiences and needs is described. The emerging research gaps, and the rational and aims of 
this dissertation are described in chapter 2 together with the context in which the PELICAN study 
took place.  
Chapter 3 comprises the PELICAN study protocol. It provides an introduction, rational and 
specific aims of the entire research project including three main studies and two subs-studies 
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combining quantitative and qualitative methodology. Methods for each study arm are detailed. This 
dissertation comprises PELICAN I and the quantitative part of PELICAN II, including the 
development and testing of the Parental PELICAN Questionnaire (PaPEQu). 
Chapter 4 reports on patterns of care at EOL in neonates and children with complex chronic 
conditions. Data from 149 paediatric patients who died in the years 2011 or 2012 due to a cardiac, 
neurological or oncological condition, or during the neonatal period were collected in 13 hospitals, two 
long-term institutions and 10 community-based healthcare service providers throughout Switzerland. 
Sixty-two percent of the patients died in intensive care units, 84% of them following the withdrawal of 
life-sustaining treatment. Reliance on invasive medical interventions was prevalent, and the use of 
medication was high, with a median count of 12 different drugs during the last week of life. Patients 
experienced an average number of 6.42 symptoms. The prevalence of various types of symptoms 
differed significantly among the four diagnostic groups. Only half of the patients who spent days at 
home received community-based healthcare. The study provides a comprehensive overview of current 
EOL care practices in a real-life setting of different healthcare providers and the findings provide a 
knowledge base for paediatric palliative care teams. 
Chapter 5 describes the development and initial validation of the Parental PELICAN 
Questionnaire (PaPEQu) – an instrument to assess parental experiences and needs during their child’s 
EOL care. The PaPEQu  was developed in four phases between August 2012–March 2014: phase 1: 
item generation; phase 2: validity testing; phase 3: translation; phase 4: pilot testing. Psychometric 
properties were assessed after applying the PaPEQu in a sample of 224 bereaved parents in April 2014. 
Validity testing covered the evidence based on tests of content, internal structure and relations to other 
variables. The PaPEQu consists of approximately 90 items in four slightly different versions 
accounting for particularities of the four diagnostic groups. The questionnaire’s items were structured 
according to six quality domains described in the literature. Evidence of initial validity and reliability 
could be demonstrated with the involvement of healthcare professionals and bereaved parents. The 
PaPEQu holds promise as a measure to assess parental experiences and needs and is applicable to a 
broad range of paediatric specialties and settings. 
Chapter 6 reports on the results of the survey with the newly developed PaPEQu. Responses 
regarding parental experiences and perceived satisfaction are described. Differences between the four 
diagnostic groups are analysed using a generalized estimation equation to account for the dyadic data 
structure. Of 307 eligible families, 267 could be contacted and 135 (51 %) consented to participate in 
this questionnaire survey. Our findings show positive parental experiences of their child’s EOL care 
and high perceived satisfaction with the care their child received. Parents of a child with cancer rated 
their experiences highest in most of the six quality domains and reported the highest satisfaction with 
care. The lowest scores were mainly reported by parents from the neurology group, with the exception 
of the shared decision making domain, where parents of neonates reported significantly less positive 
experiences. Although positive in general, our study results suggest some areas for improvement. The 
integration of specialised paediatric palliative care has the potential to minimise lost opportunities to 
support and assist parents. 
In chapter 7 finally, the results of all studies are being synthesized and discussed within the 
state of science. Strengths and weaknesses of methods are examined and implications on the level of 
policy, practice and research are derived. This dissertation concludes with the recognition that 
urgently needed data to advance the development of PPC in Switzerland is now available. It also 
recognises however, that we are challenged to demonstrate the effectiveness of PPC services in order to 
grow out of the infancy of this medical subspecialty. 
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Chapter 1  
Introduction and Background 
1.1. Setting the stage 
Children living with life-limiting complex chronic conditions (CCC) and prematurely born babies are 
part of our health care system. And despite dramatic improvements in medical care over the last 
decades, death is not preventable for some children1. Death is part of life, but when it comes during 
childhood it is definitely out of season. Each child lost is a loss of human potential and living through 
the experience of losing a child might be considered as one of the most harrowing event in one’s life. 
Dying and losing a child is accompanied by physical and emotional suffering and leaves a family 
wounded for life. All possible efforts have to be made to alleviate suffering of each dying child and to 
relieve the negative effects on families affected. Especially when death comes with some forewarning - 
as is mostly the case in children living with a life-limiting CCC and to some degree also in premature 
babies – nurses, physicians, social workers, psychologists and other healthcare professionals play an 
important role in the life of the dying child and his or her family [1]. At the same time, caring for a 
dying child and supporting his/her family is one of the most challenging situations for a health care 
team (HCT) [2]. High levels of expertise and knowledge of disease specific aspects of paediatric end-of-
life (EOL) care are required. Equally important, professionals involved in paediatric EOL care need to 
be aware of the child’s and his/her family’s needs and should understand the perspectives of parents 
facing the death of their child in order to being able to provide best possible care. Current paediatric 
EOL care practices in Switzerland and the perspectives of bereaved parents are the main topics that 
will be addressed in this dissertation and the results of two observational studies including the 
development and testing of an instrument to quantitatively assess parental experiences and needs 
during their child’s EOL care will be presented and discussed. 
1.1.1. Paediatric Palliative Care (PPC) 
The need and vision to provide compassionate professional care has led to the emergence of the 
medical subspecialty of palliative care (PC), which found its origin in the hospice movement for adults 
in the UK of the sixties [3]. Palliative is derived from the Latin term palliare, “to cloak” [4]. Terms like 
PC, comfort care, supportive care, EOL care, and terminal care are often used interchangeably and 
creating difficulties in differentiating the concepts of palliative care with other care models, such as the 
chronic care model or concepts, such as comfort care and supportive care in the oncology setting [5]. It 
has therefore been argued that in a definition for PC, a relation to death and dying should be 
recognisable [5]. The World Health Organization’s (WHO) definition for PC could therefore be 
criticised in that regard as this relation is not implicit. Nevertheless, the WHO’s definition is the one 
most commonly applied and, importantly, a separate definition for paediatric palliative care (PPC) is 
provided. 
According to the World Health Organization (WHO) “palliative care is an approach that improves the 
quality of life of patients and their families facing the problem associated with life-threatening illness, 
through the prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and spiritual” [6]. The 
definition of PC for children specifies as follows: 
• “Palliative care for children is the active total care of the child's body, mind and spirit, and also 
involves giving support to the family. 
• It begins when illness is diagnosed, and continues regardless of whether or not a child receives 
treatment directed at the disease. 
• Health providers must evaluate and alleviate a child's physical, psychological, and social 
distress. 
• Effective palliative care requires a broad multidisciplinary approach that includes the family 
and makes use of available community resources; it can be successfully implemented even if 
resources are limited. 
                                                             
1 The term child is used as an umbrella term for newborns, infants, children and adolescents. 
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• It can be provided in tertiary care facilities, in community health centers and even in children's 
homes.” [6]. 
1.1.2. Paediatric end-of-life care  
More specifically and as part of PC, the term EOL care refers to care when death is imminent [4]. The 
timeframe of EOL care is not well defined and, depending on the source, is described as a period of one 
to two years, or some weeks or days [7, 8]. A definition for paediatric EOL care is provided by together 
for Short lives, the leading UK charity with the mission to “secure the best quality of life and best end 
of life care for children who will have short lives” [9]: 
“End-of-life care is care that helps all those with advanced, progressive, incurable illness to live as well 
as possible until they die. It focuses on preparing for an anticipated death and managing the end stage 
of a terminal medical condition. This includes care during and around the time of death, and 
immediately afterwards. It enables the supportive and palliative care needs of both child/young person 
and the family to be identified and met throughout the last phase of life and into bereavement. It 
includes management of pain and other symptoms and provision of psychological, social, spiritual and 
practical support and support for the family into bereavement.” [10]. 
1.2. Epidemiology 
Fortunately, illness- and prematurity-related childhood deaths are rare events. In Switzerland, a total 
of 424 children (0 – 14 years) died in 2013. About 15% of those deaths are related to accidents, sudden 
infant death syndrome or unknown causes, leaving 361 deaths due to illness or prematurity, including 
incidents during or shortly after birth [11]. Deaths due to perinatal conditions, including prematurity, 
constitutes about 50% of all deaths during the first year of life [12]. Approximately three quarters of 
these infants die within 24 hours after birth [11]. Beyond the first year of life, life-limiting CCCs such as 
neurologic illnesses, including chromosomal anomalies and metabolic/endocrine conditions, together 
with neoplasms and cardiac/circulatory conditions, including congenital malformations, are mostly 
responsible for illness-related childhood deaths [11, 12]. Diagnostic study results from the United 
States (US)/Canada and the United Kingdom showed that the predominant conditions of children who 
received PPC services in 2008 or died in 2009/2010, respectively, were congenital/chromosomal 
(41%, 32%), neuromuscular (39%)/encephalopathy (22%), and cancer (20%, 18%) [13, 14]. A recent 
study from the United Kingdom estimating the burden of life-limiting CCCs in children (0 – 19 years) 
also found that their prevalence increased over 10 years from 25 to 32 per 10 000 population.  
1.3. Characteristics and circumstances of childhood death 
1.3.1. Place of death 
Stemming mostly from studies undertaken in adults, there is a commonly accepted view that home is 
the preferred place of death for most patients [15]. Place of death in children with life-limiting CCCs 
has been studied in the past and one conclusion from a nationwide US study was that children 
increasingly die at home, but that, overall, 82% still died in the hospital [16]. Depending on age, the 
percentage of deaths at home increased over a 15-year period between 1989 and 2003 for infants 
(4.9% vs. 7.3), for 1– to 9-year-olds (17.9% vs. 30.7%), and for 10- to 19-year-olds (18.4% vs- 32.2%). 
This shift was mostly attributed to advances in medical home-based technology and attitudes towards 
PPC. The percentages of home deaths also varied among different types of CCCs. Children with 
malignancies were most likely to die at home and infants least likely [16]. For Europe, data from a 
population-based study conducted in Belgium, the Netherlands, Italy, Norway, England and Wales 
showed home death rates of between 20% and 29% in 1037 children deceased due to a life-limiting 
CCC and aged 1 to 17 years. Again, home death was more common in children with cancer and, 
independently, also more likely in children aged 10 years and above [17]. 
While it has been recognized that children often want to be at home and families want to keep 
them at home [17, 18], in reality, most children die in hospital and many in intensive care units (ICU) 
[19, 20]. ICUs in paediatrics are differentiated into neonatal ICUs (NICU) and paediatric ICUs (PICU). 
NICUs are specialised units caring for premature and ill newborns requiring intensive medical 
treatment. Critically ill newborns needing surgical interventions are usually transferred to a PICU as 
well as all other children requiring intensive medical treatment. A single-centre Canadian study that 
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reviewed all deaths occurring between 2008 and 2010 found that 66% of the 220 included children 
died in an ICU. Of those, 53% died in an NICU and 47% in a PICU [20]. 
1.3.2. Circumstances of death 
With respect to the high percentages of children dying in an ICU, it is not surprising that paediatric 
end-of-life care includes high intensity medical care and difficult decision-making. In fact, paediatric 
deaths in an ICU are mostly preceded by a decision to withdraw life-sustaining interventions [20]. A 
cross-cultural study from the US, Canada and the Netherlands confirmed in 2010 that withdrawal of 
artificial ventilation was the primary mode of death in neonates internationally. They found that this 
was the case in 69% to 93% of all NICU deaths [21]. Even higher percentages of more than 90% of 
primary non-intervention and redirection of care were reported in a Swiss single-centre study over a 
10-year period between 1997 and 2006 [22]. 
Do not resuscitate (DNR) orders were reported to be in place for many children at time of 
death [23, 24]. Frequently, this decision was taken only shortly before the actual time of death [19, 23]. 
This circumstance is in accordance with the high percentages of treatment withdrawal and, as a result, 
only a few deaths are preceded by cardiopulmonary resuscitation (CPR). In the aforementioned 
Canadian study this was the case in 6% of the patients [20]; however, those numbers might be highly 
influenced by the type of the child’s underlying life-limiting CCC. A US single-centre study conducted 
in children that died between 2007 and 2009 with a primary cardiac diagnosis reported that 56% of 
the 111 patients included underwent CPR at some point during their final hospitalisation before death 
[25]. 
1.3.3. Interventions at EOL and medications 
As a consequence of the high intensity pattern of paediatric EOL care, children are exposed to invasive 
interventions and polypharmacy, i.e. use of several medications [13]. The most common interventions 
described in a US cohort of 515 children receiving PPC services at six different study sites were feeding 
tubes (60%), central venous catheter (22%), and tracheostomy (10%) [13]. Interventions described in 
the present literature vary to some degree by variables assessed, but mainly by the underlying life-
limiting CCC of the child receiving EOL care. In a US/Canadian multi-site study of 275 children with 
progressive, non-curable genetic, metabolic, or neurologic conditions, feeding tubes were also a 
prevalent intervention (54%) followed by routine suctioning (18%), and oxygen administration (11%) 
[24]. In the aforementioned study with 111 children with a primary cardiac diagnosis 92% were 
mechanically ventilated and mostly sedated, 46% received mechanical circulatory support, i.e. 
extracorporeal membrane oxygenation (ECMO), and 23% had a peritoneal drain. The median number 
of surgical procedures was one per patient, with a range from zero to six [25]. A similar pattern was 
described in another US study conducted in two paediatric cardiology centres including 50 children 
who died in the hospital between 2007 and 2009. They reported that 86% of the patients were 
intubated, 46% needed ECMO support, 24% had gastrostomy tubes, and 22% had peritoneal drains 
[26]. 
Extensive medication profiles have been described in children receiving palliative and EOL 
care. Reported numbers from newer studies varied between a median of 9 different medications 
(range = 0 – 18) in Feudtner et al. [13], to a mean of 3.5 different drug categories (range = 0 – 12) in 
Steele et al. [24]. Certain drugs or groups of drugs were predominantly used, such as paracetamol, 
albuterol (Ventolin), antacids and anxiolytics [13, 24]. In specific populations, such as cardiological or 
neurological patients, inotropic agents [25, 26] or anticonvulsants were also frequently used [24]. 
1.3.4. Symptoms and suffering 
At the centre of the highly intensive medical EOL care presented so far, there is a dying child with 
his/her symptoms and suffering. Suffering has been described as a state of distress that is present 
when the integrity of a person is disrupted. When the integrity of a child is threatened or disrupted, 
suffering is extended to the entire family [27]. 
Very few studies have looked at symptoms from the perspective of the children themselves. 
One notable prospective study explored determinants of symptom distress in children with advanced 
cancer via child self-report [28]. Common symptoms like pain, fatigue, drowsiness and irritability 
resulted in high levels of distress. Symptom prevalence and distress was reported as worsening during 
the last 12 weeks of life and pain stood out as being the most common and distressing symptom. [28].  
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When children cannot be asked themselves due to too young age or impaired physical 
condition, parents often serve as a proxy in reporting their child’s symptoms and suffering. Again in 
children with cancer, pain was reported by the majority of parents in two US studies and one study 
from Germany as prevalent and associated with a great deal of suffering [29-31]. Other frequently 
reported symptoms by parents of children with cancer were fatigue, loss of appetite, dyspnoea [30], 
anxiety, constipation and nausea [31]. Besides pain, suffering was highest for dyspnoea and anxiety as 
reported by parents. In children with advanced heart disease at EOL and younger than two years of 
age, parents reported difficulty breathing and feeding, pain, irritability, and sleep disturbances as 
common and associated with a lot or great deal of suffering. For children older than two years of age, 
fatigue was most commonly reported [26]. 
Other studies describing symptoms in children with a life-limiting CCC at EOL used chart 
review as a method for collecting information. Although the quality of documentation of symptoms 
other than pain was reported as being variable [32], some symptoms consistently presented among 
different studies. The most common ones included: pain, breathing problems, irritability/agitation, 
lack of energy, drowsiness and seizures [23, 32]. For neonates, it has been reported that almost all 
newborns treated in an NICU received medication for pain and sedation [33]. However, actual 
descriptions of symptoms, i.e. signs, are missing from the literature. Lack of symptom documentation 
hindered the achievement of a US single-centre study’s objective to examine symptoms exhibited by 
neonates at EOL [33]. In another recent international study categorizing neonatal deaths, symptoms 
and suffering were not addressed [21]. 
Where and how children die due to a life-limiting CCC or prematurity has been, to some 
extent, described predominantly in the USA but also internationally. For some aspects of paediatric 
EOL care however, descriptions were limited to certain diagnostic groups or care settings and no 
information at all exist for Switzerland. 
1.4. The provision of PPC at the EOL 
The focus of PPC is on ensuring the best possible quality of life (QOL) [18, 19]. Provision of PPC 
therefore has dimensions that relate to the physical, emotional and spiritual well-being of each child 
and family and include a mix of preventive, supportive and possibly life-prolonging interventions [1]. 
In 2003, the US Institute of Medicine of the National Academies released a report on improving 
palliative and EOL care for children and their families. They recommended that clinical practice 
guidelines, and institutional protocols and procedures that meet the needs of children and their 
families should be developed and implemented. The importance of interdisciplinary care teams was 
emphasized [1]. This milestone report fuelled efforts in and outside the US to create specialised PPC 
programmes and networks to facilitate the provision of comprehensive care. Information on the scope 
and characteristics of those programmes are sparsely available [14, 34]. In a recent survey among 226 
US children’s hospitals, 112 hospitals reported having an established PPC programme that was 
established in the last 10 years. A consultation model, i.e. a model in which a specialised PPC team 
consults with the treating team in charge of the medical paediatric subspecialty that matches the 
child’s primary diagnosis, was the favoured model of care and applied by 88% of the 112 hospitals. The 
consultation scope included the entire hospital in 86 hospitals and covered the whole paediatric age 
span from newborns to adolescents. Home-based PC and home visits, however, were only provided in 
11% and 30% of programmes [34]. The main goals of consultations as reported in an earlier study were 
symptom management, facilitating communication and decision-making, assisting with logistics or 
coordination of care, and assisting with transition to home [13]. 
It has been recognized that PPC should be provided in all settings where it is required, or 
wherever the child and family choose to be [6, 35, 36]. As home is the preferred place to be for many 
[37], various associations/organisations/initiatives recommend that efforts to provide home-based 
care should be undertaken [38]. Several issues have been described related to home-based care 
services for children at EOL, ranging from misconceptions among professionals and families, 
reimbursement issues, concerns for siblings or about the house being associated with the loss of a 
child, safety concerns, lack of skilled service providers, and cultural/religious beliefs [38]. Four main 
categories of barriers and needs in paediatric home care in Germany emerged from a qualitative study 
with 24 German experts in the field of PPC: “(1) specific challenges and demands in palliative care for 
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children and adolescents, (2) lack of clear legal and financial regulations, (3) gaps in the existing care 
delivery/need for expansion, and (4) access to services [39, p. 4]. Information on what services are 
included in home-based care is scarce. A recently published study in 36 children that died while they 
were enrolled in an US community-based PPC programme reported on details of care they were 
receiving during their last six months of life. Most home visits by this multiprofessional team were 
provided by registered nurses, followed by case managers and paediatric nurse practitioners and 
included a median of 24 (range = 1 – 121) visits [40]. 
So does PPC at EOL achieve its goal of sustaining or even improving QOL by providing 
multiprofessional and comprehensive care, including pain/symptom management as well as psycho-
social-spiritual care? There is little information available about specifically chosen outcomes such as 
pain and other symptoms, QOL, emergency room visits and length of stays in PICUs [41]. Efforts to 
evaluate PPC using (patient)/parent-reported outcomes in addition to a rather performance-oriented 
evaluation, i.e. characteristics of patients who received PPC, were made in the home care sector, and in 
the cancer population [2, 41, 42]. In the US, a retrospective survey of 60 parents who had lost a child 
to cancer between 2002 and 2008 was conducted to compare the symptom distress and QOL of 
children who received EOL care from a PPC home care programme with that of children who died 
without exposure to specialised PPC. The results suggested that children who were enrolled in the 
programme experienced better parent-reported QOL as measured for example by the amount of fun 
they had, by having an experience that added meaning to their lives. Symptom burden and successful 
pain- and symptom management was similar in both groups. Children in the programme were more 
likely to die at home, which was in keeping with their family’s wishes [41]. In Germany, a qualitative 
study from 2005 with bereaved parents [31] was replicated in 2010, in order to assess whether the 
profound development and improvements in the field of paediatric PPC that had occurred in the 
meantime, have led to changes in patterns of care and symptom control of children with cancer cared 
for at EOL. Symptom prevalence and degree of suffering were very similar in both cohorts as reported 
by parents. Treatment increased for all symptoms which did not, however, lead to improved treatment 
success. Significantly more children received home care in the recent cohort, and fewer children died 
in the ICU [42]. Another German research group conducted a prospective study for which one of the 
goals was to evaluate whether the involvement of a specialised paediatric palliative home care team 
increased the effectiveness of PPC as perceived by primary caregivers. Forty families reported on their 
child’s symptoms and QOL and their QOL and caregiver burden after involvement of the home care 
team compared to before. Symptom control and the child’s QOL as perceived by parents, and the 
parents’ own QOL and caregiver burden were found to have significantly improved [2]. 
1.5. The parental perspective of their child’s EOL care 
Parents facing the death of their child experience a most extreme life event, resulting in an ultimate 
loss and intolerable pain [43, 44]. The first and most important prerequisite for the provision of 
compassionate PPC and EOL care is to understand the family perspective [19]. 
1.5.1. Parental experiences and needs 
Three recent reviews, each including qualitative and quantitative studies, summarised existing 
evidence related to parental experiences and needs during their child’s palliative and EOL care. A total 
of 36 studies were reviewed (29 qualitative, 7 quantitative), many of those were part of all three 
reviews. The studies covered reports from bereaved parents but also from healthcare professionals. 
Major themes that were abstracted in all reviews in a very similar way are described as follows [45-47]: 
Sincere relationships and emotional, spiritual and cultural support. The importance and 
existence of sincere relationships with staff that are ongoing and continual was emphasized in most 
studies. Desirable staff features were described as compassionate, kind and respectful. Parents wanted 
to be respected in their role as primary caregivers and wanted staff to listen to them. Being seen as 
individuals created a sense of trust, and parents were confident that their child was well cared for. 
Genuine communication. Sincere communication was consistently reported as being most 
important for parents and families. Information should be delivered in everyday language that is easy 
to understand for both parents and child, as ppropriate. Parents consistently preferred that bad news 
about their child’s diagnosis, treatment and prognosis, or news that their child was dying was 
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conveyed openly and honestly. For many parents it was also important to receive information about 
what would happen when their child was dying. 
Decision-making. Parents mentioned the tremendous burden involved in making certain 
decisions. Nevertheless, they generally appreciated being involved in decision-making and felt 
comfortable if the guidance, support and timing were appropriate. Concerns arose when parents felt 
rushed to make decisions. Several important factors were considered by parents when faced with the 
difficult decision to withdraw life-supporting treatment of their child, including the child’s quality of 
life, her/his chances of getting better, or pain and discomfort. 
Alleviation of suffering. The need to relieve pain and symptoms in children was naturally 
very important to parents. High levels of pain have been described by parents. At the same time, many 
believed that their child’s pain was managed adequately. Commonly, parents of older children 
reported that they did not want the alleviation of pain or other symptoms to impair consciousness, or 
otherwise negatively impact the child’s ability to communicate with them. 
Continuity, coordination and accessibility of care. Being surrounded by and in contact with 
the same staff was satisfying for parents and considered to be an aspect of high-quality care. 
Continuity and coordination of care also resulted in less parental frustration and hyper-vigilance. 
Parents desired continuous and thorough documentation and reporting of the child’s care plan across 
all levels of service providers. Home care and the possibility of transitioning in and out of hospital 
were also seen as a requirement for high-quality EOL care. 
Bereavement support. Parents of neonates in particular appreciated it when staff helped 
with creating mementos, e.g. hand/footprints, locks of hair, after their child died. Some also liked to 
bathe and dress their child and there was a need for some private time. Some form of contact with the 
staff after the death of the child was enormously important and most parents felt abandoned when 
healthcare relationships ended abruptly. 
1.8.1. Deficiencies in meeting parental needs 
Several deficiencies in meeting the identified needs of parents during their child’s EOL care were 
recurrently mentioned in the articles included in the three reviews [45-47]. First and foremost, issues 
related to poor communication were described. Many parents were dissatisfied with poor 
communication processes and a lack of information provided. The information deficit created by 
missing, inadequate and non-comprehensive provision was further fostered by the parents’ inability to 
ask the right questions. The receipt of conflicting information from different healthcare staff resulted 
in confusion and stress for the parents. Problems in interacting with staff were commonly reported. 
These encompassed mainly disrespectful behaviour from the professionals’ side and the parents’ 
perception of not being taken seriously and being avoided. Other areas for improvement identified by 
parents included discrepancies between the parental positive perception of pain and symptom 
management and their description of symptoms, lacking availability or inflexibilities of scheduling of 
services, e.g. home care, clinic visits, and oversights in procedures and policies. Experiences with 
bereavement follow-up were reported inconsistently but families who did not receive it felt 
disappointed and dismissed. 
One major finding across several reviewed studies warrants special emphasis. Parental 
experience of one single negative event related to the care their child or family received could result in 
profound and lasting emotional distress. This finding leads to the assumption, that quality of PPC and 
EOL care might influence bereavement outcomes of parents who had lost a child. Support throughout 
terminal care and after the loss of a child was reported to have a positive impact on long-term grieving 
outcomes of parents who had lost a child to cancer [48]. A similar conclusion was also drawn in a 
mixed study review aiming, among other things, to summarise the psychosocial impact of hospital-
based bereavement services offered to bereaved parents who had lost a child [43]. It is therefore 
crucial to provide EOL care that meets the needs of the child and her/his family, by covering several 
domains and supporting the family as well as possible. This leads to the next topic covering 
quantitative methods to assess parental experiences and needs, and the evaluation of paediatric EOL 
care. 
The basis for understanding parental experiences and needs has been established mainly 
through qualitative research. In order to move forward towards evaluation of EOL care provided, 
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quantitative assessment of the parental perspective is needed to supplement and extend qualitative 
findings to a wider population leading to a higher degree of certainty. 
1.6. Measurement of parental experiences and needs, and related constructs 
Few researchers have attempted to quantitatively assess the parental perspective on their child’s EOL 
care. As a result there are only a few instruments, e.g. questionnaires that try to operationalise 
paediatric EOL care. Reasons for this might be that paediatric EOL care has not been well 
conceptualised so far. 
1.6.1. A possible framework 
One attempt to identify quality domains for family-centred care for children with life-threatening 
conditions was made by The Initiative for Pediatric Palliative Care (IPPC) [49]. The IPPC was 
especially designed to enhance the capacity of children’s hospitals and general hospitals with a 
paediatric unit to provide PPC in response to growing research-based recognition that the healthcare 
system has been failing to meet the needs of dying children and their families. Their project comprised 
a multiphase process, starting with needs assessment research including survey and interview data 
from healthcare professionals and parents who had lost a child. Additionally, a group was convened 
with expertise in paediatric nursing, medicine and palliative care, paediatric end-of-life care ethics, 
quality improvement, physician behaviour change, and medical and nursing education. This group 
identified six quality domains and a related set of quality indicators [50]. The quality domains are as 
follows: “Holistic Care of the Child; Support of the Family Unit; Involvement of Child and Family in 
Communication, Decision Making, and Care Planning; Relief of Pain and Other Symptoms; 
Continuity of Care; and Grief and Bereavement Support” [49, 50, p. 328]. These domains were then 
used to guide the development of a quality improvement tool which is now known as the “IPPC's 
Pediatric Palliative Care Institutional Self-Assessment Tool (ISAT)” [50, 51]. It is an institutional 
assessment tool to assist organisations in assessing their performance on issues related to family-
centred PPC. 
These quality domains were later picked up and slightly adapted in the review of Truog et al. 
[52] that sought to facilitate and inform future interventional studies by summarising existing 
evidence about EOL care in the PICU setting. They concluded that domains could be used as a 
framework for describing and evaluating the current status of paediatric EOL in the PICU [52]. 
1.6.2. Existing instruments 
In 2011, Meert et al. [53] published a systematic review that aimed to identify instruments potentially 
useful in measuring the needs of bereaved parents whose child died in a PICU. Fifteen instruments 
met their selection criteria that the instrument measured needs or expierences. However, none of the 
instruments that met these inclusion criteria was designed to specifically assess the perspective of 
bereaved parents on their child’s care in the PICU. Some tools were designed to assess family needs in 
the ICU setting (adults and paediatric) in general, some assessed experiences and needs-related 
constructs such as satisfaction of care or parental stressors in the NICU and PICU setting, and others 
were related to the assessment of parental needs of children that were hospitalised in a general 
paediatric unit. The authors concluded that a new specific instrument was needed to assess bereaved 
parents need in the PICU [53]. Consequently, the Bereaved Parent Needs Assessment (BPNA) was 
developed to assess parental needs and needs fulfilment around the time of their child’s death in the 
PICU [54]. The instrument demonstrated reliability and validity and the authors suggested using the 
instrument to assess parents’ needs and fulfilment of needs within and across PICUs rather than for 
individual parents [54].  
Other instruments used in the paediatric setting targeted satisfaction with care. Satisfaction 
with care is considered a needs-related construct as it refers to the level of fulfilment of needs or 
expectations of an individual [55]. This assumption could be challenged however, as meeting needs 
does not guarantee satisfaction and unmet needs do not always result in dissatisfaction [56]. 
Therefore, the assessment of parental experiences and needs together with satisfaction with care 
should be pursued to improve care. Based on this, the 57-item (five domains) EMPATHIC-N 
questionnaire measuring parent satisfaction in the NICU was developed and tested. It promises to be a 
valid quality performance indicator for measuring the care delivered as perceived by parents, however, 
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it has not been used with bereaved parents so far [57]. The 61-item Comprehensive Assessment of 
Satisfaction with Care (CASC) was originally developed in the adult cancer context but was also used to 
assess parent satisfaction with care after their child’s death in hospital. Satisfaction with care scores 
were high and the authors concluded that the reporting of experiences rather than simple satisfaction 
measures should be incorporated [58].  
This conclusion was supported by other authors, who suggested that the most important 
aspect of evaluating quality of care is to assess whether healthcare providers responded to the 
expectations and preferences of the dying patient and their families [59]. This can be achieved by 
asking very specific questions concerning the parents’ lived experiences [60]. The lack of a 
comprehensive and sensitive instrument that can be used to collect meaningful information from 
families who have experienced the death of a child has been recognised and, recently, a report on the 
initial development and psychometric testing of one such instrument was published [61]. An initial 
144-item version, organised in six domains, was tested in 128 bereaved mothers who had lost a child 
due to a life-limiting CCC. Based on this initial testing including exploratory factor analysis, the 
number of items could be reduced and the number of domains increased from six to ten. The domains 
read as follows. “Connect with families; Involve parents; Share information with parents; Share 
information among health professionals; Support the child; Support siblings; Structures of care; 
Provide care at death; Provide bereavement; and Follow-up”. Overall, the instrument appears valid 
and applicable to EOL care in a heterogeneous setting of illnesses, ages and healthcare providers. 
However, testing has so far been limited to bereaved mothers [61]. 
Two other questionnaires are worth mentioning as they were used in the paediatric oncology 
palliative and EOL care setting. One was developed to serve as a guide for conducting structured 
interviews to mainly assess symptom experience, as perceived by parents, during the last month of life 
of children who died of cancer. Additional topics covered in the interviews related to the quality of care 
services provided on different healthcare levels [62]. Since its development, this questionnaire has 
been applied in a series of studies in the US and Germany [30, 31, 63]. For a Swedish population-based 
study involving parents who lost their child to cancer, Kreicbergs et al. [48] developed a self-
administered instrument with 129 questions and a total of 365 items. The questionnaire focused on 
parents’ self-assessment of whether they had worked through their grief and whether professional and 
social support facilitated this process [48]. 
The construct of good quality paediatric EOL care is not well operationalised no conceptual 
model has been developed and tested. Based on existing evidence about the parental and professional’s 
perspective of PPC and EOL care, quality domains were identified that can serve as a framework for a 
quantitative assessment tool. However, few self-administered questionnaires targeting parental 
experiences and needs during their child’s EOL care have been developed and tested. 
1.7. Conducting research with bereaved parents 
The question of whether research is reasonable for bereaved families has been discussed, as they are 
clearly vulnerable subjects. The 1978 Belmont report, which led to the Declaration of Helsinki, uses the 
principles of autonomy, beneficence, and justice to offer a helpful framework for addressing ethical 
concerns [64]. Although there may be no personal benefit, parents may still find meaning in sharing 
their experiences for research purposes. On the one hand, beneficence -related concerns include 
questions on how to minimize the burden for participating parents and what steps have to be taken to 
support participants in distress. On the other, justice-related issues arise when an entire population is 
excluded from research due to a decision not made by them. 
It is remarkable that in studies with this population, the response rates were as high as 80% 
[48, 65]. This is confirmed by personal experiences revealing that parents who have lost a child want 
to tell their story. However, most studies have chosen an interval of at least 6 to 12 months, so that 
family members have passed the immediate stages of grief. This is in concordance with the study of 
Maciejewski et al. [66] who were able to show that all negative grief indicators peak within six months 
post loss and then start to slowly decline. Nevertheless, strategies should be considered to ensure that 
research with vulnerable subjects is conducted compassionately and with heightened vigilance during 
each step of the research process. Possible strategies have been addressed and published specifically 
within the field of palliative care [67, 68]. 
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1.8. Conclusion 
In the past decade, several needs assessments of paediatric palliative and EOL care have been 
conducted [18], providing important information, which was synthesised in this chapter 1. Many of 
these findings have been remarkably consistent. However, system factors and the environment in 
which paediatric EOL care takes place are crucial for the interpretation of those findings. In the 
following chapter, the Swiss strategy to promote palliative care will be shortly described which leads to 
the introduction of a broader research project, in which this dissertation was embedded. 
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Chapter 2  
The Swiss Setting -  
Rationale and Aims for the PELICAN Study and this Dissertation 
Similarly to many other countries, facing a growing population in need of EOL care, the Swiss 
Confederation and cantons have in the last decade resolved to promote palliative care in the context of 
the “National Health Policy”. The first “National Strategy for Palliative Care” was run from 2010 to 
2012 with the goal of strengthening the availability of palliative care, improving the training of 
physician and nursing professionals, and better informing society. The strategy was aimed at providing 
impulses for improvements in EOL care. Many first measures within six sub-projects, “Care”, 
“Financing”, “Awareness”, “Training”, “Research”, and an “Interdisciplinary sub-project”, were 
implemented in the following three years. However, the main objective was not completely achieved 
[1]. In October 2012, the “National Strategy for Palliative Care 2010-2012” was extended for another 
three years to allow more time to complete the broad implementation of the established principles. 
The action plan for continuing the strategy in the years 2013 to 2015 was based on the results of the 
first phase [2].  
Specialised palliative care was a topic emphasised in the first phase. Important interpretative 
documents were developed, i.e. indication criteria, overview of existing specialised offerings; however, 
these analyses were based on the context of palliative care for adults. This limitation was recognised 
and acknowledged and led to an action plan specific for paediatrics: to promote PPC in Switzerland, a 
thorough assessment of current practices, needs, available resources and existing services is required 
in order to formulate and plan further measures [2]. Following this call, the PELICAN study 
(Paediatric End-of-LIfe CAre Needs in Switzerland) was designed and will be presented in paragraph 
2.2. 
2.1. State of Paediatric Palliative Care in Switzerland 
As in other countries too, paediatric EOL care in Switzerland is provided in a heterogeneous 
setting of healthcare services. However, PPC programmes with a specialised multiprofessional team 
are implemented in only two of the five existing university children’s hospitals and in one regional 
children’s hospital. Apart from the five university affiliated paediatric centres, there are eight cantonal 
children’s hospitals and several regional hospitals with a paediatric unit. Several paediatric community 
care organisations provide healthcare services at home. Most of them are part of the Swiss association 
of paediatric community care (Verband Kinder-Spitex Schweiz) and are partly subsidised by the 
community they practice in, with a few other free-standing private organisations. There are a few long-
term institutions caring for severely cognitively and physically impaired children and adults, but no 
children’s hospices providing PPC exist in Switzerland. 
2.2. Paediatric End-of-LIfe CAre Needs in Switzerland – The PELICAN study 
This dissertation is embedded in the PELICAN study (Paediatric End-of-LIfe CAre Needs in 
Switzerland, 2012 – 2015). The overarching aims of the nationwide PELICAN study were to “provide 
comprehensive information and to understand the current practice of EOL care (i.e. in this study, the 
last 4 weeks of life prior to death) in paediatric settings in Switzerland (hospital and community care) 
and to explore and describe parental perspectives and the perspectives of the healthcare professionals 
involved. Based on the results, recommendations for best-practice during this highly vulnerable and 
critical phase of life not only for the affected child but also for the family will be formulated.” [3, p. 
1942]. The PELICAN study comprised three main studies and two sub-studies, which are described in 
the following, and in more detail in Chapter 3: 
 PELICAN I was a retrospective chart review study aiming at describing EOL care as 
documented in medical charts of children (0 – 18 years) who died in the years 2011 or 2012 
due to cardiac, neurological, or oncological diseases, or who died during the neonatal period. 
o PELICAN ICU, a sub-study of PELICAN I, focused on the sub-sample of children who 
died in an ICU describing and exploring characteristics specific to the neonatal and 
paediatric intensive care setting. 
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 PELICAN II was a mixed-methods study entailing the development and testing of an 
instrument to quantitatively assess the parental perspective, followed by single interviews to 
add further insight (sequential explanatory design).  
o PELICAN HOME, another mixed-methods study and sub-study of PELICAN I and II 
quantitative, focused on the sub-sample of children who spent at least three of their 
last four weeks of life at home. This sub-study drew on quantitative data from both 
main studies and single interviews were conducted (embedded design) in order to 
identify facilitators for and barriers to EOL care at home [4]. 
 PELICAN III was a qualitative study applying focus group interviews with health care 
professionals to explore their perspectives and needs in providing paediatric EOL care. 
This dissertation comprises PELICAN I and the quantitative part of PELICAN II, including the 
development and testing of the Parental PELICAN Questionnaire (PaPEQu) (Chapters 4 – 6). 
2.3. Research gaps and rationale for this dissertation 
Parents facing the death of their child experience an unimaginably painful life event with high levels of 
suffering in the entire family and certainly the child affected. The family’s need for compassionate 
professional support is high. For clinicians it is therefore imperative to have knowledge about 
characteristics and circumstances of childhood deaths due to a life-limiting condition or prematurity, 
and to understand the parental perspectives of their child’s EOL care in order to provide high quality 
care.  
Paediatric palliative and EOL care has commonly adopted the consultation model as the mode 
of care delivery. Providing consultation services to teams of different medical subspecialties makes the 
work of specialised PPC teams challenging because a high level of expertise is required. A thorough 
understanding of paediatric subspecialties and related knowledge of disease specific aspects of 
paediatric EOL are needed. This understanding should go beyond the horizon of a single hospital and 
take into account the heterogeneous settings where care can be provided (tertiary settings, general 
hospitals, paediatric primary care and in the community). Current population-based knowledge and 
generalisability of results are severely limited by the single site design that most studies applied. Data 
for Switzerland as a whole are vastly missing. Switzerland is lagging behind in the development and 
implementation of PPC programmes incorporating a muldidisciplinary and specialised HCT. Country-
specific information is needed to initiate the next steps towards the development of a Swiss model of 
care for paediatric palliative and EOL care that is needs-driven and accessible for all who need it. 
Awareness of parental experiences and needs is a crucial prerequisite. 
Existing knowledge about the parental perspective mainly originates from qualitative studies 
and limitations in regard to the inclusion of bereaved parents of children with certain life-limiting CCC 
(predominantly parents of children with cancer) are recognisable. The wide variety of underlying 
medical conditions leads to vastly different illness trajectories and lifespans potentially influencing 
what parents experience during their child’s EOL care. There is little evidence as to the influence of the 
child’s underlying diagnosis on the parental perspective. Empirical evidence is needed to base best-
practise on, and this includes broadening qualitative findings with quantitative data that originating 
from a heterogeneous healthcare setting 
A review of the literature revealed few self-administered questionnaires designed to assess the 
experiences and needs of parents of a dying child. At the beginning of the EPLICAN study, none of the 
instruments available included all of the quality domains identified by the IPPC and none were 
applicable to the heterogeneous field of paediatric EOL care, including children of different age 
groups, with different underlying illnesses and in different clinical settings. This led to the decision to 
develop and test an instrument that is applicable to a broad range of paediatric specialties and settings 
and specifically assesses parental experiences and needs during their child’s EOL care. 
Paediatric palliative and EOL care is based on the principle that an interprofessional team 
should care for patients and their families ensuring the best possible quality of life. The PELICAN 
study will contribute to a comprehensive understanding of EOL care in Switzerland and may be of 
importance for other Western countries as well. The survey instrument for assessing experiences and 
needs of parents who went through their child’s highly burdensome EOL care phase, may also be of 
relevance for the evaluation of current care elsewhere. 
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2.4. Study aims 
Given the gaps identified in the existing evidence, and following the strategy of the Federal Office of 
Public Health in regard to PPC by conducting a thorough needs-assessment, the following specific 
aims have been formulated for this dissertation: 
2.4.1. PELICAN I (Chapter 4): 
To ccomprehensively describe, explore and compare current practices in paediatric EOL care (for this 
study defined as the last four weeks of life) in four distinct diagnostic groups (cardiology, neonatology, 
neurology and oncology) across healthcare settings including all relevant levels of healthcare providers 
in Switzerland. 
2.4.2. PELICAN II – Instrument development and testing (Chapter 5) 
To develop and test the Parental PELICAN Questionnaire (PaPEQu), an instrument used to 
retrospectively assess parental experiences and needs during their child’s EOL care. 
2.4.3. PELICAN II – Questionnaire survey (Chapter 6) 
To assess the perspectives of bereaved parents who have lost a child due to a cardiac, neurological or 
oncological condition or during the neonatal period in order to (1) describe specific parental 
experiences in relation to the underlying medical condition causing the child’s death, and (2) explore 
differences in parental perspectives among four common medical conditions responsible for childhood 
death. 
2.5. References 
1. Binder, J. and von Wartburg, L., National strategy for palliative care 2010-2012. 2010, 
Federal Office of Public Health (FOPH): Bern, Switzerland. 
2. Von Wartburg, L. and Naef, F., National strategy for palliative care 2013-2015. 2012, Federal 
Office of Public Health (FOPH): Bern, Switzerland. 
3. Bergstraesser, E., Zimmermann, K., Eskola, K., Luck, P., Ramelet, A.S. and Cignacco, E., 
Paediatric end-of-life care needs in Switzerland: current practices, and perspectives from 
parents and professionals. A study protocol. Journal of Advanced Nursing, 2015. 71(8): p. 
1940-7. 
4. Eskola, K., Bergstraesser, E., Zimmermann, K. and Cignacco, E., Paediatric end-of-life care in 
the home care setting (PELICAN HOME)--a mixed methods study protocol. Journal of 
Advanced Nursing, 2015. 71(1): p. 204-13. 
 
 Page 20/93 
Chapter 3  
Paediatric end-of-life care needs in Switzerland: current practices, 
perspectives from parents and professionals. A study protocol 
Eva Bergstraesser1; Karin Zimmermann2,3; Katri Eskola2; Patricia Luck2; Anne-Sylvie Ramelet4;  
Eva Cignacco2,5 
1 Pediatric Palliative Care, University Children’s Hospital Zurich, Switzerland 
2 Institute of Nursing Science, University of Basel, Switzerland 
3 Department of Pediatrics, Inselspital Bern University Hospital, Switzerland 
4 Institute of Higher Education and Nursing Research, University of Lausanne, Switzerland 
5 University of Applied Sciences Bern, Health Division, Switzerland 
Published in the Journal of Advanced Nursing. 2015;71(8):1940-7. doi:10.1111/jan.12650. (IF: 1.741) 
 
  
 Page 21/100 
3.1. Abstract 
Aim. To provide comprehensive information and understanding about the current practice of end-of-
life care in paediatric settings in Switzerland. 
Background. In Switzerland, paediatric palliative care is usually provided by teams, who may not 
necessarily have specific training. There is a lack of systematic data about specific aspects of care at the 
end of a child’s life, such as symptom management, involvement of parents in decision-making and 
family-centred care, and experiences and needs of parents, as well as perspectives of health care 
professionals.  
Design. This retrospective nationwide multicentre study, Paediatric End-of-Life CAre Needs in 
Switzerland (PELICAN), combines quantitative and qualitative methods of inquiry. 
Methods. The PELICAN study consists of three observational parts, PELICAN I describes practices of 
end-of-life care (defined as the last four weeks of life) in the hospital and home care setting of children 
(0–18 years) who died in the years 2011 and 2012 due to a cardiac, neurological or oncological disease, 
or who died in the neonatal period. PELICAN II assesses the experiences and needs of parents during 
the end-of-life phase of their child. PELICAN III focuses on health care professionals and explores 
their perspectives concerning the provision of end-of-life care.  
Conclusion. This first study across Switzerland will provide comprehensive insight into the current 
end-of-life care in children with distinct diagnoses as well as the perspectives of affected parents and 
health professionals. The results may facilitate the development and implementation of programmes 
for end-of-life care in children across Switzerland, building on real experiences and needs.  
3.2. Summary statement 
Why is this study needed? 
 Paediatric end-of-life care covers particular needs during a highly vulnerable phase of life, not 
only for the affected child or young person but also for the whole family. Knowledge about 
these needs is scarce, particularly in Switzerland. 
 To develop a national, needs-adapted concept for paediatric end-of-life care and services, a 
profound analysis of current practices, experiences and needs is a precondition. 
3.3. Introduction 
Children living with life-limiting conditions have always been part of the healthcare system. Mortality 
data for children from developed countries, such as Switzerland [1] and the USA [2] highlight two 
important issues relevant for investigations in the field of paediatric palliative care (PPC) and end-of-
life (EOL) care. Death during infancy, particularly during the first four weeks of life, represents at least 
50% of deaths in children (0–18 years) [3, 4]. Beyond the first year of life, complex chronic conditions 
(CCCs) – such as congenital and chromosomal disorders, neurodegenerative diseases, cancer and 
cardiac malformations – represent the most important group of diagnoses responsible for disease-
related death in childhood [5, 6]. In childhood, the number of deaths due to diseases of the nervous 
system and to cardiac malformations is comparable to the number of deaths due to cancer diseases [5]. 
3.3.1. Background 
Several studies [7-10] have investigated the needs of children and their families once the child’s 
disease became incurable and progressive, which may also be described as the ‘palliative’ phase of a 
disease. During this phase, six domains of high-quality, family-centred care have been defined: 1) 
support of the family unit [11, 12]; 2) communication with the child and the family about treatment 
goals and plans; 3) ethics and shared decision making; 4) symptom management; 5) continuity of care; 
and 6) grief and bereavement support [10, 13]. PPC can address these aspects; it is typically delivered 
through a shared care model, where the PPC team works alongside primary attending health- and non-
health-related professionals and parents [2, 14, 15]. EOL care is part of PPC and focuses on ‘preparing 
for an anticipated death and managing the end stage of a fatal medical condition’ (p.34) [12]. 
Communication is central to the concerns of parents and thus a principle determinant of high-quality 
care [16, 17]. There is evidence that professional support provided in the last four weeks of life has a 
positive impact on the bereavement of parents [18]. 
4.  
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Dying at home is often cited as the preferred place of death for children, associated with good 
quality of EOL care and a ‘good death’ [11, 19, 20]. In reality, paediatric home-death rates, although 
growing, have remained as low as 20% between 1999-2003 in the USA [21]. Neonatal intensive care 
units (NICUs) and paediatric intensive care units (PICUs) play a particularly important role in EOL 
care, as they are places where a high percentage of paediatric and neonatal patients die [22]. 
Nevertheless, it is important to know where and under which circumstances children die and to know 
the impact of characteristics of a child’s death on the overall satisfaction of parents with EOL care [23]. 
In addition, the PPC approach, particularly at EOL, challenges health care professionals, notably those 
from intensive care units and physicians, by its requirement that those involved undergo a transition 
from a primarily curative or at least life-prolonging treatment to a treatment that takes the quality of 
life as its main focus and anticipates the death of the child [24-26]. 
As a matter of fact, evidence on how to provide optimal PPC, including EOL care, which covers 
the needs of children and their families is scarce and lags substantially behind that in the adult 
population. This is particularly true in Switzerland, where there are no systematic and comprehensive 
records of data about the current provision of PPC and EOL care in paediatric settings. Furthermore, 
in contrast to many European countries, Swiss PPC and EOL care is not provided in facilities such as 
hospices for children. As a consequence, the question needs to be raised whether new models of care 
for PPC and EOL care are needed. 
3.4. The study 
3.4.1. Aims 
The general aims of this study are to provide comprehensive information and understanding about the 
current practice of EOL care (i.e. in this study, the last 4 weeks of life prior to death) in paediatric 
settings in Switzerland (hospital and community care) and to explore and describe parental 
perspectives and the perspectives of the health care professionals involved. Based on the results, 
recommendations for best-practice during this highly vulnerable and critical phase of life not only for 
the affected child but also for the family will be formulated. The PELICAN-objectives of the three 
distinct PELICAN parts and two sub-studies are described as follows: 
 PELICAN I aims at describing the EOL phase and EOL care as documented in medical charts 
of children 0–18 years of age who died in the years 2011 and 2012 due to cardiac, neurological, 
or oncological diseases, or who died during the neonatal period and at exploring differences 
between these distinct groups of diagnoses related to disease-specific aspects and settings of 
care.  
 PELICAN II entails the development, piloting and preliminary psychometric testing of a 
survey instrument, followed by the quantitative and qualitative enquiry into parents’ 
experiences and needs during the EOL care of their child that meets the inclusion criteria of 
PELICAN I.  
 PELICAN HOME, a sub-study of PELICAN I and II that focuses on experiences and needs of 
parents whose child spent his or her EOL predominantly at home (≥ 21 days of the last 4 weeks 
of life) and thus received EOL care in the home care setting [27]. This sub-study aims at 
identifying facilitators and barriers regarding the provision of EOL care and at comparing 
results between the main settings of care in Switzerland – in hospital and in the child’s home. 
 PELICAN ICU, a sub-study of PELICAN I focuses on EOL practices specific to the population 
cared for in neonatal and paediatric intensive care units, compared with practices in other 
settings, such as general wards.  
 PELICAN III explores perspectives and needs of health care professionals who are involved 
in paediatric EOL care, but not necessarily specialised in palliative care.  
3.4.2. Design 
This retrospective, multicentre study entails different designs for each element of the study under 
investigation, which are listed below and illustrated in Figure 1. 
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Figure 1 Study overview 
Quantitative and qualitative methodology is used and combined during analyses, to explore the child’s 
last four weeks of life from different perspectives: 
PELICAN I includes the quantitative, retrospective analysis of medical charts of children (0–18 years) 
who died from cardiac, neurological and oncological diseases as well as during the neonatal period in 
the years 2011 and 2012. 
PELICAN II includes a) the questionnaire development in German (item generation, content validity 
testing by an expert panel and through cognitive debriefing), standard translation of the questionnaire 
into French and Italian, pilot testing of the instrument and preliminary homogeneity testing of items 
and application of the questionnaire for the main survey with parents; b) face-to-face interviews with 
parents. To obtain a comprehensive and deeper understanding of parents’ perspectives a sequential 
explanatory mixed methods design will be used (QUANT → qual). The combination of quantitative 
and qualitative enquiry methods will enhance analyses by exploring this existential human experience 
in a cultural and social context [28, 29].  
PELICAN HOME is a mixed-method sub-study of PELICAN I and II that focuses on EOL care in the 
home care setting [27].  
PELICAN ICU is a retrospective descriptive sub-study of PELICAN I and focuses on EOL care in the 
paediatric and neonatal intensive care setting. 
PELICAN III is a qualitative study using five to six interdisciplinary focus group interviews entailing 
around 48 health care professionals that will be performed across Switzerland in tertiary and 
secondary level hospitals.  
3.4.3. Setting 
Sixteen hospitals, two long-term institutions and ten community care organizations across the entire 
country have agreed to participate in the study.  In view of the three language regions of Switzerland, 
close collaboration has been developed with the French and Italian speaking parts by designating local 
teams who will take over responsibility for the coordination of the study in their region. 
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3.4.4. Participants 
The recruitment of subjects for PELICAN I and II was completed in the time period from August 2013 
- April 2014. To identify subjects and participants, all children’s hospitals or hospitals with a paediatric 
ward and the paediatric community care organisations in Switzerland were contacted between August 
and December 2013.  
Inclusion criteria for children were age at the time of death (0–18 years, but not younger than 
24 hours) and diagnostic group (cardiology, neonatology, neurology, oncology) even if a child died due 
to a complication, such as recurrent pneumonia and the underlying disease was a neurological 
disorder. Subjects were excluded if a child: died within 4 weeks following a traumatic injury; died 
within 2 days after the diagnosis of an oncological disease; died unexpectedly due to a treatment or 
procedural medical error; or if his or her family were not Swiss residents or did not speak/read 
German, French or Italian.  
Parents whose child met the eligibility criteria were mailed an invitation letter by the former treating 
hospital and asked to fill out an informed consent document accepting or declining study participation 
(i.e., allowing the use of data from their child’s medical charts, participation in the questionnaire 
survey and/or agreeing to be contacted for an interview). Return of the completed questionnaire was 
considered to be formal agreement to the analysis of the survey data. Additional written informed 
consent will be obtained from parents who participate in the interviews. Participants for the qualitative 
part of the PELICAN HOME sub-study have been selected in the German-speaking part of Switzerland 
only. For the overall PELICAN project, we expected a total of approximately 380-400 eligible patients 
and a response rate of 60%.  
For PELICAN III, health care professionals (paediatricians, paediatric nurses including community 
nurses) and allied-health professionals (psychologists, social workers, physiotherapists and other 
therapists and pastors) working in participating hospitals or paediatric community care will be invited 
to take part in 5 to 6 focus group interviews with approximately 8 participants in each focus group. 
Three of these group meetings will be performed in the German-speaking part of Switzerland, one to 
two in the French- and one in the Italian-speaking part.  
3.4.5. Data collection 
For PELICAN I, we developed a secure web-based data-form (secuTrial®) with approximately 200 
variables to facilitate data entry and management. These variables were selected according to the 
literature and our study objectives. They include data to verify eligibility, patients’ characteristics (e.g. 
demographic data, diagnosis), characteristics and circumstances of death (place of death and life-
sustaining treatment during the last 24 hours of life), treatment modalities (palliative care approach, 
interventions requiring anaesthesia, medical devices, type and dosage of drugs, nutrition and fluids 
regimens), treatment modalities specifically related to cancer diagnoses, EOL care in particular (e.g. 
support of the family unit, communication with the child and the family, decision making, pain and 
symptom management, continuity and coordination of care) and grief and bereavement support. The 
data-form was pilot tested with ten children who died in 2010. Only minor adaptations had to be made 
and the accessibility of data from medical charts was evaluated as sufficient. Data collection from 
patients' medical charts started in November 2013 and was completed in June 2014. At each 
participating study site (hospital, community care centre) local coordinators have been assigned to 
facilitate logistics concerning medical charts review and workspaces.  
For PELICAN II, a survey instrument was developed, as no instrument that met the criteria for 
our study objectives was found. Based on the quality domains for family-centred EOL care the 
questionnaire was structured into six themes: 1) Support of the family unit; 2) Communication with 
the child and family; 3) Ethics and shared decision making; 4) Relief of pain and other symptoms; 5) 
Continuity of care; and 6) Grief and bereavement support. For each of the four groups of diagnoses 
(cardiology, neonatology, neurology and oncology), separate versions were developed and designed for 
mothers and fathers. Each questionnaire comprises approximately 100 items (including socio-
demographic factors and questions related to overall parental satisfaction). Questions are 
predominantly closed-ended and are presented in various formats, yet the majority uses Likert-type or 
categorical response options. Validity testing included face validity and content validity indexing with 
26 experts and cognitive debriefing with 4 affected parents.  
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A purposefully selected sample of approximately 20 parents who completed the questionnaire 
and also consented to participate in an interview will be contacted by phone for an appointment for the 
interview. The interviews will be conducted by a trained study collaborator at the parents’ home or a 
place of their preference, audiotaped and transcribed verbatim. They will last approximately 60 
minutes and will be conducted from January to April 2015. An interview guideline will be developed 
according to the results from PELICAN I and II.   
For PELICAN III, an interview guideline for the focus group interviews will be developed that 
reflects the current status of care and takes into consideration potential barriers and facilitators for the 
provision of child- and family-centred care, PPC and EOL care. In addition, experiences and needs of 
health care professionals will be explored. 
3.4.6. Data analysis 
Quantitative data analysis 
All data from PELICAN I and II will undergo an exploratory analysis to describe the data and uncover 
any data inconsistencies that may impact the validity of the data analysis. Appropriate descriptive 
statistics will be used to summarise data of individual variables, considering each variable’s level of 
measurement and its observed distribution (e.g. frequency distributions with counts and percentages, 
measures of central tendency and dispersion). To test for differences between diagnostic groups, 
clustering effects of parents of the same child will be accounted for by using multilevel approaches. 
Data will be analysed using SPSS Statistics® version 21 for Macintosh (SPSS Inc., Chicago, IL, USA) 
with P-values of <0.05 considered significant. 
Qualitative data analysis 
Parental and also focus group interviews will be analysed by the method of ‘thematic analysis’ [30]. 
Thematic analysis is an analytic method for identifying, analysing and reporting patterns of themes in 
a data set. Themes will be placed into a semantic context and further examined in relation to 
frameworks defined by us for each part of qualitative data enquiry (e.g. Feudtner et al.’s multi-level 
system model for the analysis of parents’ interviews in the PELICAN HOME sub-study [6, 31]). After 
systematic analysis of each interview, the latter step will take place in a research team to deepen our 
understanding of the particularities of each perspective and to reach high congruence, credibility and 
validity of the results. ATLAS.ti® version 7 for Microsoft Windows® (ATLAS.ti GmbH, Berlin) will 
support data management and organisation. 
Mixed methods data analysis 
After sequential data collection and separate analyses, the quantitative data results will be compared 
with major themes identified across the qualitative data set using side-by-side comparison on a 
summary table. Results of this comparison will be discussed in the context of developed frameworks 
and system models. Mixed methods analysis will provide a comprehensive picture and a fuller 
understanding of the different perspectives, experiences and needs. 
3.4.7. Ethical considerations 
Research with bereaved parents may provoke acute grief reaction and may thus be of particular burden 
for participants. However, studies with these subjects have shown high response rates, as high as 70-
80% [32-35], which can be interpreted in the way that parents appreciated to share their experiences 
and burden and benefit are rather balanced. Nevertheless, we decided to ensure a timeframe of at least 
one year between the child’s death and participation in the study as this time has been found to be the 
most acute and vulnerable [36]. In addition, participation in this study is entirely voluntary. Eligible 
participants are invited with written information through the treating centre. Written informed 
consent is a precondition for all three parts of the study. Ethics committee approval has been obtained 
by the leading Human Research Ethics Committee (March 2013) and ten departmental committees 
across Switzerland.  
3.4.8. Validity and reliability 
For PELICAN I, the data-form was pilot tested with ten children who died in 2010. Only minor 
adaptations had to be made and the accessibility of data from medical charts was evaluated as 
sufficient. In the main study, 5% of the medical charts will be randomly chosen and two different 
persons will enter the data independently for quality checking. 
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For PELICAN II, the German version of the questionnaire underwent content validity testing 
by an expert panel and through cognitive debriefing with parents. Following standard translation into 
French and Italian, a pilot testing of the instrument and preliminary homogeneity testing of items and 
application of the questionnaire for the main survey with parents was performed. Qualitative data 
from interviews with parents and focus groups (PELICAN II and III) will be analysed systematically 
according to Braun and Clarke [30] and discussed in research teams (5-6 participants) to ensure 
accuracy of the analytical process and to reach high congruence, credibility and validity of the results. 
3.5. Discussion 
When the burden of a life-limiting disease increases and poor quality of life outweighs the potential 
benefit of life prolongation, the focus of care shifts towards individual needs of the child and his or her 
family. Preferences of the child and the family move into a focus of care that may be associated with 
difficult decisions about continuation or discontinuation of life-sustaining therapies, anticipation of 
the process of dying, pain and symptom management and planning of the location and/or 
circumstances of death. Even though PPC has made great advances during the last two decades, many 
needs of children and their families remain unmet [18, 37-40] and several of them are probably 
unknown. This study covering neonatal and paediatric EOL care will contribute to a comprehensive 
understanding of EOL care in Switzerland and may be of importance for other Western countries as 
well. The survey instrument for assessing the experiences and needs of parents who went through their 
child’s highly burdensome palliative and EOL care phase, may be of relevance for the evaluation of 
current care elsewhere; the impact of innovations in a distinct institution on the experience of parents 
may likewise be of broader interest. 
3.5.1. Limitations 
The current study has several limitations. First, data quality of the retrospective chart analysis will be 
moderate due to the study design with probably sparse documentation in hospitals and community 
care organisations. Second, due to the small size of the country and different language regions, we 
might gain a rather heterogeneous picture, which might hamper generalisation of our results, even for 
Switzerland. Third, it explores the situation in Switzerland and may thus be of limited relevance for 
other countries. 
In conclusion, this survey across Switzerland will provide first comprehensive insight into the 
current practice of EOL care in children suffering from the four largest and most important 
circumstances of disease-related death in childhood. 
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4.1. Abstract 
Background: End-of-life care of neonates, children and adolescents is challenging and requires a 
high level of professional expertise. Specialised paediatric palliative care has commonly adopted a 
consultation care model. It is important that teams have a thorough understanding of paediatric 
subspecialties and related knowledge of disease specific aspects of paediatric end-of-life care. 
Aim: To comprehensively describe, explore and compare current practices in paediatric end-of-life 
care in four distinct diagnostic groups including all nationwide relevant levels of healthcare providers. 
Design: Nationwide retrospective chart review. 
Setting/participants: Data from 149 paediatric patients who died in the years 2011 or 2012 due to a 
cardiac, neurological or oncological condition, or during the neonatal period were collected in 13 
hospitals, two long-term institutions and 10 community-based healthcare service providers 
throughout Switzerland. 
Results: Sixty-two percent of the patients died in intensive care units, 84% of them following the 
withdrawal of life-sustaining treatment. A smaller proportion (17%) died at home. Reliance on invasive 
medical interventions was prevalent, and the use of medication was high, with a median count of 12 
different drugs during the last week of life. Patients experienced an average number of 6.42 symptoms. 
Symptom count was significantly lower (M = 4.39) in neonates and the prevalence of various types of 
symptoms differed significantly among the four diagnostic groups. Only half of the patients who spent 
some days at home received community-based healthcare. 
Conclusions: The study provides a comprehensive overview of current end-of-life care practices in 
the heterogeneous real-life setting of hospitals, long-term institutions and community healthcare 
organisations in Switzerland. The findings provide a knowledge base for paediatric palliative care 
teams. As a consequence, a meaningful outcomes measure should be introduced into practice to 
promote quality of care and further advance research in the field. 
4.2. Key statements 
What is already known about the topic? 
 Various medical diagnoses contribute to childhood deaths due to complex chronic conditions 
encompassing the whole paediatric age span.  
 Characteristics and circumstances of end-of-life care are known to vary by age and medical 
condition. 
 No study has so far focused on comparisons between distinct diagnostic groups. 
What this paper adds? 
 Differences in characteristics and circumstances of end-of-life care are present, depending on 
the underlying medical condition. 
 Professional home care is established for a few patients only. 
 The types of community healthcare services are manifold. 
Implications for practice, theory or policy? 
 As the field of paediatric palliative care is growing internationally, specialists need 
comprehensive knowledge to base their practice on. 
 The capacity of community healthcare services needs to be expanded. 
 Bridging the gap among service providers should be emphasized. 
4.3. Introduction 
Despite continued advancements in medical care and improved survival or life expectancy, childhood 
deaths due to complex chronic conditions (CCC) or prematurity are inevitable [1]. Deaths during the 
first year of life constitute approximately 50% of disease-related deaths, the causes of which include 
perinatal complications, prematurity, or congenital anomalies [2-4]. Beyond the age of one year, the 
three most common life-limiting CCCs are neurological/neuromuscular and cardiovascular conditions 
(including genetic disorders), and malignancies [1, 2, 5]. The majority of disease- and prematurity-
related deaths occur in hospitals,[6-8] and for children dying at home, hospital use in their terminal 
stage is high [1, 2]. Symptom burden and reliance on medical technology has been reported to be 
considerable [9, 10]. Circumstances and characteristics of deaths, however, are known to vary by age 
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and medical conditions [1, 2]. Care is normally planned and performed by the team of the paediatric 
medical subspecialty matching the child’s diagnosis.  
Paediatric palliative (PPC) and end-of-life (EOL) care emerged as a medical subspecialty 
aimed at meeting the specific needs of seriously ill children and their families. Meeting these needs 
requires a comprehensive and integrative approach from a compassionate and skilled 
multidisciplinary team [11]. PPC should be provided in all settings where it is required [12], although, 
specialised PPC teams are mostly hospital based [13]. In a recent survey among 226 US children’s 
hospitals, the majority of the 112 hospitals with an established PPC programme reported that they 
offered consultation services throughout the hospital and that their programme covered the whole 
paediatric age span from newborns to adolescents [13]. 
Providing consultation services to teams of different medical subspecialties makes the work of 
specialised PPC teams challenging because a high level of expertise is required. A thorough 
understanding of paediatric subspecialties and related knowledge of disease specific aspects of 
paediatric EOL are needed. This understanding should go beyond the horizon of a single hospital and 
take into account the heterogeneous settings where care can be provided (tertiary settings, general 
hospitals, paediatric primary care and in the community). There is not much evidence on which to 
base best practice and most existing studies focus on specific diagnostic cohorts or specific care 
settings [1, 14, 15]. It was therefore the aim of this national study to comprehensively describe, explore 
and compare current practices in paediatric EOL care (for this study defined as the last four weeks of 
life) in four distinct diagnostic groups (cardiology, neonatology, neurology and oncology) across 
healthcare settings including all relevant levels of healthcare providers in Switzerland.  
4.4. Methods 
4.4.1. Study design 
This retrospective chart review was part of PELICAN (Paediatric End-of-LIfe-CAre Needs in 
Switzerland, 2012-2015, NCT01983852), a nationwide study “to provide comprehensive information 
and to understand the current practice of EOL care (i.e. in this study, the last 4 weeks of life prior to 
death) in paediatric settings in Switzerland (hospital and community care) and to explore and describe 
parental perspectives and the perspectives of the healthcare professionals involved” [16]. Human 
Research Ethics Committees from the 11 Swiss cantons in which the study took place approved the 
PELICAN study (leading committee: KEK ZH Nr. 2012-0537). Parents who had lost a child due to a 
cardiac, neurological or oncological condition or during the neonatal period (independent of the 
underlying condition) in the years 2011 and 2012 were invited to participate. Neonates < 24 hours of 
life and patients > 18 years were excluded. Information on how, where and when recruitment took 
place is described in detail elsewhere [17]. 
4.4.2. Setting and data collection 
Data from all eligible patients, whose parents had consented to the review of their child’s medical 
chart, were collected in 13 hospitals, two long-term institutions and 10 community-based healthcare 
service providers throughout Switzerland. Among the 13 hospitals, there were five tertiary paediatric 
centres, four dedicated children’s hospitals, three general hospitals with paediatric units and one 
tertiary care centre with a neonatal intensive care unit. A multiprofessional PPC team was available in 
two paediatric centres and one children’s hospital; no paediatric hospices exist in Switzerland. 
Data collection took place between November 2013 and June 2014. It was conducted mainly 
by the first author, who also developed the coding manual, all case report forms and instructed and 
supervised five assistants, who supported data collection [18]. In accordance with this study’s 
definition of EOL care being care during the last four weeks of life, data collection was restricted to the 
28 days prior to the child’s death. All extracted data was entered into secuTrial®, a browser-based 
electronic data capture system (InterActive Systems, Berlin, Germany). Five percent of the medical 
records reviewed by an assistant were promptly audited by the first author to detect and correct 
discrepancies [18]. Inconsistencies and emerging questions were continuously discussed among data 
collectors to ensure the quality of ongoing data extraction and reduce the likelihood of inter-rater 
discrepancies. 
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4.4.3. Variables 
The following data were collected for this study: (1) demographics (age, gender); (2) diagnostic 
information (the underlying diagnosis primarily responsible for the patient’s death, gestational age for 
newborns only, time since diagnosis, and whether the diagnosis was made prenatally); (3) 
circumstances of death (place of death, occurrence of resuscitation, existence of do not resuscitate 
[DNR] orders and whether these orders changed during the last four weeks of life, and treatment 
withdrawal); (4) interventions and medications (anaesthesia, ventilation, central access device, enteral 
feeds, number and types of medications); (5) symptoms (presence of various symptoms); (6) hospital 
and community healthcare utilisation (hospital days and admissions, days spent at home, number of 
days and hours, and types of care provided by community services). 
A diagnostic chapter and code from the International Statistical Classification of Diseases and 
Related Health Problems (ICD), 10th Revision, online version 2016 [19] was assigned by two 
investigators to each patient, based on the exact diagnostic information documented in the patient’s 
last medical report. All symptoms documented in the patient’s chart were recorded during data 
collection. The ones most frequently reported were categorised into 20 common symptoms based on 
existing literature [10, 14, 20]. Symptoms that affected similar areas like spasticity/dystonia for 
muscular impairments, or agitation/irritability for behavioural problems were grouped. 
4.4.4. Statistical analysis 
Descriptive statistics (measures of central tendency and dispersion, frequencies and percentages) were 
used to explore and summarize all variables. A binary logistic model with likelihood ratio statistics was 
utilised for two-tailed comparisons between the diagnostic groups of variables with a binominal 
response (Yes – No). For count outcome variables, negative binomial regression was utilised to adjust 
for overdispersion [21]. The neonatology group was specified as reference category, as it was the 
largest group, with results that often differed considerably compared to the other groups. For variables 
with a categorical response, equivalence of proportions between diagnostic groups was tested in 
contingency tables using the Pearson’s chi-square test or Fisher’s exact test when cell sizes were < 5. 
Because missing data were rare (reported in the tables) we did not pursue measures for missing value 
replacement. Due to the multiple comparisons performed, we set a conservative p-value of > 0.001 to 
indicate significance. Statistical analyses were performed using IBM© SPSS© Statistics 21 for Mac® 
(IBM Corp, Armonk, NY, USA). 
4.5. Results 
Of the 307 eligible families, 267 could be contacted and were invited to participate in the PELICAN 
study. Of those, 147 families (55%) consented. Two families lost twins resulting in a study sample of 
149 neonates, children and adolescents (Table I). With neonates comprising 38% of the sample, the 
median age at death was 0.5 years for the entire sample but substantially higher (Mdn = 8 years) for 
the oncology group. Seven ICD-10 diagnostic chapters were represented in our four groups’ 
categorisation, with the highest variety found within the neurology group. The median time between 
diagnosis of the life-limiting CCC and death for the total sample was one month (interquartile range 
[IQR], 0 – 6). Within the four groups, the median time between diagnosis and death was longest for 
the neurology group (Mdn = 6 months, IQR = 3 – 29). Diagnoses made prenatally, which were not 
taken into account in the above calculation, were significantly more frequent in the cardiology group 
compared to the other groups (p = < 0.001) and not present in the oncology group. 
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Table I. Demographic and diagnostic patient characteristics 
Characteristics 
Total 
N = 149  
(100%) 
Cardiology 
n = 19  
(13%) 
Neonatology 
n = 57  
(38%) 
Neurology 
n = 36  
(24%) 
Oncology 
n = 37  
(25%) 
Age, Mdn (range) 
in days 
in months 
in years 
 
Na 
6 (0 – 209) 
0.5 (0.0 – 17.4) 
 
Na 
6 (1 – 109) 
0.5 (0.1 – 9.1) 
 
5 (1 – 26) 
Na 
Na 
 
Na 
19 (1 – 207) 
1.6 (0.1 – 17.2) 
 
Na 
101 (20 – 209) 
8.4 (1.7 – 17.4) 
Gender, n (%) 
Female  
Male 
 
72 (48) 
77 (52) 
 
10 (53) 
9 (47) 
 
32 (56) 
25 (44) 
 
15 (42) 
21 (58) 
 
15 (40) 
22 (60) 
ICD-10 chapter, description, n (%) 
II  Neoplasms 
III  Blood/immune system 
IV  Endocrine, nutritional, metabolic 
VI  Nervous system 
IX  Circulatory systema 
XVI  Conditions originating in perinatal period 
XVII  Congenital, chromosomal 
 
36 (24) 
1 (1) 
6 (4) 
21 (14) 
5 (3) 
45 (30) 
35 (24) 
 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
4 (21) 
0 (0) 
15 (79) 
 
0 (0) 
0 (0) 
0 (0) 
2 (4) 
0 (0) 
44 (77) 
11 (19) 
 
0 (0) 
0 (0) 
6 (16) 
19 (53) 
1 (3) 
1 (3) 
9 (25) 
 
36 (97) 
1 (3) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
Gestational age (for the neonatology group only) 
24 0/7 – 27 6/7 
28 0/7 – 31 6/7 
32 0/7 – 36 6/7 
37 0/7 - > 42 0/7 
 
Na 
Na 
Na 
Na 
 
Na 
Na 
Na 
Na 
n = 52b 
17 (33) 
8 (15) 
9 (17) 
18 (35) 
 
Na 
Na 
Na 
Na 
 
Na 
Na 
Na 
Na 
Time since diagnosisc 
in days, Mdn (range) 
in months, Mdn (range) 
in years, Mdn (range) 
n = 139c 
Na 
1 (0 – 167) 
0 (0 – 14) 
n = 18c 
Na 
6 (0 - 66) 
0.5 (0.0 – 5.5) 
 
4 (1 – 26) 
Na 
Na 
n = 28c 
Na 
6 (0 - 167) 
0.5 (0.0 – 14.0) 
n = 36c 
Na 
4 (0 - 139) 
0.5 (0.0 – 12.0) 
Diagnosis made prenatally 
Yes, n (%) 
n = 139c 
31 (21) 
 
11 (58) 
 
13 (23) 
n = 34c 
7 (21) 
 
0 (0) 
Note. Na = Not applicable. ICD-10 = International Classification of Diseases, 10th Revision. 
a.Stroke included. bInformation was missing for some cases. cCalculated from date of birth, even if diagnosis was suspected prenatally. 
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Table II. Place and circumstances of death 
 
Total 
N = 149  
(100%) 
Cardiology 
n = 19  
(13%) 
Neonatology 
n = 57  
(38%) 
Neurology 
n = 36  
(24%) 
Oncology 
n = 37  
(25%) 
p-value 
Place of death, n (%) 
PICU 
NICU 
Hospital / long-term institution 
Home 
Emergency department / Transport 
 
63 (42) 
30 (20) 
26 (18) 
25 (17) 
5 (3) 
 
13 (67) 
0 (0) 
2 (11) 
2 (11) 
2 (11) 
 
27 (48) 
27 (48) 
0 (0) 
2 (3) 
1 (1) 
 
13 (36) 
3 (8) 
13 (36) 
7 (20) 
0 (0) 
 
10 (27) 
0 (0) 
11 (30) 
14 (38) 
2 (5) 
< 0.001a 
CPRb 
Yes, n (%) 
 
26 (17) 
 
7 (37) 
 
6 (11) 
 
7 (19) 
 
6 (16) 
 
0.097c 
DNR order 
Yes, n (%) 
 
91 (62) 
 
11 (58) 
 
20 (35) 
 
33 (92) 
n = 35d 
27 (77) 
 
< 0.001c 
DNR status change within the last four weeks of life 
Yes, n (%) 
n = 147d 
93 (63) 
 
11 (58) 
 
50 (88) 
n = 35d 
16 (46) 
n = 36c 
16 (44) 
 
< 0.001c 
Withdrawal of life-sustaining interventionse 
Yes, n (%) 
n = 93 
78 (84) 
n = 13 
10 (77) 
n = 54 
49 (91) 
n = 16 
12 (75) 
n = 10 
7 (70) 
 
0.203c 
Note. PICU = Paediatric intensive care unit. NICU = Neonatal intensive care unit. CPR = Cardiopulmonary resuscitation. DNR = Do not resuscitate. 
aFisher’s exact test. bWithin 24 hours before death. cLikelihood ratio chi-square. dInformation was missing for some cases. eOnly applies to patients who died in 
an intensive care unit. 
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4.5.1. Place and circumstances of death 
Ninety-three patients (62%) died in an intensive care unit (ICU) with the highest proportion (96%) of 
these patients being in the neonatology group (Table II). Twenty-five patients (17%) died at home with 
the highest proportion (38%) in the oncology group. Twenty-six patients (17%) received 
cardiopulmonary resuscitation (CPR) within 24 hours before death. A do not resuscitate (DNR) order 
was documented in 91 patients’ charts (62%). The DNR status changed within the last four weeks of 
life for 93 patients (63%), most often within the neonatology group (n = 50, 88%) and shortly before 
the child’s death. For 78 patients (84%) of the 93 who died in an ICU, death was preceded by a 
decision to withdraw life-sustaining interventions. 
4.5.2. Interventions, medication and symptoms 
During the last four weeks of life, patients underwent several interventions, suffered from a variety of 
symptoms, and received a considerable amount of medication as documented in their charts. This 
information is detailed in Table III and Figure 1. The most common documented interventions 
requiring anaesthesia were surgical interventions in 28 patients (55% of the 51 patients that received 
anaesthesia) and diagnostic procedures, e.g. imaging in 27 patients (53%). The number of medications 
with orders for standard daily doses and as needed orders was assessed for the last two weeks of life. 
The overall median number rose from 9 (range = 0 - 42) during the second last week to 12 (range = 1 
– 46) during the last week. For 133 patients (89%) the last treatment approach was documented as 
palliative. However, the approach changed during the last month in 88 patients (59%), most 
commonly in the neonatology group and least commonly in the oncology group (90% vs. 32%, p = < 
0.001). 
Pain was the most frequent symptom documented, and occurred in 110 patients (78%, N = 
141) with no significant differences between the diagnostic groups. One hundred and forty patients 
(95%, N = 148) received some sort of pain medication, most commonly opioids (93%) followed by 
paracetamol (67%), the latter predominantly in oncology patients. Other common symptoms included 
breathing problems (n = 107, 72%), followed by behavioural problems such as agitation or irritability 
(n = 89, 60%). Some symptoms such as respiratory secretion, fever, nausea/vomiting, coughing, 
sweating, fatigue, drowsiness, anxiety, including worry and sadness, and poor appetite differed 
significantly (p = < 0.001) between the diagnostic groups (Figure 1). Overall, an average of 6.42 (SD = 
3.14) symptoms were recorded per patient. Significantly fewer symptoms were reported in neonates 
(M = 4.39, SD = 2.15) compared to all other groups (p = < 0.001). 
4.5.3. Hospital and community healthcare utilisation 
Overall, our study patients stayed in the hospital for a median of six days (IQR = 2 – 19) during their 
last four weeks of life, with the highest number of hospital days for patients in the cardiology group 
(Table IV). Twenty patients (13%) had no hospital days, 12 (60%) from the oncology, 5 (25%) from the 
neurology, 3 (15%) from the cardiology, and zero from the neonatology group. Among the 129 patients 
who had at least one hospital day,61 patients (47%) had one hospital admission, 11 patients (8.5%) 
two, and 2 patients (2%) had 3 admissions during the last four weeks of life. Fifty-six patients (43%) 
had zero hospital admissions, meaning that those patients were hospitalised at the beginning of data 
collection and remained there until their death or discharge. Of the 57 patients in the neonatology 
group, 23 patients (40%) were born in a hospital with no ICU and had to be transferred to a referral 
tertiary hospital with an ICU. Patients from the other diagnostic groups were most commonly 
admitted from home (Table IV). 
Seventy-two patients (48%) stayed at home for at least one day during their last four weeks of 
life, with patients from the oncology group having the highest number of home days (Mdn = 24, IQR = 
4 - 28), followed by patients from the neurology group (Mdn = 21, IQR = 4 - 26). Of the 72 patients 
who stayed at home, 36 (50%) received professional care from a community-based service. The 
provision of education and support to empower the family was the most commonly provided service as 
documented by the care provider, and patients from the neurology group received more care hours 
than patients from the other groups (Table IV). 
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Figure 1. Symptom prevalence and comparison between  
the four diagnostic groups. 
Note. ** = p-value  < 0.001. 
aAdjusted for mechanical ventilation. bAdjusted for enteral feeds.  
cNeonatology group excluded due to 0 % of symptom presence. 
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Table III. Interventions and medications during the last four weeks of life 
 
Total 
N = 149  
(100%) 
Cardiology 
n = 19  
(13%) 
Neonatology 
n = 57  
(38%) 
Neurology 
n = 36  
(24%) 
Oncology 
n = 37  
(25%) 
p-value 
Interventions requiring anaesthesia 
Yes, n (%) 
 
51 (35) 
 
11 (58) 
 
21 (37) 
n = 35a 
6 (17) 
 
13 (35) 
 
0.021b 
Mechanical ventilation 
Yes, n (%) 
 
94 (63) 
 
14 (74) 
 
55 (97) 
 
15 (42) 
 
10 (27) 
 
< 0.001b 
ECMO 
Yes, n (%) 
 
7 (5) 
 
4 (21) 
 
3 (5) 
 
0 (0) 
 
0 (0) 
 
< 0.001b 
CAD 
Yes, n (%) 
n = 148a 
106 (72) 
 
14 (74) 
 
55 (97) 
 
12 (33) 
n = 36a 
25 (69) 
 
< 0.001b 
Enteral feeds via nasogastric or gastrostomy tube 
Yes, n (%) 
n = 148a 
114 (77) 
 
17 (90) 
 
51 (90) 
n = 35a 
33 (94) 
 
13 (35) 
 
< 0.001b 
Medication count in the last week of lifec 
Mdn, (range) 
n = 146a 
12 (1 - 46) 
 
19 (3 - 45) 
 
12 (1 - 34) 
n = 35a 
10 (3 - 39) 
n = 35a 
13 (4 - 46) 
 
0.006b 
Pain medication 
Yes, n (%) 
n = 148a 
140 (95) 
 
18 (95) 
 
54 (95) 
n = 35a 
33 (94) 
 
35 (95) 
 
1.000b 
Anxiolytic medication 
Yes, n (%) 
n = 145a 
84 (58) 
 
14 (74) 
 
27 (47) 
n = 35a 
18 (51) 
n = 34a 
25 (74) 
 
0.032b 
Antiemetic medication 
Yes, n (%) 
n = 146a 
25 (17) 
 
2 (11) 
 
0 (0) 
n = 35a 
0 (0) 
n = 35a 
23 (66) 
 
< 0.001b 
Note. ECMO = Extracorporeal membrane oxygenation. CAD = Central access device, either venous or arterial. 
aInformation was missing for some cases. bLikelihood ratio chi-square. cIncludes both standing daily dosages and as-needed orders. 
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Table IV. Hospital and community healthcare utilisation during the last four weeks of life 
 
Total 
N = 149  
(100%) 
Cardiology 
n = 19  
(13%) 
Neonatology 
n = 57  
(38%) 
Neurology 
n = 36  
(24%) 
Oncology 
n = 37  
(25%) 
p-value 
Hospital days, Mdn (range) 6 (0 - 28) 20 (0 - 28) 5 (1 - 26) 7 (0 - 28) 4 (0 - 28) 0.035a 
Care setting before hospital admissionb, n (%) 
Home 
Other hospital 
Emergency department 
Outpatient clinic 
Long-term institution 
n = 88c 
37 (42) 
35 (40) 
8 (9) 
7 (8) 
1 (1) 
n = 17 
11 (64) 
3 (18) 
3 (18) 
0 (0) 
0 (0) 
n = 23 
0 (0) 
23 (100) 
0 (0) 
0 (0) 
0 (0) 
n = 26 
16 (62) 
4 (15) 
4 (15) 
1 (4) 
1 (4) 
n = 22 
10 (45) 
5 (23) 
1 (5) 
6 (27) 
0 (0) 
 
NAd 
NAd 
NAd 
NAd 
NAd 
Patients at home at least for one day, n (%) 72 (48) 11 (58) 3 (5) 27 (75) 31 (84) < 0.001a 
Days spent at home, Mdn (range) 0 (0 - 28) 8 (0 - 28) 0 (0 - 16) 21 (0 - 28) 24 (0 - 28) 0.001a 
Care days with community care servicee,  
Mdn (range) 
n = 72 
1 (0 - 28) 
n = 11 
0 (0 - 24) 
n = 3 
1 (0 - 5) 
n = 27 
5 (0 - 28) 
n = 31 
0 (0 - 28) 
 
0.001a 
Hours of care by community care servicee 
Mdn (range) 
n = 36 
34 (2 - 315) 
n = 5 
12 (7 - 190) 
n = 2 
6 (3 - 8) 
n = 15 
38 (4 - 315) 
n = 14 
23 (2 - 108) 
 
0.111a 
Type of community care service 
Family education/support, n (%) 
Needs assessment, n (%) 
Monitoring of vital signs/general condition, n (%) 
Administration of medication, n (%) 
Interventions related to enteral feeds, n (%) 
Respiratory interventions, n (%) 
Interventions related to excretion, n (%) 
 
35 (97) 
31 (86) 
29 (81) 
25 (69) 
22 (61) 
18 (50) 
14 (39 
 
5 (100) 
4 (80) 
5 (100) 
5 (100) 
5 (100) 
2 (40) 
1 (20) 
 
2 (100) 
1 (50) 
2 (100) 
0 (0) 
1 (50) 
0 (0) 
0 (0) 
 
14 (93) 
13 (87) 
13 (87) 
10 (67) 
13 (87) 
11 (73) 
6 (40) 
 
14 (100) 
13 (93) 
9 (64) 
10 (71) 
3 (21) 
5 (36) 
7 (50) 
 
NAd 
NAd 
NAd 
NAd 
NAd 
NAd 
NAd 
Note. NA = Not applicable. 
aLikelihood ratio chi-square. bRepresenting the cumulative hospital admissions in all patients. cInformation was missing for some cases. dNo significance testing 
conducted due to small numbers. eConsisting of nurses, most of them specialised in paediatric and/or community nursing
 Page 40/93 
4.6. Discussion 
There are several principal findings in this nationwide study looking at patterns of care at EOL in four 
distinct cohorts of diagnostic groups: patients had a variety of primary diagnoses, covering seven 
different ICD-10 diagnostic chapters; sixty-two percent of all patients died in ICUs, with 84% of them 
following a decision to withdraw life-sustaining treatment; reliance on invasive medical interventions 
was prevalent and patients were exposed to polypharmacy; patients experienced many symptoms with 
an average of six symptoms per patient; and less than half of the patients were at home at any point 
during their last four weeks of life with patients in the cardiology and neonatology groups having 
considerably fewer home days than patients in the neurology and oncology groups. However, the days 
of care provided by community healthcare providers were also low for these groups.  
The study provides a comprehensive overview of current EOL care practices in a 
heterogeneous real-life setting of hospitals, long-term institutions and community healthcare 
organisations. The inclusion of patients with all major diagnoses responsible for disease- and 
prematurity-related childhood deaths and comparisons across the diagnostic groups provides 
additional insight and understanding for healthcare professionals. Previous studies in this field were 
frequently limited to the hospital setting [1, 9] or to a specific diagnostic group [10, 14, 15]. Our study 
is limited by its cross-sectional, primarily descriptive design incorporating a retrospective chart 
review. This approach does not allow conclusions to be drawn about care quality and quality of life at 
the EOL. Future analysis of other data from the PELICAN study will overcome some of these 
limitations by linking results about the parental perspective, which are reported elsewhere [17]. Known 
reliability issues related to chart reviews were kept to a minimum by taking established and 
appropriate measures. However, mixed quality of documentation among healthcare personnel 
resulting in incomplete or missing data still limits the data’s reliability [18]. 
The comparisons between the four major diagnostic groups highlight elements that warrant 
discussion. Medication counts in our study were high, with an overall daily median of 12 drugs daily or 
as-needed medication orders during the last week of life. This number is higher than the reported 
average of 9 drugs in a study involving 515 paediatric patients with a similar diagnostic profile 
receiving and PPC [9], and considerably higher than the total number of 3.5 different drug categories 
reported in a study of 275 children during PC with diagnoses matching our neurology group [14]. We 
found that the medication count increased from the second-to-last week to the last week of life. Thus it 
seems that the intensity of medical treatment increases as the child nears death, a phase which is 
accompanied by a greater need for pharmacological interventions, especially for relieving pain. The 
high number of medications in the cardiology group is often due to frequent need for CPR and a high 
prevalence of surgical interventions, which are also described in other studies with cardiological 
patients [15, 20]. Although not perfectly comparable, symptom type and prevalence differed from the 
aforementioned study of 515 patients receiving PPC, in which pain was only the sixth most frequent 
symptom as extracted from patients’ charts [9]. However, pain has been reported as the most frequent 
symptom in other studies with various paediatric cohorts in PC or EOL care [10, 14]. Our study adds to 
existing knowledge by demonstrating that symptom prevalence is dependent on the underlying CCC 
and that it can differ considerably. 
Slightly less than 50% of our study’s patients were at home at some point during their last four 
weeks of life. Naturally, this was only true for very few neonates. In light of the probably growing rate 
of prenatal diagnosis of a life-limiting CCC, early initiation of PPC may allow better planning and 
implementation of specialised care services at home [22]. A recent study from the US showed that 54% 
of hospital-based PPC programmes participating in a 2012 survey provided prenatal consultation 
[13].Of our study patients who spent at least one day at home, only half received community-based 
healthcare services. Recent data from Germany and the US show that the coordination and provision 
of specialised palliative home care is able to alleviate caregivers’ distress and burden [23]. and to 
improve both the child’s [24]. and the caregivers’ quality of life [23]. As reported by our study, 
community nursing care encompasses a range of service types. The high level of coordination with the 
leading team in the hospital and the expertise required makes it especially challenging. Further 
subgroup analysis of our study’s at-home population is ongoing and will target facilitators for and 
barriers to EOL care in the home setting. 
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PPC is growing internationally and the provision of consultation by a hospital-based 
multiprofessional PPC team seems to be the favoured model of care [13]. This requires a high level of 
expertise and efficient collaboration across a variety of paediatric subspecialties. The capacity of 
community healthcare services needs to be expanded with an emphasis on efficient coordination and 
continuity of care. As already recommended by an EAPC White Paper [25], outcome measurement has 
to be introduced into practice to evaluate quality of care and further advance research in the field. 
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5.1. Abstract 
Aim. To develop and test the Parental PELICAN Questionnaire, an instrument to retrospectively 
assess parental experiences and needs during their child’s end-of-life care. 
Background. To offer appropriate care for dying children, healthcare professionals need to 
understand the illness experience from the family perspective. A questionnaire specific to the end-of-
life experiences and needs of parents losing a child is needed to evaluate the perceived quality of 
paediatric end-of-life care. 
Design. This is an instrument development study applying mixed methods based on 
recommendations for questionnaire design and validation. 
Method. The Parental PELICAN Questionnaire was developed in four phases between August 2012–
March 2014: phase 1: item generation; phase 2: validity testing; phase 3: translation; phase 4: pilot 
testing. Psychometric properties were assessed after applying the Parental PELICAN Questionnaire in 
a sample of 224 bereaved parents in April 2014. Validity testing covered the evidence based on tests of 
content, internal structure and relations to other variables. 
Results. The Parental PELICAN Questionnaire consists of approximately 90 items in four slightly 
different versions accounting for particularities of the four diagnostic groups. The questionnaire’s 
items were structured according to six quality domains described in the literature. Evidence of initial 
validity and reliability could be demonstrated with the involvement of healthcare professionals and 
bereaved parents. 
Conclusion. The Parental PELICAN Questionnaire holds promise as a measure to assess parental 
experiences and needs and is applicable to a broad range of paediatric specialties and settings. Future 
validation is needed to evaluate its suitability in different cultures. 
5.2. Summary statements 
Why is this research needed? 
 Paediatric end-of-life care is challenging and complex, covers several paediatric specialties and 
different age groups, and has specificities other than in adult end-of-life care. 
 To offer appropriate care for dying children and adolescents, healthcare professionals need to 
understand the illness experience from the parental perspective and to anticipate their needs. 
 No valid instrument exists that allows a standardised assessment of parental experiences and 
needs in order to evaluate the quality of paediatric and neonatal end-of-life care. 
What are the key findings? 
 The Parental PELICAN Questionnaire (PaPEQu), designed to assess parental experiences and 
needs, aims at providing an evaluation tool for the perceived quality of family-centred 
paediatric and neonatal end-of-life care. 
 The PaPEQu was developed based on six quality domains of family-centred care identified in 
the literature, providing a conceptualization of themes deemed most important to parents. 
 Evidence of initial validity and reliability were demonstrated with the involvement of 
experienced healthcare professionals and more than 200 bereaved mothers and fathers. 
How should the findings be used to influence policy/practice/research/education? 
 The four slightly different versions of the PaPEQu make it applicable to a broad range of 
paediatric specialties and settings.  
 The instrument should be further tested in populations with different cultural backgrounds 
and with a bigger sample for each diagnostic group. 
 Future research should focus on empirical model development and testing, to facilitate the 
development, implementation and evaluation of appropriate interventions. 
5.3. Introduction 
Losing a child is a traumatic life event for parents, siblings and the extended family, in which highly 
stressed parents try to maintain hope while readying themselves for the loss of their child. When the 
death of a child is imminent, care focuses on preparing for an anticipated death while managing the 
end stage of a life-limiting medical condition. End-of-life (EOL) care of these vulnerable patients and 
families demands a comprehensive approach that includes the need for healthcare professionals to 
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understand the illness experience from the perspective of the dying child and his/her family in order to 
offer appropriate care [1-3]. Prior studies describing the experiences of parents who lost a child show 
that open and honest communication, true relationships and adequate emotional support, symptom 
control and alleviation of suffering, continuity and coordination of care, and support after the death of 
the child are central issues for parents [2, 4]. Most of this evidence originates from qualitative 
research; only three quantitative studies were identified in two recent integrative reviews [2, 4]. 
Quality improvement initiatives risk meeting the values of healthcare professionals rather than those 
of parents, if the parental perspectives are not evaluated with valid measures [3, 5]. To assess and 
explore the parental perspective effectively, an approach combining quantitative and qualitative 
information is likely to provide the most comprehensive view of experiences and unmet needs [6]. 
5.3.1. Background 
Family experiences and needs are influenced by the quality of care [6]. Healthcare quality is a complex 
concept, which is challenging to measure. The assessment of care quality requires indicators which can 
be used to develop a valid and reliable measure [3]. Existing evidence from qualitative research has led 
to the Initiative for Pediatric Palliative Care (IPPC) and the identification of six quality domains to 
guide quality improvement and development of healthcare services for families of 
children/adolescents with life-threatening illnesses [7, 8]. These domains include: “Holistic Care of the 
Child; Support of the Family Unit; Involvement of Child and Family in Communication, Decision 
Making, and Care Planning; Relief of Pain and Other Symptoms; Continuity of Care; and Grief and 
Bereavement Support” [7, p. 328] and should be addressed to enhance the capacity of children’s 
hospitals and home care organisations to provide high quality family-centred palliative and EOL care. 
A literature review revealed few self-administered questionnaires designed to assess the 
experiences and needs of parents of dying children and adolescents. Meert et al. [9] developed the 68-
item Bereaved Parent Needs Assessment (BPNA) instrument to measure parents’ needs and need 
fulfilment around the time of their child’s death in the paediatric intensive care unit (PICU). The 
instrument showed high reliability (Cronbach’s ɑ > 0.92) for the importance, fulfilment, and percent 
fulfilment scales. Criterion validity was partly demonstrated by correlating the BPNA with the 
Inventory of Complicated Grief and the World Health Organization Quality of Life questionnaires. 
The authors suggest using the instrument to assess parents’ needs and fulfilment of needs within and 
across PICUs rather than for individual parents [9]. Another questionnaire for PICU settings in the 
United States was developed by Meyer et al. [10] to examine the perspectives and priorities of parents 
for improved EOL care. No validity or reliability data were reported for this 28-item Parental 
Perspectives Questionnaire. In a Swedish population-based study involving parents who lost their 
child to cancer and focusing on parents’ self-assessment of whether they had worked through their 
grief and whether professional and social support facilitated this process, Kreicbergs et al. [11] 
developed a self-administered instrument with 129 questions and a total of 365 items. Part 1 of the 
questionnaire covered domains such as communication, symptom control and treatment, and issues 
around the impending death of the child. The questionnaire was developed involving bereaved parents 
and piloted to test for participation rate, failure to respond and logistics, but no validity data were 
reported.  
Teno et al. [12] suggested that the most important aspect to evaluate quality of care is to assess 
whether healthcare providers responded to the expectations and preferences of the dying patient and 
their families. This can be achieved with asking very specific questions concerning the parents’ lived 
experiences [13]. Widger and Picot et al. [13] stated, that “one of the major barriers to evaluating end-
of-life care provided to children and their families has been the lack of a comprehensive and sensitive 
instrument that can be used to collect meaningful information from families who have experienced the 
death of a child” [13p. 53]. Just recently Widger et al. [3] reported on the initial development and 
testing of an instrument to measure the quality of children’s EOL care. The 95-item instrument 
demonstrated initial evidence for test-retest reliability, internal consistency and construct validity for 
six subscales, and content validity for four additional domains. The instrument shows promise for the 
retrospective application in bereaved mothers. However, the applicability in bereaved fathers remains 
an open question [3]. 
None of the instruments available at the beginning of this study included all of the quality 
domains identified by the IPPC and were applicable to the heterogeneous field of paediatric EOL care, 
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including children/adolescents of different age groups, with different underlying illnesses and in 
different clinical settings, and finally, none considered maternal and paternal perspectives. Gaining 
uniform information across these different situations will help identifying differences between 
subgroups and thus, add important and essential knowledge needed for healthcare professionals to 
provide individualized family-centred care during this difficult period of time. 
5.4. The study 
5.4.1. Aim 
The purpose of this study was to develop and test the Parental PELICAN Questionnaire (PaPEQu), an 
instrument to retrospectively assess parental experiences and needs during their child’s EOL care. This 
study is part of a larger study; the PELICAN study (Paediatric End-of-LIfe CAre Needs, 2012-2015, 
NCT 01983852). The overarching aim of the PELICAN study is to provide comprehensive information 
and understanding about current practices of EOL care in Switzerland (PELICAN I, retrospective chart 
review), about parental perspectives (PELICAN II, mixed methods) and the perspectives of the 
healthcare professionals (PELICAN III, focus groups) in order to formulate recommendations for best 
care during this highly vulnerable and critical phase of life. The PELICAN study is a nationwide study 
encompassing three Swiss language regions and including patients who died in the years 2011 and 
2012 due to a cardiac, neurologic or oncologic illness or during the neonatal period and their parents, 
and healthcare professionals [14].  
5.4.2. Ethical considerations 
The question had been raised about whether research in bereaved families is reasonable. However, 
studies with bereaved subjects have shown response rates as high as 80% [11], which is consistent with 
our experience that parents who lost a child want to tell their story. Nevertheless we decided to choose 
an interval of at least 12 months after the child’s death so that parents would have passed the 
immediate stages of grief. This is in concordance with Maciejewski et al. [15] who reported that all 
negative grief indicators peaked within six months post loss. 
The PELICAN study was approved by the ethics committees in all of the Swiss cantons in 
which the study took place. Eligible parents were informed and invited to participate in the study by 
the former treating team, who also acted as gatekeeper as needed. Only a few families were excluded 
because it would have been inappropriate to invite them. Participation was entirely voluntary and 
written informed consent was obtained from all participants and for each study part independently. 
Due to the sensitive topic, psychological support was offered to potentially distraught parents. 
5.4.3. Methodology 
Questionnaire development followed recommendations by Streiner and Norman et al. [16] and Rattray 
and Jones et al. [17]. The development process was conducted in four phases: phase 1: item 
generation; phase 2: validity testing; phase 3: translation; and phase 4: pilot survey. Psychometric 
properties were assessed using the results of the PELICAN II study, quantitative part. Validity testing 
covered evidence based on test content, internal structure, and relations to other variables according 
the Standards for Educational and Psychological Testing [18].  
5.4.4. Instrument development phase 1: Item generation 
The first set of items, written in German, was generated from August-September 2012 within the study 
group and was based on scientific evidence and existing similar instruments found in the literature [9-
11, 13], the expertise of group members within the field of paediatric PC and/or in the four paediatric 
sub-specialties (cardiology, neonatology, neurology and oncology). It became clear early in the 
development process that separate questionnaires for each of the four diagnostic groups (cardiology, 
neonatology, neurology, and oncology) were needed to account for age and illness trajectories 
differences between the four groups. However, item differences between the four questionnaires were 
kept to a minimum to preserve the opportunity to analyse data from the entire sample. The items were 
thematically structured according to the six quality domains grounded in the framework of the IPPC 
[7]. As proposed by Truog et al. [19], “Holistic Care of the Child” and “Support of the Family unit” were 
integrated and “Shared Decision Making” was disentangled from “Communication” and became a 
separate domain. Within each of the six domains, items were organised into scales concerning parental 
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experiences and indexes for parental needs [20]. For experience-related items, 7-point adjectival 
response options with varying end-points anchors, “never-always”, “not clear at all-very clear”, “not 
honest-honest”, or 5-point Likert-type response options where respondents indicated the extent to 
which they agreed with the statement were crafted. For needs-related items, 7-point adjectival indexes 
with end-point anchors “not important at all-very important” were used [16]. Content of the needs-
related items was closely linked to the experience-related items within the same domain unless it was 
not appropriate, e.g. asking how important parental need was to alleviate pain in their child. Questions 
requiring a multiple choice or dichotomous response pattern were also integrated in the domains as 
appropriate. To summarise, parents were asked to indicate their overall satisfaction with each of the 
topics of the six domains on a 7-point scale with end-point anchors of “not satisfied at all and totally 
satisfied”, and a “neutral” label in the middle. Additionally they were asked to: (1) list three positive 
experiences and three negative experiences in an open-ended question; (2) indicate what areas of their 
personal life were negatively influenced by the illness and loss of their child by choosing all that apply 
from given response options; and (3) how they would rate their current overall quality of life (QoL) on 
a vertical visual analogue scale (VAS) ranging from 0 (worst possible) to 10 (maximum). The final 
section of the questionnaire included socio-demographic items. For the pilot test only, parents were 
asked to indicate, the level of burden of completing the questionnaire again on a (VAS) ranging from 0 
(no burden) to 10 (maximum burden). For scoring, only experience-related scale items were summed 
to yield one experience score for each domain. All other items were treated as single items. 
5.4.5. Instrument development phase 2: Validity testing – evidence based on test content 
The validity of the questionnaires based on test content was assessed in three stages.  
Stage 1: Item review, face validity and content validity index (first round) 
In a first round, 26 German-speaking Swiss medical, nursing and psychology clinicians in the field of 
paediatric PC and/or working in one of the four paediatric sub-specialties (7, 7, 7, and 5 for the 
cardiology, neonatology, neurology, and oncology version respectively) reviewed the initial drafts of 
the questionnaires between October and December 2012. For each individual item, the experts were 
asked to rate its clarity (not clear (0) / clear (1)) and relevance (not relevant (1) / somewhat relevant 
(2) / quite relevant (3) / highly relevant (4)) in relation to parental experiences and needs related to 
their child’s EOL care [21]. In addition, the experts were told that they could add comments for each 
item. To evaluate the agreement among experts concerning the clarity and relevance of single items, 
item content validity indexes (I-CVI) were calculated. The I-CVI was computed as the number of 
experts giving a rating of either 1 for clarity and either 3 or 4 for relevance, divided by the total number 
of experts. An item with an I-CVI of ≥ 0.78 for its relevance was considered to have excellent validity, 
whereas items with an I-CVI < 0.78 needed to be revised. As for the validity of the entire 
questionnaire, the average I-CVI across all items (S-CVI/Ave) [21] and the proportion of items with an 
I-CVI > 0.78 were calculated. For the S-CVI/Ave Polit et al. [21] recommends at least a value > 0.8, but 
ideally, better than 0.9. The same thresholds were also applied to the calculations for the clarity of the 
items. The written expert’s comments were summarised for each item and taken into consideration 
when discussing potential revisions of the items by the study group. 
Stage 2: Cognitive interviews 
To ensure that the perspectives and issues relevant to parents who lost a child were captured by the 
questionnaire, individual cognitive interviews were conducted with four parents who lost a child in 
2010. The goal of cognitive debriefing is to pre-test survey instruments by evaluating sources of 
response errors. It explicitly focuses on the cognitive processes respondents use to answer survey 
questions [22]. The parents in the current study were recruited purposefully from two tertiary care 
centres with the goal of having one representative of each of the four diagnostic groups. All interviews 
were conducted at the parents’ home between April and May 2013. During the interviews the parents 
were asked to repeat the questions in their own words to assess comprehensibility, and they were 
asked to evaluate the relevance of items and single words. They were also asked about their ability to 
recall their child’s EOL period and about the burden associated with answering the questions. The 
interviews were structured, using an interview guide with probing questions to gain a deeper 
understanding of the way respondents interpreted the questionnaire items. All interviews were audio 
recorded and analysed within the study group based on the written interview protocol which 
summarised interview content.  
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Stage 3: Item review, face validity (second round).  
In a second round, a subsample of 7 (3 physicians, 4 nurses) was chosen from the 26 clinicians who 
participated in the first round to review the revised questionnaires again and to provide written 
feedback for the current items focusing on which domain the item was measuring and whether the 
concepts of parental experiences and needs during their child’s EOL care were covered. 
5.4.6. Instrument development phase 3: Translation 
The four versions of the PaPEQu were then translated into French and Italian, the two other main 
languages in Switzerland, during June/July 2013. The translation process followed the guidelines of 
the International Society of Pharmacoeconomics and Outcome Research (ISPOR) taskforce for 
Translation and Cultural Adaptation [23]. The three steps applied included: (1) forward translation 
(conducted by a French or Italian bilingual layperson); (2) back translation (conducted by professional 
translators); (3) back translation review and harmonisation. The cognitive debriefing step was omitted 
for the French and Italian versions. The study team reasoned that potential comprehensibility issues 
could be uncovered and resolved during step 3 of the translation process and during the planned pilot 
survey. Additionally, the target population of the questionnaires in the French and Italian part of 
Switzerland was very small and the goal was to minimize parental burden associated with 
participation. 
5.4.7. Instrument development phase 4: Pilot survey 
In order to further identify items that lack clarity or may not be appropriate for bereaved parents, to 
test the recruitment strategy and logistics, and to assess the level of burden associated with filling out 
the questionnaire, a pilot survey was conducted in a sample of French, German and Italian speaking 
parents This survey was conducted in three Children’s University Hospitals in the German part, one 
paediatric department of a University Hospital in the French part and the Paediatric Medical Centre in 
the Italian part of Switzerland. Purposefully chosen parents of patients who died in the year 2010 due 
to a cardiac, neurologic or oncologic illness or during the first four weeks of the child’s life were invited 
to participate. The recruitment goal was to reach a stratified sample of 36 families (3 for each 
diagnostic group and each language). Eligible parents received an invitation letter together with the 
study documents from the hospital where their child had been treated. Following parental written 
informed consent, the families’ demographic information was transmitted by the research coordinator 
from each site to the study team and the questionnaires were sent out from the study centre during 
September 2013. Each questionnaire was assigned a unique ID to enable follow-up of those who did 
not complete the questionnaire. Three weeks after sending out the questionnaires, a reminder card 
was sent to those parents who did not return their questionnaire. Non-responders to this reminder 
were dropped from the study. 
5.4.8. Setting and sample of the PELICAN II study, quantitative part 
The same recruitment processes were applied for the PELICAN II study. Beforehand, all Swiss 
children’s hospitals, general hospitals with a paediatric unit, long-term institutions and paediatric 
community care services had committed to participate and execute the recruitment procedures. All 
parent couples of the population-based available sample of 307 deceased children were invited if; 1) 
their child died in the years 2011 or 2012 due to a cardiac, neurologic or oncologic illness or during the 
neonatal period (from the first day up to four weeks of life); 2) they could read French, German or 
Italian. Parents were excluded if their child died within the first 24 hours after birth. Recruitment took 
place in 17 hospitals, 2 long-term institutions, 4 paediatric community care services, and at 2 
paediatric practitioners’ practices between July 2013 and March 2014. Other than in the pilot survey, 
parents who did not provide written informed consent within three weeks after receipt of the study 
documents were called by phone, and verbal study information and clarification of potential questions 
was offered by the local study coordinator. Of the 307 families invited, 135 (44%) consented for the 
questionnaire survey (PELICAN II, quantitative part). In April 2014, questionnaires were sent out to 
224 mothers and fathers who individually consented. 
5.4.9. Data Analysis 
For each item the percentage of missing responses was calculated. Possible reasons identified for not 
responding to an item were that respondent found the item objectionable or found the item too 
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difficult to understand [16, 17]. The distribution of responses was checked by measures of central 
tendency and dispersion. Evidence based on internal structure was assessed through inter-item 
correlation, Cronbach’s alpha, and exploratory factor analysis (EFA). Items within a scale should be 
positively and moderately correlated, after negatively formulated items are recoded. Cronbach’s alpha 
gives the average of all possible split-half reliabilities of a scale and values above 0.7 are considered 
“good” for scales with fewer than seven items [16]. EFA, using principle axis factoring was applied to 
test for unidimensionality of the six different experience scales. Sampling adequacy for analysis was 
verified following the Kaiser-Meyer-Olkin measure of sampling adequacy (KMO) for individual and for 
multiple items. Values > 0.5 are considered mediocre, > 0.7 good and > 0.8 great. Factors were 
extracted based on eigenvalues > 1. Since only one factor for each scale was expected, no rotation was 
needed for interpretation [24]. Only scale items that were applicable to all respondents were included 
in reliability testing and used to calculate a scale mean. For two scales, the responses to two items that 
were worded differently for the neonatology and cardiology groups but were equivalent content-wise 
with items from versions administered to other two groups were aggregated. The scale mean was then 
used to calculate the Spearman’s rho correlation coefficient between the corresponding single item 
measuring overall satisfaction of care of each of the six domains. We hypothesised that high 
correlations may indicate evidence on relation to other variables, i.e. criterion validity. Questionnaire 
responses were entered into and analysed using IBM© SPSS© Statistics 21 (IBM Corp., Armonk, NY, 
USA). 
5.5. Results 
5.5.1. Phase 1, 2 and 3: Item generation, item review and translation 
The first draft of the four questionnaires for cardiology (C), neonatology (Neo), neurology (N) and 
oncology (O), consisted of 131/139/146/143 items respectively representing the six domains, followed 
by either 12 summary items for C, O and N or 10 for Neo, and 17 socio-demographic items for all 
versions. This added up to a total initial item count of 160/166/175/172 for the C/Neo/N/O 
questionnaires respectively. 
Phase 2, Stage 1: Item review, face validity and content validity index (first round) 
The average content validity index was > 0.78 and therefore considered excellent for all four 
questionnaire versions. However, when looking at single items, there were still a substantial 
percentage of items below the threshold of 0.78 for clarity and fewer for relevance (Table 1). Based on 
these results and the written feedback from the expert panel, the total number of items was reduced by 
approximately 50, resulting in total item count for the C/Neo/N/O versions of 109/114/117/116 
respectively (including 13 socio-demographic items in all versions). Additionally, a number of items 
were reformulated or put in a different order. 
Table 1 Average and percentage of expert agreement of the first set of items 
 Clarity Relevance 
Questionnaire S-CVI/Ave 
% of items with 
I-CVI < 0.78 
S-CVI/Ave 
% of items with 
I-CVI < 0.78 
Cardiology 0.82 29 0.85 23 
Neonatology 0.82 27 0.90 14 
Neurology 0.84 24 0.87 21 
Oncology 0.89 22 0.94 13 
S-CVI/Ave, scale-level content validity index, averaging method; I-CVI, item-level  
content validity index 
Phase 2, Stage 2: Summary of cognitive testing 
The input from the cognitive debriefings of the four participants led to a further item reduction of 7 
items (C), 11 items (Neo), 11 items (N) and 10 items (O) resulting in a second draft of the questionnaire 
containing 102/103/106/106 items for C/Neo/N/O respectively. The main reasons for item deletion 
were: that they were not relevant, not comprehensible, or too similar to other questions. The ability to 
recall the events around the last days/weeks of their child was not a problem for any of the 
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participating mothers. Although remembering this time was surely painful, all of the participants 
stated that the burden of answering the questions was tolerable and justified by the importance of the 
study. 
Phase 2, Stage 3 and Phase 3: Item review, face validity (second round) and translation 
All experts agreed that the six quality domains structuring the questionnaires were well represented by 
the existing items and that the items were well formulated. 
The translation process led to several small adaptations of the wording in all languages. 
5.5.2. Phase 4: Pilot survey 
For the pilot survey, 31 individual questionnaires (mother and father versions) were sent to 20 families 
covering all four diagnostic groups and all three languages. Recruitment for this pilot test taught us 
that the target population of parents who lost a child is limited in the Italian speaking part of 
Switzerland and the single recruited parent did not return the questionnaire. The receipt of 24 
completed questionnaires represented a response rate of 77% and covered all diagnostic groups and 
the German and French languages. 
The number of items, rationale for revision and examples of items dropped based on the pilot 
survey are presented in Table 2. The median level of burden related to completing the questionnaire, 
as reported by 23 parents, was 5.5 (interquartile range, 0.8-6.6) on a scale between 0 and 10. Based on 
this last development step, the final number of items for the C/Neo/N/O questionnaires was 
91/92/95/95 respectively. A graphical illustration of the complete development process is displayed in 
Figure 1. A complete list of all final items (socio-demographic items excluded) for all four 
questionnaire versions can be accessed via http://nursing.unibas.ch/PELICAN-PaPEQU or 
www.kispi.uzh.ch/fzk/PaPEQu (see end of chapter). The questionnaires were then used for the main 
PELICAN II study. 
Of the 224 questionnaires sent out, 200 were completed and sent back, representing a 
response rate of 89%. The frequencies according to diagnostic groups, language and mothers/fathers 
are presented in Table 3. The neonatology group was the largest one with 81 (41%) questionnaires 
followed by 48 (24%) neurology, 45 (22%) oncology and 26 (13%) cardiology questionnaires. For the 
total of 96 items (socio-demographic items excluded) across all four versions, the average percentage 
of true missing responses was at 1.8%. There were some items for which the response option “not 
applicable/don’t know” was present and for those items the percentage of information not available 
increased up to 38%. Therefore, two items were dropped from analysis completely. As a result, the 
scale items assessing experiences in the communication with physicians were analysed as single item 
as only two items remained. 
5.5.3. Evidence based on internal structure and relations to other variables 
Psychometric information for each scale of the six quality domains assessing parental experiences is 
shown in Table 4. The KMO measure verified the sampling adequacy for proceeding with EFA, only 2 
of the 24 items remained under the desired threshold of 0.7. As expected, the factor solution 
demonstrated one factor only for each scale, supporting evidence of unidimensionality within each 
domain. Scale means were high in each domain and the distribution was skewed showing a ceiling 
effect. This was also true for the overall satisfaction ratings for each domain. All correlations between 
the scale mean and the corresponding satisfaction score were statistically significant with Spearman 
rho coefficients between 0.37 and 0.63. All other questionnaire items were analysed as single items 
and were not subject to reliability testing [20]. The results of the PELICAN II study, applying the 
PaPEQu, will be covered in future reports. 
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Table 2 Criteria applied to revise the PaPEQu (based on the pilot survey) 
Criteria Description 
Questionnaire domain: 
Revision 
Examples of removed items 
Homogeneity 
of subscale 
items 
As measured by inter-item 
correlation and Cronbach’s alpha. 
Very high and negative inter-item 
correlations were undesirable and 
those items were removed. 
Support of the family unit: 
Three items removed 
Communication: 
Two items removed 
Relief of pain and other symptoms: 
Two items removed 
Continuity and coordination of care: 
Two items removed 
 
Bereavement support: 
Six items removed 
I knew to whom to turn to when in need of 
help. 
I understood the information about my 
child’s condition. 
That my child received fluids until the end. 
(Neo only) 
My child was always admitted to the same 
ward for repeated hospitalisations. (C, N, O 
only) 
My child’s death has completely caught me 
off guard. 
Equivalence  We strove for equivalent item count 
and content in all four questionnaire 
versions as much as justifiable. 
Support of the family unit: 
Two items removed, one item added 
Relief of pain and other symptoms: 
One item removed, one item reformulated 
My expertise in caring for my child was 
respected. (N, O only) 
I needed that my child received medication 
to calm her/him. (C, N, O only) 
Clarity When it was suspected that missing 
responses were caused by lacking 
clarity. 
Shared decision making: 
Two items reformulated 
Relief of pain and other symptoms: 
One item removed 
 
 
I needed to be able to nurse my child. (Neo 
only) 
C, cardiology; Neo, neonatology; N, neurology; O, oncology 
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Table 3 Sample characteristics of the PELICAN II study, quantitative part 
Diagnostic groups 
 Cardiology 
n (%) 
Neonatology 
n (%) 
Neurology 
n (%) 
Oncology 
n (%) 
Total 
n (%) 
Language      
German 21 (81) 66 (82) 44 (92) 31 (69) 162 (81) 
French 5 (19) 9 (11) 3 (6) 12 (27) 27 (15) 
Italian 0 (0) 6 (7) 1 (2) 2 (4) 9 (4) 
Total 26 (100) 81 (100) 48 (100) 45 (100) 200 (100) 
Parent      
Mother 14 (54) 43 (53) 28 (58) 27 (60) 112 (56) 
Father 12 (46) 38 (47) 20 (42) 18 (40) 88 (44) 
Total 26 (100) 81 (100) 48 (100) 45 (100) 200 (100) 
Table 4 Parental experiences scale characteristics 
Questionnaire domain 
Scoring 
Number 
of 
items 
Scale Mean  
(SD) 
Cronbach’s  
alpha 
Minimum/Maximum  
Inter-item 
correlations 
Kaiser- 
Meyer-Olkin  
MSA+ 
Number of factors* 
% of explained 
variance 
Unrotated  
Factor 
loadings 
Support of the family unit 
Scale range 0 - 6 
 
4 
4.97  
(1.01) 
 
0.77 
 
0.25 – 0.70 
 
0.75 
1 
61 
 
0.40 – 0.85 
Communication in general: 
Scale range 0 - 6 
 
6 
4.68  
(1.06) 
 
0.83 
 
0.28 – 0.67 
 
0.85 
1 
57 
 
0.51 – 0.80 
Shared decision making: 
Scale range 0-6 
 
3 
4.82  
(1.23) 
 
0.79 
 
0.53 – 0.63 
 
0.70 
1 
71 
 
0.68 – 0.81 
Relief of pain and other symptoms: 
Scale range 0-6 
 
3 
4.99  
(1.10) 
 
0.88 
 
0.62 – 0.78 
 
0.71 
1 
81 
 
0.76 – 0.95 
Continuity and coordination of care: 
Scale range 1-5 
 
4 
3.86  
(0.91) 
 
0.69 
 
0.31 – 0.46 
 
0.72 
1 
53 
 
0.57 – 0.64 
Bereavement support: 
Scale range 1-5 
 
4 
4.30  
(0.79) 
 
0.75 
 
0.33 – 0.62 
 
0.71 
1 
58 
 
0.54 – 0.86 
+ Measure of Sampling Adequacy: Values for the 24 single items ranged between 0.65 and 0.89; * Based on exploratory factor analysis and eigenvalues > 1. 
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5.6. Discussion 
In this article we describe the development and validation of a questionnaire designed to 
retrospectively assess parental experiences and needs during EOL care of their child. The process 
followed existing recommendations and applied various rigorous quantitative and qualitative methods. 
The PaPEQu aims at providing an evaluation tool of perceived quality of family-centred paediatric 
EOL care. Evidence of initial validity and reliability were demonstrated using a sample of experienced 
healthcare professionals and more than 200 bereaved mothers and fathers. The four slightly different 
versions of the PaPEQu make it applicable to a broad range of paediatric specialties and settings. The 
questionnaire’s items were structured according to six quality domains described in the literature, 
providing a conceptualisation of themes deemed most important to parents during the EOL phase of 
their child. In a recently developed and tested instrument to measure the quality of children’s EOL 
care, 10 domains arose from EFA [3]. While the domains were labelled differently, most content was 
actually overlapping which strengthens the validity of the items chosen for the PaPEQu. Within the six 
PaPEQu domains, some questions assess experiences, while others assess needs related to the 
experiences of parents. Parental experiences reflect the quality of care provided and might be linked to 
parent satisfaction. However, assessing parental satisfaction with standard satisfaction scales may not 
be appropriate as parents may have a low level of expectation and are easily satisfied [13]. Although all 
the experience scores from the six domains were significantly correlated with the corresponding single 
item measuring overall satisfaction of care, interpretation has to be done cautiously. The ratings of 
most adjectival and Likert-type items were high in our study sample and considerable ceiling effects 
were present. Little variability existed in the scores between the domains to render those correlations 
meaningful. Nevertheless, on the single item level, the full range of possible response options was used 
and the required variation for psychometric testing was present. EFA and Cronbach’s alpha 
demonstrated the unidimensionality and internal consistency of the experience scale within each 
domain, indicating that these scale items represent a single construct consistently. However, to test 
how well the items represent the six quality domains would need confirmatory factor analysis and thus 
requiring a bigger study sample.  
A questionnaire response rate of 89% was achieved within the PELICAN II study, quantitative 
part after 49% of the invited parents agreed to participate in the study. High response rates have been 
achieved in other studies with bereaved family members [11]. This is however, not always the case and 
the added burden that research participation imposes during bereavement should not be 
underestimated. Low response rates, e.g. 22%, 18.6%, have been reported elsewhere [3, 9]. Our high 
response rate together with the low percentages of missing items indicates that the items are clear and 
appropriate, considering that the burden for our participants was far from zero with a median of 5.5 on 
a scale from 0 to 10. 
One limitation of the study is related to the sample diversity concerning culture and ethnicity. 
As part of the inclusion criteria participants had to be proficient in reading one of the three main Swiss 
languages. This proficiency is often not present in Switzerland’s migrant residents (25%) resulting in 
the exclusion of a group of bereaved parents, which mostly represented ethnic minorities. The 
questionnaire’s usefulness in this population therefore remains unclear and should be specifically 
tested before application. 
5.7. Conclusions 
Developing, testing and refining a new instrument is an iterative process and requires a series of 
studies. Although the PaPEQu will need some revisions for future use, the instrument has promise as a 
method to assess parental experiences and needs during their child’s end-of-life. Information about 
specific needs is required to plan and implement needs-driven specialized care models. Quality 
improvement initiatives for paediatric palliative care are happening in many countries and the body of 
research within this field is growing. Evaluating the quality of care, requires a measure that is 
grounded in a sound conceptual model, which captures the reality of affected families and healthcare 
professionals, and explains the mechanisms of structures, processes and outcomes. Future research 
should focus on empirical model development and testing, in order to being able to develop, 
implement and evaluate appropriate interventions. 
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List of items of all PaPEQu versions* 
Support of the family unit domain 
Presence in  
questionnaire version 
Items assessing parental experience: 
7 point adjectival scale, never – always 
Card Neo Neur Onc 
(1) I felt taken seriously with the difficult situation my child and I 
were in. 
    
(2) I could be involved in my child’s care as much as I wanted to be.     
(3) a. When I needed respite there was a professional (e.g. nurse, 
volunteer) who could take my place. 
    
(3) b. My privacy was respected.     
(4) The care team was aware of my worries and fears.     
(5) I trusted the healthcare professionals.     
(6) What services were offered to you or your child during the 
child’s last four weeks of life? 
List of 10 possible services to choose all those applicable + Other. 
    
Items assessing parental needs: 
7 point adjectival scale, not important at all – very important 
I needed 
    
(7) a. To have a place to sleep in the hospital close to my child.  
 Response option “not applicable” available 
    
(7) b. To be involved in my child’s care.     
(8) a. To have a room where my family and I could spend some 
private time  together. 
    
(8) b. To have respite from the care of my child.     
(9) To share my fears and worries with someone from the 
healthcare team.     
*Card, cardiology; Neo, neonatology; Neur, neurology; Onc, oncology. 
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Communication domain 
Presence in  
questionnaire version 
Items assessing parental experiences: 
7 point adjectival scale, never – always 
Card Neo Neur Onc 
(10) Information concerning my child’s condition was provided 
appropriately. 
    
(11) Bad news was communicated in a sensitive manner.     
(12) Information I received was contradictory.     
(13) My questions were taken seriously by the healthcare team.     
(14) To get information concerning my child’s condition I had to 
ask. 
    
(15) I had the impression that the information I received about 
treatment options was complete. 
    
How did you experience communication with the 
attending physicians? 
7 point adjectival scale, not clear at all – very clear 
    
(16) In general: 
Additionally: 7 point adjectival scale, not honest – honest 
    
(17) About treatment options to alleviate symptoms:     
(18) About the prospects and limitations of life-sustaining 
measures: 
Additionally: 7 point adjectival scale, not honest – honest 
Response option “not applicable” available 
    
(19) About what kind of physical changes to expect when my child 
is dying: 
Additionally: 7 point adjectival scale, not honest – honest 
Response option “not applicable” available 
    
(20) Were you informed that your child could die? 
Yes – No 
    
(21) a. When were you informed that your child could die? 
Multiple choice: A few days before my child died – Less than 4 weeks 
before my child died – Less than 6 months before my child died – 
More than 6 months before my child died 
 
 
  
(21) b. When were you informed that your child could die? 
Multiple choice: Before the birth of my child – Less than 24 hours 
before my child died – Less than 1 week before my child died – 2 to 4 
weeks before my child died 
  
  
(21) c. When were you informed that your child could die? 
Multiple choice: Before the birth of my child – Less than 24 hours 
before my child died – A few days before my child died – Less than 4 
weeks before my child died – Less than 6 months before my child 
died – More than 6 months before my child died 
 
   
(22) Who informed your child that she/he could die? 
Multiple choice: It was not possible to inform my child – Myself or 
the other parent – A physician together with me or the other parent 
– A physician alone – My child did not want to speak about it – I did 
not want anyone to speak to my child about dying. 
 
 
  
*Card, cardiology; Neo, neonatology; Neur, neurology; Onc, oncology. 
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Items assessing parental needs: 
7 point adjectival scale, not important at all – very important 
I needed 
 
   
(23) To have the opportunity to ask questions at all times.     
(24) To be continuously informed about my child’s condition.     
(25) To find out how my child would die.     
(26) a. To be informed early about my child’s imminent death.     
(26) b. To be supported in maintaining hope despite the hopeless 
situation.  
 
  
Shared decision making domain 
Presence in  
questionnaire version 
Items assessing parental experiences: 
7 point adjectival scale, never – always 
Card Neo Neur Onc 
(27) I was involved in taking decisions.     
(28) I was sufficiently informed to contribute to the decisions 
taken. 
    
(29) I had the opportunity to question prior decisions and to re-
discuss them. 
    
(30) Was a decision taken concerning the potential need to 
resuscitate your child? 
Yes – No 
    
(31) Who decided in favor or against potential resuscitation of your 
child? 
Multiple choice: The topic was never discussed – Me – The other 
parent – Us as family – The healthcare team – My family together 
with the healthcare team – Someone else 
    
(32) a. Was the cessation of non-helpful treatments discussed with 
you? 
Yes – No 
 
 
  
(32) b. Was the cessation of life-sustaining measures discussed with 
you? 
Yes – No 
  
  
(33) a. Who decided in favour of or against the cessation of non-
helpful treatments? 
Multiple choice: The topic was never discussed – Me – The other 
parent – Us as family – The healthcare team – My family together 
with the healthcare team – Someone else 
 
 
  
(33) b. Who decided in favour of or against the cessation of life-
sustaining measures? 
Multiple choice: The topic was never discussed – Me – The other 
parent – Us as family – The healthcare team – My family together 
with the healthcare team – Someone else 
  
  
(34) Did you receive written documentation concerning these 
decisions? 
Yes – No 
 
 
  
*Card, cardiology; Neo, neonatology; Neur, neurology; Onc, oncology. 
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Items assessing parental needs: 
7 point adjectival scale, not important at all – very important 
I needed 
 
   
(35) To be involved in taking decisions.     
(36) That my personal beliefs and values were considered when 
taking decisions. 
    
(37) Not to have the feeling that I had to take decisions all by 
myself. 
    
(38) a. That the cessation of life-sustaining measures was discussed 
with me. 
    
(38) b. That the measures to resuscitate my child were discussed 
with me. 
 
   
(38) c. That the cessation of non-helpful treatments was discussed 
with me  
 
  
Relief of pain and other symptoms domain Presence in  
questionnaire version 
Items assessing parental experiences: 
7 point adjectival scale, never – always 
Card Neo Neur Onc 
(39) It was my impression that my child’s discomforts were eased 
in the best way possible. 
    
(40) My child’s pain was recognized.     
(41) My child’s pain was adequately treated.     
(42) Which of the following 3 of your child’s discomforts stressed 
you the most? 
List of 12 to 17 different symptoms of discomfort to choose from and 
rate in descending order. 
    
Items assessing parental needs: 
7 point adjectival scale, not important at all – very important 
I needed 
    
(43) That my child received enough medication to ease her/his 
suffering. 
    
(44) To have physical contact with my child.     
(45) That my child was awake and receptive enough to be able to 
play/speak/or do things with us or other people around. 
 
 
  
(46) That my child received medication to calm her/him.     
(47) That my child received complementary and alternative 
medicine. 
 
 
  
(48) To be able to use non-pharmacological measures to ease my 
child’s suffering, e.g. massage, tucking. 
  
  
(49) To take my child in my arms.     
(50) That my child received fluids until the end.     
(51) That I could give my child milk, either through the tube, with a 
bottle or a cotton swab.   
  
*Card, cardiology; Neo, neonatology; Neur, neurology; Onc, oncology.  
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Continuity and coordination of care domain Presence in  
questionnaire version 
Items assessing parental experiences: 
5 point Likert scale, strongly disagree - rather disagree – agree 
partly – rather agree – strongly agree 
Response option “not applicable” available 
Card Neo Neur Onc 
(52) There was a healthcare professional who coordinated my 
child’s care. 
    
(53) In the hospital, there was a physician in charge of our case 
whom I could always talk to. 
    
(54) a. In the hospital, there was a nurse in charge of our case 
whom I could always talk to. 
    
(54) b. At home, my child’s care was mostly provided by the same 
nurse. 
    
(55) Information concerning the condition of my child was 
appropriately shared among the whole healthcare team. 
    
(56) Who mainly supported you in the organization of your child’s 
care during her/his last four weeks of life? 
Multiple choice: List of 10 possible professionals and combinations to 
choose the most applicable 
    
Items assessing parental needs: 
7 point adjectival scale, not important at all – very important 
I needed 
    
(57) To have a professional from the healthcare team to coordinate 
the care of my child. 
    
(58) To have the same physician providing care.     
(59) That my child’s care was mostly provided by the same nurses.     
Bereavement support domain Presence in  
questionnaire version 
Items assessing parental experiences: 
5 point Likert scale, strongly disagree - rather disagree – agree 
partly – rather agree – strongly agree 
Response option “don’t know” available 
Card Neo Neur Onc 
(60) I could spend as much time with my dying child as I wanted to.     
(61) a. I received the necessary support from the healthcare team so 
that my child could die where I wished. 
    
(61) b. I was supported by the healthcare team in creating 
mementos of my child. 
  
  
(62) I could say goodbye to my child in the way I wanted to.     
(63) There was solace around my child’s death     
(64) a. Where did your child pass away? 
Multiple choice: In the paediatric intensive care unit – In the adult 
intensive care unit – On a ward in the paediatric hospital – On a 
ward in an adult hospital – At home – At another place 
    
(64) b. Where did your child pass away? 
Multiple choice: In the neonatal intensive care unit - In the 
paediatric intensive care unit - On a ward in the paediatric hospital 
- At home – At another place 
    
(65) Were you with your child when she/he passed away? 
Yes - No 
    
*Card, cardiology; Neo, neonatology; Neur, neurology; Onc, oncology. 
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(66) Were siblings, other family members and/or friends with your 
child when she/he passed away? 
Yes - No 
    
(67) Did you wash and dress your child or help others to do it after 
she/he passed away? 
Yes - No 
    
(68) Were you in contact with someone from the healthcare team 
during the first weeks after the death of your child? 
Yes - No 
    
(69) Has there been a follow-up meeting with someone from the 
healthcare team? 
Yes - No 
    
(70) Could you please tell us what kind of support services you used 
or still use during your bereavement? 
Free text field to describe the kind of service(s). 
    
Items assessing parental needs: 
7 point adjectival scale, not important at all – very important 
I needed 
    
(71) To have the choice of where child might die. 
Response option “not applicable” available 
    
(72) That family and friends could say goodbye to my child.     
(73) That I was supported by the healthcare team to structure the 
hours after the death of my child according my needs. 
    
(74) To take my child home after her/his death so that family and 
friends could say goodbye. 
Response option “not applicable” available 
    
(75) That someone from the healthcare team attended my child’s 
funeral or burial. 
Response option “not applicable” available 
    
(76) To stay in contact with someone from the healthcare team 
after my child’s death.     
Summary Presence in  
questionnaire version 
Overall, how satisfied were you with the: 
7 point adjectival scale, not satisfied at all – neutral - satisfied 
Card Neo Neur Onc 
(77) Support for you and your family?     
(78) Communication with you and your family?     
(79) Shared decision-making?     
(80) Relief of pain and other symptoms?     
(81) Continuation and coordination of care?     
(82) Bereavement support     
(83) Could you please list three positive experiences concerning the 
care you and your family received: 
Free text field to list up to three examples. 
    
(84) Could you please list three negative experiences concerning the 
care you and your family received: 
Free text field to list up to three examples 
    
(85) What areas of your personal life were negatively influenced by 
the illness and death of your child? 
List of 7 potential areas to choose from; choose all those applicable + 
Other. 
    
*Card, cardiology; Neo, neonatology; Neur, neurology; Onc, oncology. 
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(86) How would you rate your current quality of life on the 
following scale? 
Vertical visual analogue scale ranging from 0 (worst possible) to 10 
(maximum). 
    
(87) Is there something else you would like to tell us? 
Free text field to write.     
Note. The 13 socio-demographic items are excluded from this list. 
*Card, cardiology; Neo, neonatology; Neur, neurology; Onc, oncology. 
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6.1. Abstract 
Background: Parents facing the death of their child have a strong need for compassionate 
professional support. Care services should be based on empirical evidence, be sensitive to the needs of 
the families concerned, take into account the heterogeneity within the medical field of paediatrics, and 
fit into the local health care system. We need to better understand the perspectives of parents facing 
the death of their child in order to guide further development and evaluation of specialised paediatric 
palliative and end-of-life (EOL) care services. 
Methods: Questionnaire survey to assess the EOL care perspectives of a Swiss population-based 
sample of bereaved parents who had lost a child due to a cardiac, neurological or oncological 
condition, or during the neonatal period in the years 2011 or 2012. The parental perspective was 
assessed with a newly developed and tested instrument that was structured according to six evidence-
based quality domains. Responses regarding parental experiences and perceived satisfaction are 
described. Differences between the four diagnostic groups are analysed using a generalized estimation 
equation to account for the dyadic data structure. 
Results: Of 307 eligible families, 267 could be contacted and 135 (51%) consented to participate in 
this questionnaire survey. Our findings show positive parental experiences of their child’s EOL care 
and high perceived satisfaction with the care their child received. Parents of a child with cancer rated 
their experiences highest in most of the six quality domains and reported the highest satisfaction with 
care. The lowest scores were mainly reported by parents from the neurology group, with the exception 
of the shared decision making domain, where parents of neonates reported significantly less positive 
experiences. 
Conclusions: Although positive in general, our study results suggest some areas for improvement. 
The integration of specialised paediatric palliative care has the potential to minimise lost opportunities 
to support and assist parents. 
6.2. Background 
When facing the death of their child, parents experience an unimaginably painful life event and severe 
crisis that affects the whole family for life. In this highly stressful time parents are confronted with 
uncertainty and are required to make difficult decisions, e.g. withdrawal of life-sustaining 
interventions. Their need for compassionate professional support is high. Support throughout 
terminal care and after the loss of a child was reported to have a positive impact on long-term grieving 
outcomes of parents who lost a child to cancer [1]. For clinicians it is therefore imperative to know how 
parents experience their child’s end-of-life (EOL) and what their specific needs are in order to provide 
good quality care. Two recent integrative reviews and a qualitative metasummary extracted existing 
evidence from 36 studies (29 qualitative, 7 quantitative) about parental perspectives on their child’s 
palliative care (PC) or EOL care [2-4]. This evidence provides an overview of themes/domains most 
important to parents and can be summarised as: sincere relationships and emotional, spiritual and 
cultural support; genuine communication; alleviation of suffering; continuity, coordination and 
accessibility of care; and bereavement support [2-4]. Deficiencies in meeting parental needs were 
identified across all themes, e.g. insufficient communication, lack of respect, and lack of emotional 
support [2]. 
Caring for a child at the end of her/his life and supporting the family is most challenging for 
health care professionals. It requires a skilled multidisciplinary health care team that adopts a 
comprehensive and integrative care approach [5]. This has led to the emergence of the medical 
subspecialty of paediatric palliative care (PPC), which is defined by the World Health Organization as 
the active total care of the child’s body, mind and spirit, and involves giving support to the family. It 
requires a broad approach that includes the family. It can be provided in tertiary care facilities, in 
community health centres and even in children's homes [6]. Many countries have recognized the need 
for PPC and a series of hospital-based programs have been developed and implemented during the last 
decade [7, 8]. In Switzerland, this need is acknowledged by the Federal Office of Public Health by 
incorporating it in its national strategy and conception for implementation [9, 10]. Their proposed 
framework emphasizes the importance of a person-centred approach focusing on the complexity of the 
situation and needs of the person concerned [10]. In the field of paediatrics especially, person-
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centeredness must be extended to family-centeredness, with the child and family as the unit of care. 
Paediatric care encompasses the whole age continuum from infants and children who have never 
experienced or expressed preferences to adolescents able to discuss their situation and express 
expectations [11], and it takes place in various in- and outpatient care settings and at home. 
Fortunately, childhood deaths are a rare event. In Switzerland 424 deaths in children (0 to 14 
years of age) were registered in 2013. Mortality data from developed countries show, that perinatal 
conditions contribute to 50% of all deaths in the first year of life. Beyond the first year, external causes, 
e.g. accidents, are the most common causes of death. Complex chronic conditions such as 
genetic/congenital disorders, neurological and cardiac conditions, and cancer represent the main 
causes of disease-related deaths [12]. This wide variety of underlying medical conditions leads to vastly 
different illness trajectories and lifespans potentially influencing what parents experience during their 
child’s EOL care. There is little evidence concerning the influence of the child’s underlying diagnosis 
on the parental perspective. It has been suggested that different challenges arise and that families from 
the oncology group can generally draw on a better developed professional support infrastructure than 
other affected families [13, 14]. 
In many of the existing studies covering parental perspectives of their child’s PPC or EOL care, 
samples were limited either by case numbers, the inclusion of underlying illnesses causing the child’s 
death (i.e. predominantly parents of children with cancer [13]) or the care setting (e.g. paediatric 
intensive care unit) [15, 16]. Care services should be based on empirical evidence, sensitive to the 
needs of the families concerned, take into account the heterogeneity within the medical field of 
paediatrics, and should fit the local health care system. We need to better understand the perspectives 
of parents facing the death of their child in order to guide further development and evaluation of 
specialised PPC and EOL care services. It was therefore the purpose of this study to assess the 
perspectives of bereaved parents who had lost a child due to a cardiac, neurological or oncological 
condition, or during the neonatal period in order to (1) describe specific parental experiences in 
relation to the underlying medical condition causing the child’s death, and (2) explore differences in 
parental perspectives between four common medical conditions responsible for childhood death. 
6.3. Methods 
6.3.1. Design, setting, participants, and recruitment 
The cross-sectional questionnaire survey was embedded in a larger research project concerned with 
paediatric EOL care needs in Switzerland (Paediatric End-of-LIfe CAre Needs – PELICAN, 2012-2015, 
NCT01983852) drawing from a population based sample of deceased children, their bereaved parents 
and health care professionals. The PELICAN study aimed to provide comprehensive information and 
understanding about the current practices of EOL care (in this study, defined as the last 4 weeks of life 
prior to death) in paediatric settings in Switzerland (hospital and community care), and about the 
perspectives of the parents and health care professionals involved [17]. The questionnaire survey 
reported on here covered the quantitative assessment of parental perspectives by including parents of 
all children that had died due to a cardiac, neurological or oncological condition or during the neonatal 
period in the years 2011 and 2012. These four groups were chosen, as they represent the major 
diagnoses causing illness-related death in children [18]. Eligible parents were identified using 
administrative death data from all Swiss children’s hospitals, general hospitals with a paediatric unit, 
long-term institutions and paediatric community care services. All institutions with probable events of 
death were informed of the study and committed to participate and execute the recruitment 
procedures, which involved sending out an invitation letter together with the informed consent 
documents. Parents were not invited if their child had died during the first 24 hours of her/his life. 
Parents were included if they consented to participate and were proficient in the German, French or 
Italian language. Once parents sent back their written consent, their demographic information was 
then transmitted to the research team. If written consent was not received three weeks after receipt of 
the study documents, the family was telephoned by a local study coordinator to provide verbal study 
information and to clarify potential questions. Recruitment occurred between July 2013 and March 
2014 in 8 children’s hospitals (5 of them tertiary paediatric care centres), 9 general hospitals with a 
paediatric unit, 2 long-term institutions, and 4 paediatric community care services. For two families, 
the hospital delegated recruitment to a paediatric practitioner’s practice which then invited the family. 
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Human Research Ethics Committees from the 11 Swiss cantons in which the recruiting institutions 
were located approved the PELICAN study (leading committee: KEK ZH Nr. 2012-0537, additional file 
1) [19]. 
6.3.2. Measures 
To retrospectively assess the parental perspective on the child’s EOL care, a survey instrument, the 
Parental PELICAN Questionnaire (PaPEQu) was developed by the PELICAN study group. A detailed 
description of the development and validation of the PaPEQu has been published elsewhere [19], and a 
complete list of items with corresponding response options is provided (additional file 2, chapter 5). 
Initial validity and reliability of the PaPEQu were demonstrated in a sample of health care 
professionals and bereaved parents [19]. 
Four slightly different versions for the four diagnostic groups (cardiology, neonatology, 
neurology, and oncology) were created to account for differences in illness trajectories between the 
groups. The PaPEQU is thematically structured following the framework of six quality domains 
identified by the Initiative for Pediatric Palliative Care [20] and adapted by Truog et al. [21]. The six 
domains are in accordance with existing evidence and include: support of the family unit, 
communication, shared decision making, relief of pain and other symptoms, continuity of care, and 
bereavement support. Within each domain, the items were organised into scales or single items 
related to parental experiences and indexes for parental needs. The item count of experience related 
items ranged from 44 to 48 items, depending on the diagnostic group version. With 34 needs-related 
items and 13 socio-demographic items, the total item count of the PaPEQu ranged from 91 to 95 items. 
In this article, we report on the items related to parental experiences and socio-demographic 
information only. The results of the needs-related items showed high ceiling effects and little variation 
across the four diagnostic groups, making a thorough interpretation of these results difficult. Those 
items can still be checked in the complete item list (additional file 2, chapter 5). 
For experience-related scale items, the response option was either a 7-point (0 to 6) with 
varying end-point anchors (“never-always”, “not clear at all-very clear”, “not honest-honest”), or a 5-
point Likert-type (1 to 5), where respondents indicated the extent to which they agreed with the 
statement. The assessment of parental experiences was supplemented with single items with multiple 
choice or dichotomous response options (Yes-No) as appropriate. In addition, parents were asked to 
rate their perceived overall satisfaction with the care their child received for each of the six quality 
domains on a 7-point scale (1 to 7) with end-point anchors “not satisfied at all -satisfied” and a 
“neutral” label in the middle. They were also asked to list three positive and three negative experiences 
associated with their child’s EOL care and to indicate what areas of their lives were negatively 
influenced by their child’s illness and death with a question allowing multiple responses. Finally, on a 
0 (worst possible) to 10 (best possible) vertical visual analogue scale they were asked to rate their 
current quality of life (QoL). Socio-demographic information was collected at the end of the 
questionnaire. Scale items were summed and averaged to yield one score per domain with higher 
values representing more positive experiences. The unidimensionality of the parental experiences 
score for each domain separately was demonstrated with exploratory factor analysis; internal 
consistency testing showed Cronbach’s alpha levels between 0.69 – 0.88 [19]. 
6.3.3. Study procedures 
The PaPEQu was sent out in April 2014 to mothers and fathers who individually consented to 
participate in this part of the PELICAN study. An identification code was assigned to each 
questionnaire allowing mapping of the family dyad. Parents who had not sent back the completed 
questionnaire within three weeks received a reminder card. Non-responders to this reminder were 
dropped from the study. All questionnaires were hand checked for completeness upon receipt, and 
electronically scanned to be downloaded onto an IBM© SPSS© data file. 
6.3.4. Data analysis 
The responses to all items were explored using measures of central tendency and dispersion. 
Descriptive statistics were used to summarize parental experiences for the total sample as well as for 
the four diagnostic groups. For each item the percentage and pattern of missing responses were 
calculated and explored using missing value analysis. Items that more than 30% of respondents either 
did not answer or responded to with “not applicable”/“don’t know” were only analysed descriptively. 
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Scale items related to parental experiences that were present in all four questionnaire versions 
were used to calculate a scale score as described above. All other items were analysed as single items. 
Since most responses were skewed showing a ceiling effect, data transformation was applied. i.e. base 
10 logarithm, square root, or reciprocal as indicated [22], for continuous dependent variables. 
Correction of severe distributional violations such as the presence of outliers was achieved. To explore 
differences in parental perspectives between the four diagnostic groups, various statistical tests were 
applied. For the experiences scores and the perceived satisfaction scores as continuous dependent 
variables, and for items with a dichotomous response (Yes-No), the method of generalized estimating 
equations (GEE) was used. GEE is an extension of the generalized linear model and allows analysing 
data with correlated residuals, i.e. clustered data [23, 24]. Data was clustered due to the dyadic design 
with correlated data between partners (mother and father), based on partner effects and common fate 
[25]. Diagnostic group was the model’s predictor (factor with four levels) with the neonatology group 
set as reference for comparison since it was the group with the most cases. To control for potential 
gender effects independent of the dyadic structure, gender (female/male) was specified as a 
confounder. For items with multiple choice response options, Pearson’s chi-square or Fisher’s exact 
test were calculated as appropriate. Contribution to a potential significant main effect was interpreted 
by breaking down the standardized residuals with values outside ±3.29 representing significance at P 
<0.001 [26]. To adjust for multiple testing, a probability of ≤ 0.001 was set to decide significance. All 
quantitative data were analysed using IBM© SPSS© Statistics 21 for Mac® (IBM Corp, Armonk, NY, 
USA). 
Text responses from the three open-ended questions concerning support services in 
bereavement, and positive and negative experiences were imported in the text management program 
ATLAS.ti7, 7.5.4 for MS Windows® (ATLAS.ti GmbH, Berlin, Germany). These qualitative data were 
coded deductively, following the questionnaire’s six quality domains, by two trained research 
assistants independently. The two solutions were merged based on consensus between the two coders. 
To summarise this information on the item level, frequencies of codes within the domains were 
counted to demonstrate which domains were prominently presented. 
6.4. Results 
Flow of study recruitment and participation is displayed in Figure 1. The participation rate was 51% (n 
= 135) of the 267 eligible families who received the study documents. Study participation differed 
between the diagnostic groups with parents from the neonatology group showing the lowest rate and 
parents from the oncology group the highest (Figure 1). Of the 224 individual questionnaires (mothers 
and fathers) sent out to the 135 families, 200 questionnaires from 124 families were completed and 
sent back, representing a questionnaire response rate of 89%. Parents of deceased neonates 
represented the largest group, followed by parents from the neurology, oncology and cardiology group 
(Table 1). The sample mainly consisted of Swiss residents (87%), with 13% migrant families. With 
neonates comprising the largest group of deceased children, most deaths occurred on a neonatal 
intensive care unit (ICU), as reported by the parents. The age of the deceased child differed among the 
diagnostic groups, with neonates obviously being the youngest (Table 1). 
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Eligibile families
(n = 307)
Cardiology
(n = 38)
Neonatology
(n = 135)
Neurology
(n = 73)
Oncology
(n = 61)
Written informed consent
(n = 135)
Family could not be contacted
(n = 40)
Cardiology
(n = 18)
Neonatology
(n = 50)
Neurology
(n = 36)
Oncology
(n = 31)
Families who completed the 
questionnaire
(n = 124)
Cardiology
(n = 17)
Neonatology
(n = 47)
Neurology
(n = 31)
Oncology
(n = 29)
Questionnaires sent out to families
Family refused to particpate
(n = 132)
Family dropped out
(n = 11)
 
Fig 1. Study recruitment and participation 
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Table 1 Sample characteristics of parents (N = 200), place of death and age of child (N = 124) 
Characteristics 
Cardiology 
n = 26  
(13%) 
Neonatology 
n = 81  
(41%) 
Neurology 
n = 48  
(24%) 
Oncology 
n = 45  
(22%) 
Total 
N = 200  
(100%) 
Agea, M (SD) 
Mothers,  
 n = 112 (56%) 
Fathers,  
 n =   88 (44%) 
 
 
38 (4.38) 
 
40 (6.88) 
 
 
37 (4.29) 
 
39 (5.77) 
 
 
41 (6.07) 
 
42 (6.56) 
 
 
43 (7.30) 
 
48 (5.85) 
40 (6.48) 
 
39 (6.05) 
 
42 (6.83) 
Language, n (%) 
German 
French 
Italian 
 
21 (80.8) 
5 (19.2) 
0 (0.0) 
 
66 (81.5) 
9 (11.1) 
6 (7.4) 
 
44 (91.7) 
3 (6.3) 
1 (2.1) 
 
31 (68.9) 
12 (26.7) 
2 (4.4) 
 
162 (81.0) 
29 (14.5) 
9 (4.5) 
Marital status, n (%) 
Married /Partnership 
Divorced/Separated 
Single 
 
22 (84.6) 
4 (15.4) 
0 (0.0) 
n = 80 
79 (98.8) 
1 (1.3) 
0 (0.0) 
 
43 (89.6) 
4 (8.3) 
1 (2.1) 
 
41 (91.1) 
2 (4.4) 
2 (4.4) 
N = 199 
185 (93.0) 
11 (5.5) 
3 (1.5) 
Religious affiliation, n (%) 
Catholic 
Protestant 
None 
Other 
 
7 (26.9) 
7 (26.9) 
8 (30.8) 
4 (15.4) 
n = 80 
37 (46.3) 
25 (31.3) 
12 (15.0) 
6 (7.5) 
 
21 (43.8) 
17 (35.4) 
3 (6.3) 
7 (14.6) 
n = 44 
14 (31.8) 
15 (34.1) 
10 (22.7) 
5 (11.4) 
n = 198 
79 (39.9) 
64 (32.3) 
33 (16.7) 
22 (11.1) 
Education, n (%) 
School levelsb 
Post school educationc 
Tertiary leveld 
University degree 
 
0 (0.0) 
11 (42.3) 
10 (38.5) 
5 (19.2) 
 
2 (2.5) 
39 (48.1) 
15 (30.9) 
15 (18.5) 
 
1 (2.1) 
19 (39.6) 
22 (45.8) 
6 (12.5) 
 
5 (11.1) 
20 (44.4) 
16 (35.6) 
4 (8.9) 
 
8 (4.0) 
89 (44.5) 
73 (36.5) 
30 (15.0) 
Employment status at  
death of the child 
Working 
Off worke 
 
 
10 (38.5) 
16 (61.5) 
 
 
41 (50.6) 
40 (49.4) 
 
 
28 (58.3) 
20 (41.7) 
 
 
16 (35.6) 
29 (64.4) 
 
 
95 (47.5) 
105 (52.5) 
Employment status at  
time of the survey 
Working 
Off worke 
 
 
19 (73.1) 
7 (26.9) 
 
 
65 (80.2) 
16 (19.8) 
 
 
43 (89.6) 
5 (10.4) 
 
 
39 (86.7) 
6 (13.3) 
 
 
166 (83.0) 
34 (17.0) 
Family incomef, n (%) 
≤ CHF 100,000.- 
> CHF 101,000.- 
n = 19 
9 (47.4) 
10 (52.6) 
n = 66 
33 (50.0) 
33 (50.0) 
n = 44 
17 (38.6) 
27 (61.4) 
n = 40 
24 (60.0) 
16 (40.0) 
N = 169 
83 (49.1) 
86 (50.9) 
Deceased child was the  
only child, Yes (%) 
 
1 (3.8) 
 
13 (16.0) 
 
6 (12.5) 
 
4 (8.9) 
 
24 (12.0) 
Previous loss  
of a child, Yes (%) 
 
4 (15.4) 
 
6 (7.4) 
 
5 (10.4) 
 
2 (4.4) 
 
17 (8.5) 
Place of death 
Intensive care unit 
Hospital 
Home 
Somewhere else 
n = 16 
10 (62.5) 
2 (12.5) 
3 (18.8) 
1 (6.2) 
n = 51 
47 (92.1) 
0 (0.0) 
3 (5.9) 
1 (2.0) 
n = 29 
13 (44.8) 
8 (27.6) 
6 (20.7) 
2 (6.9) 
n = 28 
5 (17.8) 
11 (39.3) 
11 (39.3) 
1 (3.6) 
N = 124 
75 (60.5) 
21 (16.9) 
23 (18.6) 
5 (4.0) 
Deceased child’s age 
in days, Mdn (range) 
in years, Mdn (range) 
 
 
0.5 (0.1 – 9.1) 
 
5 (1 – 26) 
 
 
4.8 (0.1 – 17.2) 
 
 
8.0 (1.7 – 17.4) 
 
Na 
3.3 (0.1 – 17.4) 
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6.4.1. Parental experiences and perceived satisfaction with care 
Overall parental experiences and their perceived satisfaction with care their child received will first be 
summarised, followed by more detailed reporting, focusing on differences between the diagnostic 
groups within the six quality domains. Parents rated experiences with their child’s EOL care as 
generally positive (Figure 2). After accounting for the different scoring ranges among the six quality 
domain scales (7-point and 5-point), experience scores were highest for the domain relief of pain and 
other symptoms (M = 4.99, SD = 1.05) and lowest for the domain continuity and coordination of care 
(M = 4.29, SD = 1.37). Across all six domains, parents of children with cancer rated their experiences 
during their child’s EOL care highest (M = 4.80, SD = 0.51), while parents of children with a 
neurological condition rated their overall experiences lowest (M = 4.51, SD = 0.44). The cardiology, 
neurology and oncology groups all showed the same pattern in experience scores across the six quality 
domains. Parents of neonates showed a different pattern, with a significantly lower score in the 
domain shared decision making (main effect, P = 0.001) and a high score in the domain relief of pain 
and other symptoms (M = 5.13, SD = 1.01).  
 
Fig 2. Parental experiences and satisfaction with care according to the six quality domains 
Overall perceived satisfaction with the child’s EOL care was also rated highly, with a mean of 
5.92 (SD = 1.05) out of 7 across all quality domains and all diagnostic groups. However, the score 
patterns of the four diagnostic groups across the domains showed a different picture than for 
experiences. The domain shared decision making received the highest satisfaction rating (M = 6.07, 
SD = 1.42), and the domain continuity and coordination of care the lowest (M = 5.69, SD = 1.55). 
Consistently with parental experiences, parents from the oncology group rated their overall perceived 
satisfaction highest among all groups, while parents from the neurology group rated it lowest (Figure 
2).  
Support of the family unit 
Parents or their dying child had access to a variety of support services. The most frequently reported 
were pastoral care (n = 108 Yes responses), followed by psychological care (n = 88) and physiotherapy 
(provided to the child, n = 71). Community, social and bereavement services were less common, but 
still offered to a quarter of the parents. Again, there were some differences between the diagnostic 
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groups. Pastoral care and bereavement services were predominantly offered to parents of neonates 
(main effects, P = <0.008 and P = <0.007 respectively), and physiotherapy to children with a 
neurological condition (P = <0.001). Access to complementary medicine was mostly reported by 
parents with a child with cancer and almost never by parents of neonates. (P = <0.001). Thirty-five 
(18%) parents reported that they received specialised palliative care services. This was most often the 
case for parents of children with cancer (n = 7 Yes responses, 38%), and rarest for parents of neonates 
(6, 7%). 
 
Communication in general and with physicians 
Experiences with the clarity and honesty of the information physicians provided were analysed as 
single items and are summarised in Table 2. Parents from the oncology group consistently reported the 
most positive experiences (Table 2). All but seven parents (97%, n = 193) confirmed that they were 
informed that their child could die. However this occurred at differing time points, depending on the 
diagnostic group. In the cardiology and neonatology groups 42% (n = 11) and 36% (n = 28) of parents, 
respectively, reported being informed that their child would die prenatally (this response option was 
available for those two groups only). Information was provided within 24 hours or a few days prior to 
the child’s death to an additional 59% (n = 46) of parents of neonates and 20% (n = 9) of parents in the 
neurology group. Most parents in the neurology and oncology group (76%, n = 35, and 89%, n = 40, 
respectively), and 42% (n = 11) of parents in the cardiology group were informed that their child was 
likely to die from a few months to more than six months before her/his death. Only the parents in the 
neurology and oncology groups were asked who had informed their child that she or he could die. In 
the neurology group most parents (91%, n = 42) reported that their child could not be informed 
because of the child’s age or mental state. This was less frequently the case in the oncology group 
(32%, n = 14). Children with cancer were informed about the possibility of dying by their parents alone 
(27%, n = 12) or by their parents and a physician (25%, n = 11). A few parents from the oncology group 
reported that they did not want anyone to talk to their child about dying (7%, n = 3) or that their child 
did not want to talk about it (5%, n = 2). 
Table 2 Communication domain:  
Parental experiences related to clarity and honesty of information provided by physiciansa 
 
 
Cardiology 
M (SD) 
Mdn 
(range) 
Neonatology 
M (SD) 
Mdn (range) 
Neurology 
M (SD) 
Mdn 
(range) 
Oncology 
M (SD) 
Mdn 
(range) 
Total 
M (SD) 
Mdn 
(range) 
In generalb 
Clarity,  
 
Honesty 
 
 
5.88 (0.82) 
6 (4 - 7) 
6.19 (1.10) 
7 (4 – 7) 
 
6.00 (1.23) 
6 (1 - 7) 
6.31 (1.20) 
7 (1 – 7) 
 
5.83 (1.33) 
6 (2 - 7) 
6.17 (1.26) 
7 (2 – 7) 
 
6.23 (1.10) 
6 (1 - 7) 
6.53 (0.84) 
7 (3 – 7) 
 
5.99 (1.18) 
6 (1 - 7) 
6.31 (1.13) 
7 (1 - 7) 
Treatment options 
to alleviate suffering 
Clarityc 
 
 
6.08 (1.02) 
6 (4 - 7) 
 
 
5.96 (1.29) 
6 (1 - 7) 
 
 
5.79 (1.03) 
6 (3 - 7) 
 
 
6.31 (0.85) 
7 (4 - 7) 
 
 
6.02 (1.11) 
6 (1 - 7) 
Prospects of life-
sustaining measures 
Clarity 
 
Honesty 
 
 
6.14 (0.96) 
6 (4 – 7) 
6.14 (1.35) 
7 (2 – 7) 
 
 
6.11 (1.15) 
6 (2 – 7) 
6.32 (1.09) 
7 (2 – 7) 
 
 
6.37 (0.95) 
7 (2 – 7) 
6.36 (1.23) 
7 (1 – 7) 
 
 
6.53 (0.72) 
7 (4 – 7) 
6.68 (0.62) 
7 (5 – 7) 
 
 
6.27 
(1.00) 
7 (2 – 7) 
6.39 
(1.09) 
7 (1 – 7) 
Note. No statistically significant differences between the diagnostic groups. 
aParents were asked to rate their experiences concerning communication with the attending physicians 
in terms of clarity and honesty. bAll items were coded on a scale from 1 to 7. cHonesty response option 
not provided for this item. 
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Shared decision making 
Overall, 60% of parents (n = 110) reported that a decision about resuscitating their child had been 
made. Those decisions were made significantly less often within the neonatology group (42%, n = 33), 
especially when compared with the neurology group (88%, n = 42; main effect, P = <0.001). Parents 
reported that resuscitation-related decisions were made by the family together with the health care 
team (HCT) in 39% of the cases (n = 45), by the family alone in 34% (n = 40), or by the HCT alone in 
20% of the cases (n = 20). More parents in the neurology group reported that the decision was made 
by the family alone (52%, n = 22), whereas in the other groups it was commonly made by the family 
together with the HCT. Only parents of neonates were asked whether the cessation of life-sustaining 
interventions was discussed. Eighty-three percent (n = 63) confirmed that it was discussed and that 
the decision to end those measures was made by the family together with the HCT in 65% of cases (n = 
46). 
Relief of pain and other symptoms 
Of all quality domains, experiences with pain management were rated most positively on a scale from 
0 to 6 (M = 4.99; SD = 1.05), and highest of all by parents from the neonatology and oncology group 
(M = 5.13). Parents from the neurology group rated their experiences lowest (M = 4.63, SD = 1.17). 
Those parents were also less satisfied and reported the lowest value of all groups within this quality 
domain (Figure 2). 
Parents were asked to rank the three symptoms from which their child suffered and that were 
most stressful to them from a list of more than 10 different symptoms. Problems with breathing was 
ranked most frequently by parents from the cardiology, neonatology and neurology groups, followed 
by pain. Parents in the oncology group ranked pain first. Breathing problems and pain were overall the 
symptoms most frequently ranked among the top three as being most stressful for parents. Other 
stressful symptoms were different according the diagnostic group. For the cardiology group, agitation 
and anxiety were frequently ranked in first or second place. Parents of neonates frequently ranked 
circulatory problems in first and third place among the top three. Parents from the neurology group 
frequently ranked mucus in the airways and seizures among the top three, and for parents from the 
oncology group, their child’s fatigue and impaired verbal or nonverbal communication frequently 
appeared among the top three. 
Continuity and coordination of care 
Experiences related to continuity and coordination of care were rated least positively of all six quality 
domains by all parents. Between the diagnostic groups, parents of children with cancer rated their 
experiences highest, with a mean of 4.10 (SD = 0.81) on a scale from 1 to 5. This was also reflected in 
the overall satisfaction rating of that domain (on a scale from 1 to 7), where parents from the oncology 
group were more satisfied (M = 6.09, SD = 1.20) than parents from the other groups (M = 5.53, SD = 
1.64) (Figure 2). 
Parents from the cardiology, neurology and oncology group were asked who mainly supported 
them professionally in the organisation of their child’s care. The most frequent answer for all groups 
was: a hospital-based physician (36%, n = 37). For the oncology group this was followed by a hospital-
based nurse (26%, n = 11), which was less often the case for the neurology group (8%, n = 3). Evenly 
spread across all diagnostic groups, parents also reported that a community-based nurse supported 
them in organising care (18%, n = 19) but 19% (n = 20) answered that no one supported them. Main 
support was provided by a primary care paediatrician (PCP) in 8% of cases (n = 8). 
Bereavement support 
Sixty-nine percent (n = 137) of the parents stayed in contact with someone from the HCT shortly after 
their child’s death. This applied most often to parents from the oncology group, with only 16% (n = 7) 
of parents having no further contact. Overall 65% (n = 130) of the parents reported having a follow-up 
talk with someone from the HCT. The lowest rate was reported by parents from the neurology group, 
where it was the case in 50% (n = 23) of respondents. Parents were asked to write down what kind of 
support services they used or still use during their bereavement. We received written information from 
140 parents. Of those, 59 (42%) parents reported making use of psychological support services, 
followed by support groups with other bereaved parents (32%, n = 45). Other common answers were 
related to alternative support services (26%, n = 36) such as kinesiology, art therapy, dream therapy, 
and spiritual services (24%, n = 34) with a pastor or in a religious community. 
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6.4.2. Positive and negative experiences and quality of life 
Parents were asked to describe three positive and three negative experiences related to their child’s 
EOL care. Responses were classified according to the questionnaire’s six quality domains and are 
summarized with frequencies and a sample quote in Table 3. Both positive and negative experience 
descriptions were most frequently about the support the family received. 
Table 3 Positive and negative experiences  
 Number of  
quotesa 
Sample quote 
Positive experiences  180  
Support of the family unit 174 Our individual needs were always supported. (18:6)b 
Communication 54 Honesty when informing about our child’s situation. 
(22:2) 
Shared decision making 8 Ethics council helped to take the right decision. (35:4) 
Relief of pain and other 
symptoms 
8 Oxygen support at home, mail order of medication. 
(101:2) 
Continuity and 
coordination of care 
46 Reachability day and night (hospital and community 
care). (17:1) 
Bereavement support 39 That a lot of time was provided (by the hospital) to be 
with my son after his death. (3:1) 
Negative experiences 165  
Support of the family unit 110 I felt left alone (75:3) 
Communication 73 Not having enough information about my child’s 
situation (61:3) 
Shared decision making 14 The night doctors did not support and follow our 
decision to end treatments. (5:7) 
Relief of pain and other 
symptoms 
27 Pain and shortness of breath. There was a phase when 
effective medication lagged behind the symptoms. 
(33:10) 
Continuity and 
coordination of care 
53 When the physicians and nurses always change. (116:2) 
Bereavement support 51 No follow up care for us after her death. I needed to find 
my own psychologist/support group. (97:7) 
aEach listing of a positive or negative experience (quote) was potentially coded to more than one 
domain. bNumbers in parenthesis represent the quote’s identification number. 
Current quality of life (QoL) was rated high overall, with a mean of 7.19 (SD = 2.09) on a scale from 0 
to 10. However six parents reported low QoL below the 5th percentile with values between 2.30 and 0. 
Parents who had lost a child due to cancer rated their QoL lower than parents from the other groups 
with a mean of 6.55 (SD = 2.17) vs. cardiology (M = 8.09; SD = 1.18), neonatology (M = 7.46; SD = 
1.88), and neurology (M = 6.84; SD = 2.49). To further investigate this difference and based on the 
sample’s characteristics, the parents’ age and income was added to the GEE model. In this extended 
model, income was the most influential predictor of QoL (P = 0.002) with higher income predicting 
higher QoL. 
Finances were also one of seven response options for the question about areas of the parents’ personal 
life that were negatively influenced by the illness and death of their child (Figure 3). Overall, 37 
(18.5%) parents responded that finances were an area that was negatively influenced. Significantly 
fewer parents in the neonatal group reported that their finances were negatively affected compared to 
the other groups (main effect, P = <0.001) whereas in parents from the neurology group the 
proportion of “Yes” responses was highest (35%). The areas most commonly affected across all 
diagnostic groups were their own health (n = 80, 40%) followed by the family (n = 70, 35%) and the 
partnership (n = 64, 32%) (Figure 3). 
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Fig. 3 What areas of your personal life were negatively influenced by the illness and death of your 
child? 
Parents could choose from a list of seven potential areas and check all that applied. The areas are 
represented by the different colours. The number of checks per participant was for cardiology 2.3, 
neonatology 1.5, neurology 2.3, and oncology 2.2. 
6.5. Discussion 
This is one of the few studies that quantitatively described and explored parental experiences related 
to their child’s EOL care in a population-based sample of bereaved mothers and fathers of children 
from the major diagnostic groups in which childhood deaths occur. This allowed us to compare 
findings in four distinct diagnostic groups, which adds to existing knowledge about parental 
perspectives. Overall, parental scores on their experiences and perceived satisfaction with their child’s 
end of life care were high across all six quality domains. Parents of a child with cancer rated their 
experiences highest in most of the six quality domains and reported the highest satisfaction with care. 
The lowest scores were mainly reported by parents from the neurology group, with the exception of the 
domain shared decision making, where parents of neonates reported significantly less positive 
experiences. 
6.5.1. Satisfaction with care 
Evaluation of health care is considered the most important purpose of measuring patient/parental 
satisfaction [27]. However, ceiling effects are a methodological concern when measuring the construct 
of satisfaction, i.e. high levels of satisfaction are consistently reported, which reduces the ability to 
discern differences. Such high levels might be due to inherently low expectations and should thus not 
be automatically interpreted to mean that care was good but simply that nothing bad happened [27]. 
This was, for example, the case in Wolfe et al.’s study [28] which showed substantial parent-reported 
EOL suffering in children with cancer as well as, simultaneously, high levels of satisfaction with care. A 
similar mechanism might contribute to this study’s high perceived satisfaction levels, e.g. results for 
the domain shared-decision making of the neonatology group. Assessing specific experiences with 
aspects of care shows promise as a means of overcoming limitations in general satisfaction measures. 
This is supported in this study where there were more variable results between the six quality domains 
and four diagnostic groups, and substantial differences were present in regard to some domains. The 
role of domains is important as they present a structural framework for good quality care and 
evaluating experiences offers insight into processes of care that is less biased by expectations than 
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measuring satisfaction of care. The domains chosen for the PaPEQU were established by experts in the 
field and mostly in accordance with domains established through exploratory factor analysis by 
Widger et al. [29]. Future research however, should further focus on empirical model development and 
testing to measure good quality paediatric EOL care [19]. 
6.5.2. Communication 
Parents consider genuine communication with sincere and honest provision of information to be most 
central [3], and lacking or poor communication were recurrent themes in the Aschenbrenner et al. [2] 
review and a recent meta-synthesis by Xafis et al. [30]. Experiences and satisfaction scores related to 
communication in this study were high. However, extreme negative outliers were present and reflected 
in the parents’ written comments about their negative experiences, where a lack of or inconsistent 
provision of information and also insensitive communication in general were predominantly 
described. Similar complaints were also described in a meta-synthesis on the information needs of 
parents facing an EOL decision for their child [30]. Even though it might affect only a few parents, 
these experiences should not be taken lightly as their negative impact can last for years after the 
traumatic event. 
6.5.3. Shared decision making 
Consistent with our findings, a majority of paediatric deaths occur in the ICU [31], and, especially for 
neonates, these are preceded by a decision to limit or withdraw life-sustaining measures [32]. More 
than 80% of parents from the neonatal group in this study reported that the withdrawal of life-
sustaining treatment had been discussed; however only 65% indicated that they made those decisions 
in consultation with the HCT. Some parents felt that the decision was made by them alone or by the 
HCT alone. This finding contradicts what was found in a another Swiss study evaluating how EOL 
decisions were made in neonatology and how consistently a framework for structured ethical decision 
making was applied [33]. They concluded that 92% of parents were actively involved in the decision by 
having received full information about the baby’s condition, prognosis, therapeutic possibilities and 
the approach the treating team would take [33]. A Canadian study exploring processes of death in 
neonates reported that there was agreement between physicians and parents in 84% of cases where a 
decision to withdraw life-sustaining measures was made [32]. All parents in our study were also asked 
if there had been a decision concerning the potential need to resuscitate their child; 60% said there 
had been. However, one third of those parents, predominantly parents from the neurology group, 
indicated that they perceived themselves making this decision without input from the HCT. Such 
results are unexpected and call into question our perceived reality of family-centred care. The child’s 
best interest is always central in making these decisions. However, professional caregivers and parents 
have their own personal perceptions, values and interpretations of what is best for the child and the 
balance of power is not equal in this context. Following the traditional principles of bioethics may not 
ensure that parents have the opportunity to participate to their satisfaction in those important 
decisions. It might be that other communication models ensuring shared decision making should be 
considered and introduced. One such model, communicative ethics, is explained and discussed in the 
context of neonatal intensive care by Daboval and Shidler et al. [34]. It builds on the shared-decision 
model which is considered as gold standard [35], acknowledging that the decision made cannot be 
separated by the communicational process used to reach it [34]. 
6.5.4. Relief of pain and other symptoms 
Although experiences with alleviation of suffering were rated highest among the six quality domains 
and perceived satisfaction levels second highest, parents still reported that their child experienced a 
wide variety of stressful symptoms, indicating that significant symptom burden is present at EOL [36]. 
Breathing changes are part of the dying process and were probably witnessed by most parents. Even 
though it is recommended that parents be informed about what physical changes to expect when their 
child is dying, witnessing this process remains very stressful. In a US study with 50 bereaved parents 
of children with cardiac diagnoses, breathing difficulties were associated with considerable suffering in 
77% of the 30 parents who reported that symptom [15]. Pain was another frequently reported 
symptom in our study and experiences related to pain management were rated lowest by parents from 
the neurology group. This reflects the tremendous challenges we face when caring for nonverbal 
children with a variety of neurological impairments [37]. 
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6.5.5. Continuity and coordination of care 
Continuity and coordination of care is recognized as an important factor in promoting caring, reducing 
parental frustration, and enhancing parents’ confidence in the quality of their children’s care [38]. 
Experiences as well as perceived satisfaction with this aspect of care were rated lowest of all domains 
by parents in this study and point to an area with a need for substantial improvement. Supported 
transition between inpatient, outpatient and home care is essential to high quality EOL care [4]. This 
however, requires appropriate structures concerning health care services and professional palliative 
care support. While parents in our study felt most supported by a hospital-based physician or nurse, 
many felt left alone. Community-based nurses and PCPs only played a minor role. The latter was also 
described in a study that explored the involvement of PCPs when their patients faced the EOL [39]. 
The fact that multidisciplinary PPC teams only exist in three Swiss paediatric hospitals and only 18% 
percent of all parents reported having received specialised PPC services might contribute to our study’s 
findings.  
6.5.6. Bereavement support 
Continuity and attention remain important after the death of the child. Parents described great 
appreciation for staff sending cards or attending the child’s funeral and said that the loss of this 
connection added to their bereavement [38]. Interpreting our study’s findings, this might be especially 
true for parents of a child with cancer who, although the palliative care period tends to be rather short, 
experience a long illness/treatment phase with many hospital stays in a dedicated paediatric oncology 
unit, creating a special bond between the family and the HCT [40]. Only half of our parents from the 
neurology group reported having had a follow-up consultation with the former treating 
team/physician. We cannot conclude whether this reflects those parents’ wishes or rather highlights an 
area for improvement. Several other studies, however, indicate that parents value the HCT following 
up with them, that they need help in preparing for what to expect at the time of death, including 
funeral arrangements, and that they want bereavement services to be available immediately after their 
child’s death [4]. As also reported by the parents in our study, many desire contact and peer support 
from other families who have lost a child [40]. 
6.5.7. Positive and negative experiences and quality of life 
The death of a child disrupts the parents’ well-being and can influence various areas of their personal 
lives and their quality of life (QoL) [41]. The perception of the quality of medical care has been 
described as a factor associated with psychosocial morbidity in parents who have lost a child due to 
cancer [42]. The parents from the oncology group in this study reported the most positive experiences 
and the highest perceived satisfaction with care. The finding that they reported the lowest current QoL 
of diagnostic groups was therefore surprising. A similar result was found by Bergstraesser et al. [43] in 
their study of dyadic coping of parents, where mothers from the oncology group had poorer 
psychosocial health than fathers and parents from other diagnostic groups. Further exploration of our 
results revealed that income appeared to be the most influential predictor of QoL. This could in part 
explain the aforementioned finding, since parents from the oncology group were more frequently in 
the lower income category. Interestingly, financial strain was described as a major burden for families 
of children with life-threatening illnesses in Western Australia [14]. The study reported that families in 
the non-cancer group experienced a high degree of financial strain, which is congruent with our 
findings that the neurology group reported finances as an area negatively influenced more often than 
did parents from the other diagnostic groups. Although expenses in this patient group are mostly 
covered by the Swiss Federal Invalidity Insurance, refund processes seem to work very slowly and 
putting parents in an economical burdening situation. In addition, financials strains in these families 
are also due to the duration of care and the fact that one parent will be fully absorbed by the task of 
care, leading to loss of earning. 
6.5.8. Limitations 
Although a high percentage of parents completed the questionnaire, generalisability might still be 
limited as only parents who had previously provided informed consent received the questionnaire. Our 
participation rate of 51% lies within a wide participation range from below 20% to up to 80% reported 
in other studies with bereaved parents [1, 29, 44]. Our findings might be biased in that only parents 
with favourable experiences may have been motivated to participate. Also, the requirement of being 
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proficient in German, French or Italian excluded some migrant residents representing cultural 
minorities. The retrospective nature of this study could have introduced a recall bias and parental 
perceptions of care could have changed over time. However, during the cognitive testing phase of 
questionnaire development, remembering details of the devastating experience of losing a child was 
not a problem for participants [19].  
6.6. Conclusions 
Our findings show positive parental experiences of their child’s EOL care and high perceived 
satisfaction with the care their child received. In the context of this national study with heterogeneous 
inpatient and community care settings the differences between the four diagnostic groups were small 
and within one scoring category. Nevertheless there are some areas worthy of our attention. Parents of 
neonates reported significantly lower experience ratings related to shared decision-making. As these 
parents mostly face a decision to withdraw life-sustaining measures, particular attention should be 
paid to shared decision-making processes. Apparent consensus between the parents and the HCT does 
not imply that the process was well perceived by the parents. Differences as to how discussions went 
and on the opportunities or time available might be present. 
Parents of children with neurological impairments face many challenges. Symptom 
management can be a source of distress for parents, as the children are mostly nonverbal and the 
potential for suffering is high due to a variety of impairments. This makes them dependent on a variety 
of different care services, which creates a highly complex care environment with a great need for 
continuity and coordination. Experiences with continuity and coordination of care were rated lowest of 
all quality domains by parents from all diagnostic groups, and perceived satisfaction with care within 
this domain was lowest as well. This might be the direct result of lacking specialised PPC services. We 
have to recognize that the integration of specialised PPC has the potential to minimise lost 
opportunities for supporting and assisting parents. This has been acknowledged by policy in many 
countries and there is a growing availability of specialised PPC programs worldwide; unfortunately 
Switzerland lags behind in this area. 
However, the development and implementation of needs-driven and specialised services will 
fall behind if the benefits of these services are not evidenced in the near future. Structural evaluation 
and performance data provide one part of the evaluation. However intervention research is needed 
evaluating processes and outcomes that are meaningful to patients and their families, siblings 
included. Promoting the best possible outcomes after such a devastating experience has implications 
for the whole family, the healthcare system and society. 
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Chapter 7  
Synthesis and Discussion 
How to best care for children at their EOL and provide support for their families, which have to endure 
a most painful event that is considered to create a ripple effect of grief for the rest of their lives [1]? 
There is no easy and simple answer to this question and with answering one, more questions arise. 
This dissertation project, as part of the nation-wide PELICAN study, provides comprehensive and 
direly needed information about the characteristics and circumstances of childhood deaths due to a 
life-limiting CCC or prematurity in Switzerland. It allows invaluable insight into the experiences of 
parents and produced a promising instrument for future use in initiatives to improve paediatric EOL 
care in heterogeneous healthcare settings internationally. 
7.1. Key findings 
In a population-based sample of 149 children including prematurely born babies, 62% died in an ICU, 
84% of them following the withdrawal of life-sustaining treatment. Only 17% of the children died at 
home and 48% (n = 72) spent at least one day at home during the last four weeks of their life. Half of 
those 72 children received professional community care services. EOL care was characterized by a 
variety of prevalent symptoms, on average 6.42 symptoms per patient, and intensive treatments with 
high medication counts. Parents rated their experiences with their child’s EOL care mostly positive, 
with high satisfaction with care. Among the six quality domains that structured the questionnaire, 
continuity and coordination of care was rated lowest in regard of experiences and satisfaction with 
care as well. Relevant differences between the diagnostic groups could be demonstrated and were most 
accentuated between the neonatology group and the other groups. 
7.2. Parental experiences, needs and satisfaction with care as measures of quality of 
care 
Quality of care is a complex construct and can be assessed on different levels within the healthcare 
system and from different perspectives. Information from which inferences about care quality can be 
drawn were most famously conceptualised into the tree categories of structure, process and outcome 
by Donabedian et al. [2]. The expression of satisfaction or dissatisfaction represents the patients’ 
judgement on care and is considered by some as an outcome measure of the care received [3, 4]. 
Although, Donabedian et al. [2] stated that satisfaction with care concerned mostly interpersonal 
processes as part of practitioner’s performance in delivering health care and is therefore a measure of 
the process of care. Satisfaction with care, including the perspective of relatives, might be even more 
important in the field of palliative and EOL care, where outcomes such as mortality, recovery or 
readmission rates are inappropriate [5]. However, confusion between patients’ satisfaction and the 
actual care experiences exists and these concepts are often used interchangeably [6]. Additionally, 
ceiling effects, i.e. high satisfaction with care ratings that reduce the ability to discern differences, are 
an inherent problem when measuring satisfaction with care [5]. 
7.2.1. Parental experiences and satisfaction with care 
As discussed in chapter 6, parental experiences as measured by asking specific questions organised in 
scales with an adjectival response option showed more variable results within and between the six 
quality domains as the corresponding single satisfaction question for each domain. Also, the pattern of 
responses was not consistent between experience scores and satisfaction scores. Therefore it seems 
that parental experiences and satisfaction with care might be two distinct constructs. This assumption 
was recently supported by a series of studies as part of a doctoral thesis covering patients’ perceptions 
and satisfaction of care in hospitals [6]. A lack of theoretical underpinning in the measurement of 
satisfaction in healthcare was recognised. Nevertheless, a relationship between satisfaction and the 
fulfilment of expectations has often been hypothesised, meaning that one is satisfied when he gets 
what he expects [5, 7]. If this assumption held true, high satisfaction levels with little variance should 
be expected when evaluating paediatric EOL care as families’ expectations during this most stressful 
phase might be inherently low. Additionally it could then also be questioned whether satisfaction with 
care really measures quality of care or whether it is not rather just an indication of better experiences 
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than expected [5]. The question then arises of what influences patients’ satisfaction with care? When 
used as a construct to assess quality of care, it is important that the services received rather than 
external factors, i.e. socio-demographics, determine levels of satisfaction. In our study we did not 
explore the relationship between socio-demographic factors such as age, gender, educational level of 
participants, or family income. These factors however, have been studied in the past with inconclusive 
results [5, 8] and it remains uncertain what factors mainly determine satisfaction with care. In that 
sense, assessing parental experiences in the context of paediatric palliative and EOL care, and possibly 
even in general, seems to be a valid and appropriate approach to measure the quality of care processes. 
7.2.2. Parental needs 
In addition to the quantitative assessment of parental experiences we strived to integrate specific 
closed questions concerning parental needs. In our conceptualisation of the PaPEQu we theorized that 
specific parental needs related to their child’s EOL care would emerge based on how they experienced 
the professional care they received. This is an opposite view on needs than for example described in 
Maslow’s hierarchy of human needs [9], where needs are inherently present. Following our mental 
framework, we wanted to assess the importance of needs as a result of experiences made. This led to 
the formulation of items asking about the importance of specific needs in the conditional mood. 
Importance ratings assessing parental needs have been used in paediatric research before. The “needs 
of parents of hospitalised children” (NPQ) is an instrument developed by Kristjánsdóttir [10] that has 
been used in different countries and languages [11]. The comprised needs statements used a two-part 
item response format rating the importance and fulfilment of needs [10]. The same response format 
was also taken up by Meert et al. [12] for their BPNA questionnaire that assesses parental needs and 
fulfilment around the time of their child’s death in the PICU.  
Our results of the needs-related items in the PaPEQu, assessing importance of needs parents 
would have had based on their experiences made during and after the EOL of their child, showed high 
ceiling effects and little variation across the four diagnostic groups. Similar effects were found when 
applying the NPQ questionnaire as none of the needs statements were rated as unimportant [10]. The 
high importance ratings and the fact that we did not assess to what extent the needs were met limited 
the interpretation of the results of this part of the PaPEQu. It became apparent that healthcare 
provided not only determines what needs are expressed but also to what extent those needs are met 
[13]. 
7.2.3. Reflections on the Parental PELICAN Questionnaire (PaPEQu) 
Initial validity of the six evidence-based quality domains that structured the PaPEQu was 
demonstrated in our instrument deveopment study. This study’s results were partly confirmed by the 
testing results of another recently developed instrument to measure the quality of children’s EOL care 
[14]. The six subscales that initially structured that other, similar instrument overlapped with five of 
the six PaPEQu domains: support of the family unit, communication, shared decision making, relief 
of pain and other symptoms, and bereavement support (continuity and coordination of care 
missing). Exploratory factor analysis during their phase two of instrument development revealed four 
additional domains related to individual support to the child and siblings, and to information sharing 
among health professionals and structures of care [14]. One important difference to the PaPEQu that 
stands out is the integration of the siblings’ perspective, even though not self-reported but as reported 
by mothers. There is no question that special attention is required to meet the needs of siblings of a 
dying child and a few issues related to that will be covered in paragraph 7.3. 
A major weakness of the PaPEQu lies in our operationalisation of parental needs. Assessing 
only the importance of needs derived from experiences does not capture the needs construct in its 
entirety and in the context of healthcare evaluation, assessing the level of need fulfilment may 
represent the quality of services provided. 
Although the PaPEQu will need some revisions for future use, the instrument shows promise 
in moving forward towards a valid measure of processes of paediatric EOL care. The burden of 
participating in a questionnaire survey should not be underestimated for bereaved parents and 
professional support should be offered for anyone in need. The questionnaire response rate of 89% of 
parents that consented to participate beforehand however, is an indication that parents are motivated 
to contribute. 
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7.3. Siblings 
Siblings are often referred to as “shadow children” as they tend to become invisible as a consequence 
of their parents’ enormous investment in caring for the ill child. The effects on psychological well-
being and functioning in siblings of children with CCC have been summarised regularly in meta-
analyses and integrative reviews and the conclusion is that those siblings were more at risk for 
psychological problems [15-17]. Obviously this evidence is based in the field of psychology; a 
circumstance that holds true for most existing literature around (bereaved) siblings. Clinical (nursing) 
research on bereaved siblings is extremely scarce. However, certain issues related to siblings of a dying 
child have been described in various books [18-20]. How children perceive and understand the illness 
trajectory and -experience of their dying sibling and the parents’ reactions, hugely depends on their 
own age, i.e. developmental stage [21]. Helping small children “understand” is challenging and often 
perceived as futile. However, creating confusion and actions of ignorance add to the feeling of 
“hurting” in the sibling. Parents and healthcare staff also are often reluctant to involve the sibling(s) 
into the dying child’s care, trying to protect them from trauma. Unfortunately this reinforces the 
siblings’ feelings of “not belonging” and “not being enough” [20]. Siblings who lost a sister or brother 
due to cancer - as participants in a qualitative study - expressed their dissatisfaction concerning 
information and support they received and their involvement in the dying process [22]. Those feelings 
of abandonment can persist long into bereavement and it is important that the needs of siblings are 
recognized and support is offered [18]. 
In striving to provide holistic and good quality family-centred paediatric EOL care it seems 
apparent that the siblings’ perspective should be part of care evaluation. If not, we continue denying 
them the opportunity to voice their experiences and a piece is missing towards a family systems 
perspective. However, including children in research opens a whole new dimension of ethical 
considerations which are challenging to address. It also remains unclear whether parents would be 
willing to let their healthy children participate in research projects. A recent UK study to explore 
parents’ and young people’s perspectives of hospice support, including siblings aged eight years and 
above, achieved approval from the ethics committee. In the end however, the researchers were unable 
to recruit any siblings to take part in the study. Unfortunately, no explanation was provided [23]. 
7.4. Paediatric EOL care in distinct diagnostic groups 
Based on diagnoses mainly responsible for childhood death due to a life-limiting CCC or prematurity 
we classified the PELICAN study patients into four distinct diagnostic groups: cardiology, neonatology, 
neurology, and oncology. The neonatology group comprised all newborns between 1 and 28 days of 
age, independent of their medical diagnoses. The neurology group was the most heterogeneous, 
including patients with endocrine, nutritional, metabolic diseases and diseases of the nervous system, 
and congenital, chromosomal conditions. Comparisons between these four diagnostic groups in regard 
to parental experiences and care practices highlighted relevant differences adding to the body of 
scientific knowledge. 
7.4.1. Cardiology 
Children with congenital heart conditions and diseases of the circulatory system represented with 19 
patients (13%) the smallest of the four diagnostic groups in the PELICAN study. This small number 
however is biased by the fact that all neonates that died within their first four first weeks of life, were 
assigned to the neonatology group per study definition. Five patients in the neonatology group 
suffered from a congenital heart disease.  
EOL care in the cardiology group was characterised by a high dependency on intensive care; 
more than half of the patients received medical treatment requiring anaesthesia, mostly for surgery, 
37% needed cardiopulmonary resuscitation at some point and 21% were dependent on extracorporeal 
membrane oxygenation (ECMO). Medication count in the last week of life was highest compared to all 
other diagnostic groups. This can be explained by the higher rate of cardiopulmonary resuscitation in 
this group compared to the other groups, which is associated with a long list of as needed drug orders. 
Consequently, 67% of the patients died in a PICU. Comparable evidence about practices at EOL for 
children with cardiac disease is rare. Only one study was found that looked at patterns of care at end of 
life in children with advanced heart disease [24]. Accounting for the different inclusion criteria in that 
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study where only children who died in the hospital were included, that study’s results were very 
consistent with ours [24]. 
The illness trajectory and progression of paediatric advanced heart disease is highly variable 
and often unpredictable. With advancements in surgical techniques and the broadening of treatment 
options the impression might form that “broken” hearts can always be fixed. Timely initiation of PPC is 
challenging in this context. Rather than finding the “right moment” during the hectic phase of a 
declining health status, PPC should be an integral component from the moment on a child is 
diagnosed with a complex congenital heart disease. The PELICAN I study showed that especially for 
children in the cardiology group, this is often the case already before birth. Through a recent review 
about palliative care models in the perinatal setting it has been recognised that the antenatal period 
should also be considered [25]. The authors found evidence that antenatal palliative care have been 
explicitly organised in PPC programmes in some cases and that the concept was mentioned in 27 of the 
101 articles included in their review. They concluded that antenatal palliative care is the latest 
advancement in the conceptual evolution of perinatal palliative care that started with pain relief and 
evolved from family-centred to integrative care during the last decades [25].  
Synthesising the scarce evidence about the characteristics and circumstances of death in 
children with severe cardiac problems it seems obvious that considerable suffering is involved. The 
association between high intensity care and suffering has been suggested in children with cancer at 
their EOL [26]. It would be important then that PPC were an integral part of the treatment concept in 
children with congenital heart disease, starting early on and also in cases where the possibility of a 
“curative” surgery exists. 
7.4.2. Neonates 
Neonates constituted the largest group in our study which is in accordance with what is already known 
about conditions and diseases responsible for childhood death [27]. This patient population was 
different from the other diagnostic groups on several levels; time between diagnosis and death was 
with several days the shortest by far, almost all neonates died in an ICU, were mechanically ventilated 
and most relevantly, death was preceded by a decision to withdraw life-sustaining interventions in 91% 
of the cases. Making those decisions is challenging for the HCT involved and certainly most difficult for 
parents who might feel that they have to decide over life and death of their child during a phase of time 
that is characterised by immense vulnerability and uncertainty. Parents in the PELICAN II study rated 
their experiences with shared-decision making significantly lower than the parents from the other 
diagnostic groups. However their satisfaction with care rating for that quality domain was not below 
the whole group’s average. A circumstance that might best be explained with the presence of low 
expectations as discussed in chapter 6. 
Possible factors that affect parental decision-making for medically complex infants have been 
synthesised in a recent integrated literature review including 31 articles from the years 2000 to 2013. 
One major theme of factors influencing the parents’ ability to make decisions was “communication” 
including information needs and the delivery of needed information [28]. The need for compassionate 
communication, building on trust between the family and the healthcare team is well known and is a 
main component in the framework of good quality paediatric EOL care that structured the PaPEQu. 
The concept of shared-decision making incorporates communication processes between the HCT and 
the family, and builds on a trustworthy relationship. Contrary to other models of decision-making, 
information sharing between the healthcare professional and the family is a continuous mutual 
process. Both the professionals and the family bring in their own expertise, experiences and attitudes 
and decisions are made in partnership [29]. Whether the shared-decision model could be 
implemented in neonatology has been reflected upon in the past, with the conclusion that the attempt 
to achieve a joint decision should be made [30]. Several studies reported on high percentages of active 
parent involvement in decision-making in the NICU setting [31-33]. Although it has been described 
that ethical guidelines regarding the withdrawal of intensive care are being followed [32], this does not 
automatically imply that shared-decision making as a process of care was applied. It therefore remains 
unclear to what extent the concept of shared-decision making is integrated in neonatal palliative care 
in Switzerland and how this might be associated with the experiences of parents from neonates in the 
PELICAN II study. 
 Page 85/100 
Further exploration of possible factors influencing parental decision-making is indicated to 
explain the significantly lower experience ratings found in parents of neonates compared to the other 
parents participating in the PELICAN II study. Other factors than the ones related to “communication” 
that were described in the abovementioned review were: factors related to the child’s condition and the 
availability of treatment options, the child’s best interest, religiosity and spirituality, and parental 
factors such as sociodemographics [28]. As some of this information is available from the PELICAN 
datasets, future secondary data analysis could potentially add further insight on this issue. 
7.4.3. Neurology 
The primary diagnoses of the patients in the neurology group were more diverse than in the other 
diagnostic groups. Most of the represented diagnoses affect the central nervous system leading to 
physically and cognitively severely impaired children with many distressing symptoms [34]. For most 
of those conditions cure is not possible, disease progression is variable and the decline in health can by 
slow. Life-threatening health exacerbations are part of the illness trajectory and it is often not possible 
to know when the next event might end in the death of the child [34]. Apart from the “continuity and 
coordination with care” quality domain, parents of children in the neurology group rated their EOL 
care experiences consistently lower compared to the other parents and their satisfaction with care was 
generally lower as well. They also reported more often than all other parents, that their family’s 
financial situation was negatively influence by the child’s illness and death. The long illness duration 
seen in children with neurological conditions usually leading to the full absorption of one parent and 
together with rigid and slow insurance refund processes make those families especially susceptible for 
financial strains, constituting a problem that has been described outside of Switzerland as well [35]. 
Based on these patient’s population illness trajectories with high care dependency over longer 
periods of time, families of a child with a life-limiting neurologic condition may benefit tremendously 
from PPC services. Benefits of PPC specific to this group of patients were synthesized recently and 
included fewer invasive interventions at the EOL, decreased hospital length of stay, and improved 
symptom management [34]. Symptom control to establish comfort in these patients is challenging as 
they suffer commonly from neurologic symptoms such as spasticity and dystonia [36]. These type of 
symptoms lead to significant physical discomfort, i.e. pain, which is probably under-recognized and –
treated as these children are commonly not able to express their discomforts verbally [37]. 
Spasticity/dystonia was more frequently documented in children from the neurology group compared 
to the other diagnostic groups in the PELICAN I study. However, the prevalence of 28% was not high 
and an under-documentation of these symptoms should be assumed. Interdisciplinary teamwork 
including the expertise of the child’s parents is highly recommended in managing the complex 
symptomatology of children with severe neurologic impairment [36]. 
Many of the other discussed benefits and also barriers from the Hauer & Wolfe article [34] are 
transferable to our entire study population and the relevant issues will be discussed under paragraph 
7.5. about the provision of paediatric EOL care in Switzerland. To conclude the specificities of the 
neurologic group, it can be said that the variety of primary diagnoses leads to the involvement of 
different specialists and healthcare providers. When these providers work independently, care can be 
fragmented, adding to the family’s burden. Additionally because the care is complex and very 
challenging, healthcare professionals may reach the limit of their expertise which might negatively 
influence the validity of and certainty with end-of-life decisions. 
7.4.4. Oncology 
Experiences and satisfaction with care were rated consistently highest by parents of a child that died 
due to cancer compared to parents from the other diagnostic groups. One explanation might be that 
the care experiences from parents in the oncology group were positively influenced by components of 
standard paediatric oncology care that are also typical in the PPC model. In Switzerland, paediatric 
oncology care is provided in dedicated units situated in tertiary care centres and specialised children’s 
hospitals. Just as in PPC, care is provided by a specialised multiprofessional team including social 
workers and psychologists. The provision of in-patient care by those dedicated teams creates an 
environment of second home for families and the perceived level of support is high. Outpatient clinic 
services are sometimes directly linked to the inpatient unit and even when separated, the teams 
 Page 86/100 
collaborate. Through this mode of care delivery, fragmentation of care is much less an issue than, e.g, 
for families of a child with a neurologic condition.  
What has just been discussed stands in contrast to the lower QOL found in parents from the 
oncology group compared to the other parents. There is no reported evidence about comparisons 
between parents of children with cancer and other bereaved parents. Factors associated with 
psychosocial morbidity among bereaved parents of children with cancer however, have been 
summarized in a systematic review including 13 studies presenting results mainly from a Swedish 
registry sample (5 studies) and an Australian database sample (2 studies) [38]. Those factors included 
economic hardship, duration and intensity of the child’s cancer-therapy, location of death and the 
perception of medical care [38]. Economic hardship, i.e. lower income, was the most influential 
predictor for lower QOL in our exploratory model, but our insight into determinants of QOL in 
bereaved parents with cancer is limited as it was not one of the PELICAN study’s research question. 
QOL certainly is an important outcome in bereaved parents in general and further conceptual 
work exploring possible influencing factors including characteristics of EOL care, the parents’ 
perspectives and socio-demographic factors is indicated. 
7.5. The provision of paediatric EOL care in Switzerland 
The overall positive experience ratings and high satisfaction with care reported by parents in the 
PELICAN study seem to indicate that all is well. However, on the single item level, extremely negative 
responses were present including low satisfaction and in six cases QOL ratings below the 5th percentile. 
Examples from the listings of negative parental experiences showed that deficiencies in all of the six 
quality domains existed and we were concerned by the implication of some of the statements. 
Switzerland lags behind in the movement of PPC programme development seen internationally over 
the last decade. In the year 2015, the “Schweizerisches Institut für ärztliche Weiter- und Fortbildung, 
FMH“acknowledged and promoted palliative care as a new sub-specialty within the field of medicine 
and professorships exist at two Swiss universities. So far, only two of the five existing Swiss university 
children’s hospitals provide PPC as part of a programme with a specialised multidisciplinary team. It 
should be expected that university hospitals offer the whole range of subspecialty healthcare services, 
so hopefully more PPC programmes will be implemented in the future. This current lack of specialised 
PPC is reflected in some of the PELICAN I and II results which will be discussed hereinafter. 
7.5.1. Place of death 
Sixty-two percent of the PELICAN study patients died in an ICU. A similar high rate of 65% was found 
in a sample of 220 children that died between 2008 and 2010 and were recruited by a Canadian 
university-affiliated hospital [39]. On the one hand, this high rate can be explained by the high 
proportion of neonates and NICU deaths in our and the Canadian study’s sample. Neonates, especially 
when born preterm, are highly dependent on intensive treatment, e.g. mechanical ventilation. When 
life-sustaining treatment is withdrawn, time until death occurs is mostly short with minutes to a few 
hours (unpublished data from the PELICAN ICU sub-study). Under those circumstances, there is no 
other realistic choice of place than the hospital. On the other hand, death rate in the PICU was with 
42% higher than the proportion of NICU deaths in our study. Again, some of the patients dying in a 
PICU are preterm neonates but a substantial proportion of patients from the other diagnostic groups 
are represented as well. We were especially surprised and concerned by the 36% of children from the 
neurology group. 
Dying outside an ICU has been associated with the receipt of PPC. A retrospective study 
compared demographic and clinical characteristics associated with receipt of inpatient PPC using 
routine data from 24’342 children who died between 2001 and 2011. Data was extracted from a 
paediatric health database generated by more than 40 hospitals across the US. It was found that 
overall, children who received PPC were less likely to die in an ICU [40]. Changes in place of death 
were also observed in the course of time. Another retrospective study from a US tertiary level 
paediatric hospital compared data from a cohort of 102 children with cancer who died between 1990 
and 1997 with a more recent cohort of 119 children who died between 1997 and 2004. Significantly 
fewer children from the more recent cohort died in an ICU [41]. More data from the US support this 
shifting place of death among children with a life-limiting CCC over time. In a big retrospective 
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nationwide case series drawn from the National Center for Health Statistics’ Multiple Cause of Death 
Files spanning from 1989 to 2003, it was observed that the odds of dying at home increased 
significantly each year [42]. 
It must be noted that paediatric death in an ICU does not imply poor quality of care but rather 
indicates a lack of choices presented to the families. Therefore an important mechanism explaining 
those shifting places of death for children with life-limiting CCCs can be attributed to elements of 
advanced care planning. 
7.5.2. Advanced care planning 
Advanced care planning, i.e. planning for care at EOL is a core element of PPC and has been described 
and recommended by the 2003 Institute of Medicine report “When children die” [18]. The purpose of 
care planning is to offer choices to families and to set goals applying a family-centred and integrated 
model of care [18, 43]. Advanced care planning has been linked to earlier discussions about the child’s 
EOL including preferred location of care and death, and earlier documentation of do not resuscitate 
(DNR) orders before death [41, 44]. Advanced care planning can only succeed when crucial goals and 
decisions are well documented and available to the range of providers that are involved in an 
individual’s child EOL care. In a recent chart review including a set of 114 notes relating to a cohort of 
48 children from the UK who died between 2008 and 2010 within a defined geographical area, it was 
found that current documented EOL care planning varied between services [44]. When plans were 
documented, the information was often unstructured and in narrative form buried in the patient’s 
healthcare record. Even though certain templates for DNR orders or child and family wishes existed, 
their existence alone did not ensure its adoption into practice [44].  
The involvement of different healthcare providers creates not only challenges regarding the 
planning and documentation of care but the provision of continuous and coordinated care in general, a 
domain identified as being important to families of a dying child [45]. 
7.5.3. Continuity and coordination of care 
Parental experiences as well as satisfaction with care related to continuity and coordination of care 
were rated lowest among all six quality domains in the PELICAN II study. Many of the listed negative 
experiences related to relational aspects of continuity of care such as frequent changes of physicians 
and nurses. Continuity of care has been conceptualised and three types were identified: (1) 
Informational continuity; (2) Relational continuity; and (3) Management continuity [46]. Relational 
continuity refers to “the importance of knowledge of the patient as a person; an ongoing relationship 
between patients and providers is the undergirding that connects care over time and bridges 
discontinuous events.”[46, p. i]. 
Since so many patients spend substantial time during their EOL phase in an ICU, relational 
continuity in this care setting seems particular relevant. The delivery of continuity of nursing care in 
the PICU from the perspective of both parents and nurses was recently explored in a qualitative study 
from the USA [47]. The authors concluded that the family’s desire for continuity of care often 
competed with how care is structured in the PICU environment. As PICUs are mostly part of a 
teaching hospital, the learning needs of the staff members often took precedence over relationship 
development and skill development was of primary importance. The authors however agreed that the 
origins of deficits in relational continuity was likely multidimensional and aspects like staffing 
fluctuations and fear of emotional entanglement added to the discrepancy of parental needs and the 
ability of nurses to meet those needs [47].  
If and to what extent that study’s result are transferable to experiences of the parents 
participating in PELICAN II is arguable. For a deeper insight and understanding of the PELICAN II 
results related to continuity of care, the results of the qualitative study arm will be connected and help 
explaining this quantitative result (not part of this dissertation). As for care coordination, this aspect 
becomes most relevant when several providers are involved in caring for the child and his/her family 
and especially, when outpatients care, e.g. home-based care is available. 
7.5.4. Home-based PPC 
Derived from the high proportion of hospital deaths in the PELICAN study, only a few children (17%) 
died at home. A higher proportion of 48% of the patient spent at least one day at home during the last 
four weeks of life, and half of those, received home-based nursing care. Only half of the children who 
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spent some time at home during their EOL phase receiving professional home care seem to be a low 
number. Based on these quantitative results we could not infer whether this circumstance reflected the 
family’s choice or was rather a result of limited access. Absence or inadequate home care services was 
identified as one of several barriers for EOL care at home in the PELICAN HOME sub-study based on 
single interviews with parents who cared for their dying child at home (unpublished result). Paediatric 
community care organizations providing paediatric care are well established in Switzerland. They are 
however massively challenged by funding structures and processes resulting in lacking compensation, 
and are often limited in their geographical and daytime range of action. These limitations collide with 
the major need of families for individually tailored support and flexibility in care during the EOL phase 
of their child. In a recent integrative review aiming at identifying the key elements of optimal models 
of paediatric palliative care, access to a specialised paediatric team was considered crucial by parents, 
as was specialist support around the clock [48]. A positive impact on the QOL of children and their 
parents and on the burden of home care for families of severely ill children has been demonstrated by 
the provision of paediatric palliative home care by a specialised team [49]. The team under inquiry was 
established at a centre for PPC in Germany and consisted of trained specialists in PPC such as 
paediatricians, nurses, a social worker and chaplain. A 24/7 on-call service, psychosocial support and 
coordination of care were the team’s main tasks besides the provision of medical and nursing care 
[49]. 
Our study results indicate that the family’s need for access to specialised EOL home care 
services is not met. Home is the preferred place to be for most children, but without appropriate 
support at home, parents might opt for hospital care instead. 
7.6. Strengths and limitations of methods used 
This dissertation was part of the nationwide PELICAN study, an extensive and comprehensive needs 
assessment of paediatric EOL care needs in Switzerland. Some of the PELICAN study results are 
influenced by the context, in which care is provided, e.g. health care system, care models. This limits 
generalisability internationally. However, the diagnostic group categorisation and group comparisons 
generated knowledge that is novel and valuable for healthcare providers offering services within the 
entire field of paediatrics, as is often the case for specialised PPC teams. Strengths and weaknesses of 
the single studies have been described in chapters 4 – 6. Apart from that, some topics warrant more 
emphasis and will be further discussed in the next paragraphs. 
7.6.1. Recruitment and study participation 
The major strength of the PELICAN study was the inclusion of all children who died due to a life-
limiting CCC or prematurity, covering all major conditions responsible for childhood death. 
Additionally, the study was conducted in the entire country including patients and families from all 
main Swiss language regions. Thus, the results provide urgently needed information that is 
representative for Switzerland. Recruitment was conducted by all Swiss children’s hospitals and 
paediatric community care organisations. In Switzerland, treatment of children with a life-limiting 
CCC is organised by hospital-based paediatric specialists. Hence we are confident that all children 
matching the PELICAN study’s inclusion criteria were identified and that the sample can be 
considered population-based. However, it is known that clinicians, by knowing their patients and their 
families, sometimes decide that research participation might not be reasonable for certain families. 
They then act as gatekeeper and impede recruitment of those families [50]. We are aware of only one 
example, where this was the case in the PELICAN study. Another potential source of bias lies in study 
participation, and this was a more realistic threat in the PELICAN study. Study results might have 
been biased in that only parents with favourable experiences may have been motivated to participate. 
In accordance with ethical guidelines, study participation was entirely voluntary and we did not ask for 
reasons of non-participation. 
The requirement of being proficient in German, French or Italian excluded some migrant 
residents representing cultural minorities in Switzerland. This is of concern as notable differences in 
location of death across racial and ethnic groups in the US have been described in children with life-
limiting CCCs in general [42], and recently again in children with cancer [51]. This raises questions 
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regarding equity of paediatric EOL care which need to be addressed in future evaluation of care and 
research. 
7.6.2. Questionnaire development and testing 
For the development and testing of the PaPEQu, rigour procedures were applied following existing 
recommendations. The questionnaire will need revisions for future use, mainly due to the conceptual 
weaknesses related to the assessment of parental needs. Nevertheless, the PaPEQu shows promise as a 
tool to retrospectively assess the parental perspective of EOL care their child and family received.  
The PaPEQU was developed in German and content validity was established before translation 
into French and Italian. In the following pilot test including parents that lost their child in 2010, the 
sample for the French version was small and in the Italian-speaking part of Switzerland no childhood 
death was registered for that year. Although we emphasized the harmonisation step during the 
translation process ensuring that there were no translation discrepancies that arose between the 
different languages, content validity of the French and Italian PaPEQu versions is not fully established 
and the instrument should not be used to explore differences in paediatric EOL care between the three 
main Swiss language regions. 
7.7. Implications for policy, practice and future research 
Fortunately rare, childhood deaths due to illness or prematurity are still a reality and part of our health 
care system. Advances in medicine and technology, lacking awareness in society and a social 
perception of unnaturalness when a child dies all contribute to the medicalized deaths we see in 
paediatrics today. The contribution of lacking PPC models in Switzerland, incorporating advanced care 
planning, is however, equally important. The PELICAN study provides urgently needed country-
specific basic knowledge which allows for planning and implementing the next steps in improving 
paediatric EOL care in Switzerland. 
7.7.1. Policy 
The gaps related to paediatric PC have been recognised in the” National Strategy for Palliative Care 
2013-2015” [52]. In the framework of the Federal Office of Public Health that guides implementation 
of PC in Switzerland, PPC is categorized on the level of specialised care [53]. This means that in order 
to meet the complex health care needs of those patients and their families, a specialised HCT should be 
available. Specialised teams are formed by specialised professionals, and specialised professionals are 
formed by appropriate education and training. With the promotion of PC as medical sub-specialty and 
the creation of professorships at universities, palliative medicine started to be incorporated into the 
formal medical training. Similar offerings for nurses however are still vastly missing. The 
incorporation of PC in non-university health and social professions is part of the action plans within 
the sub-project “Training” of the ”National Strategy for Palliative Care 2013-2015” [52]. Also, in 
accordance with the multiprofessional approach of PC, efforts to create shared training for different 
professional groups seem to be the way to go. On how this will be achieved however, remains to be 
seen. 
Another development on the national and cantonal level(s) of Switzerland involve tarification 
of PC with the goal to create a performance-related structure that is uniformly applicable throughout 
Switzerland [52]. This is an important and needed endeavour as specific PC interventions are not 
represented well enough in existing codes. As always in these matters, professionals involved are 
challenged to ensure that paediatric specificities are represented as well, which was a problem in the 
past and stands out to be an issue in PC as well. 
7.7.2. Practice 
Elements of optimal PPC for children and young people have been described based on an integrative 
review including empirical studies that reported primary data evaluating models of PPC from the 
perspectives of children or parents [48]. The elements identified as most important were “access to 
tailored support including flexibility in location of care, psychosocial care, 24h specialist support, 
respite care and support for siblings” [48, p. 430]. A consultative model of PPC, comprising a 
multiprofessional team of PPC specialists that provide specialist support and advice to the child’s 
primary care team, might be well suited to address those identified elements. Concepts to such an 
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approach exist and are implemented in only three children’s hospitals (only two among the five Swiss 
university hospitals). Nevertheless, together with the PELICAN study results, those examples can serve 
as a good starting point in promoting and supporting further initiatives on the of hospital level and 
possibly on a regional or national level.  
Flexibility in location of care and 24h specialist support have been identified as important 
elements of PPC and our study results raised important questions in terms of home-based care in 
Switzerland. The scope and range in which hospital-based PPC teams can operate need to be extended 
in order for them to reach patients at home or to collaborate closer with community-based nursing 
care and possibly general practitioners. The model from Germany described and evaluated by Groh et 
al. [49] might serve as another example to look at, as the coordination of professional assistance in 
cooperation with the local health care professionals and a 24/7 on-call service were described as main 
tasks of that multiprofessional team. Additionally, efforts needs to be put into the support related to 
financial issues. Refund processes of insurances work very slowly and put some families in situations, 
where financial shortcomings decide on location of care. 
So what can be recommended to the individual health care provider who is inherently 
motivated to do good and support dying children and their families to the best of their knowledge and 
skills, but within the structural and management limits sometimes present in their institutions? Not an 
easy question to answer. I would tell them to stay true to themselves and be open and honest with the 
family to build up this trustworthy relationship that is so important. And always keeping in the back of 
their minds, that only one negative interpersonal event between the child or the parent and the health 
care professional is needed for potential lasting emotional distress in parents who lost a child. 
7.7.3. Research 
To only recommend that hospitals should develop and implement a presumed state of the art PPC 
programme seems too easy in the light of the current evidence base in terms of effectiveness. One 
result of the abovementioned review describing elements of optimal PPC was, that definitive 
information on effectiveness could not be provided due to the lack of high quality data [48]. In a 
performance-oriented health care system where financial resources are always in short supply and 
medical successes are cherished, for a hospital to decide to invest in PPC seems to be a tough call. A 
scenario in which solid outcome measures put the child and his/her family at the centre of care and 
demonstrate what meaningful differences PC can make might influence how funding is allocated. The 
call for introducing outcome measurement into practice has been issued by the task force on outcome 
measurement of the European Association for Palliative Care (EAPC) in their White Paper publication 
[54]. Concerning PPC it was mentioned that due to age- and cognitive function-related specifics in 
paediatrics, outcome measurement is particularly challenging and should be extended to parents and 
siblings [54]. Common outcome measures applied in adult PC include multidimensional tools to assess 
symptoms, distress and functioning indifferent areas. Although systematic pain assessment is well 
established in paediatrics, valid multidimensional tools for palliative care in children could not been 
identified by the EAPC task force [54]. 
Due to the particular situation in paediatric palliative and EOL care, where a child passes away 
early and leaves behind parents and siblings, it is my strong opinion that evaluation of PPC and EOL 
care has to go beyond measuring outcomes on the patient level. “Patient”-reported outcome 
measurement has to be extended and applied on the family level. However, consensus on meaningful 
outcomes on the family level has not yet been found. Self-reported QOL of parents and possibly 
siblings seems relevant and has been used before to evaluate PPC services [49]. However, I believe the 
mechanisms determining QOL are not yet well understood and should further be explored. This holds 
also true for satisfaction with care, considering the conceptual deficiencies described in paragraph 
7.2.1. Themes of needs most important to parents are well defined and can be compiled to build a 
construct of good quality EOL care. The contribution and therefore importance, of each of the various 
domains to the construct however, is not yet clear and should further be tested. Further exploratory 
research to better define and establish measurement constructs should eventually evolve into 
intervention and the drawing of causal conclusions. 
Following the multiprofessional approach in PC practice, I strongly support 
interprofessionality in research as well. The perspectives of e.g. physicians, adds to the relevance of 
questions asked. Related to EOL care outcomes, a special benefit could lie in the collaboration with 
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psychologists. Bereavement research, which is occupied by the discipline of psychology, should be part 
of EOL care evaluation as bereavement support is an integral part of PPC. Considering that 
bereavement might be influenced by experiences made during the EOL of the child [1], it would be 
interesting to further explore factors influence that some families do better than others. 
7.8. Conclusions 
PPC has emerged as a medical subspecialty over the last decade. I builds on the principles of respect 
and dignity, focuses on ensuring the best possible QOL of life for the child and his/her family by 
extending beyond the physical domain into psychosocial and spiritual wellbeing [55]. To eventually 
grow out its infancy, PPC practitioners are challenged by demonstrating effectiveness of their services 
in performance-oriented healthcare systems with scarce resources. 
The PELICAN study helped define the Swiss population in regard to the characteristics of 
children dying in various diagnostic groups, their circumstances of death and the experiences of their 
parents during the child’s EOL care. This so far missing basis of data is needed to plan and implement 
a needs-driven and evidence-based model of PPC for Switzerland. 
The inclusion of all relevant diagnoses responsible for illness-related childhood death and 
preamaturity allowed comparisons between four distinct diagnostic groups. This approach provided 
novel information related to circumstances of death and symptoms, and related to the parental 
perspecitve of their child’s EOL care, which is valualbe to health care providers involved in paediatric 
EOL care worldwide. 
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